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Abstract
Intensive, community-based, prospective studies have become increasingly 
popular for the study of the common diseases of childhood (diarrhoea, 
respiratory infections and malaria). The wealth of data collected in these studies 
permits the estimation of a range of outcome measures describing the incidence, 
prevalence and duration of disease. However, standard epidemiological and 
statistical techniques for the analysis of prospective studies were conceived with 
rare and non-recurrent diseases in mind, and their application to the case of 
common diseases is not always valid.
This thesis provides a comprehensive approach to the analysis of longitudinal 
studies of common diseases of childhood. Starting w ith recommendations for 
successful data handling, it describes the definition, evaluation and calculation of 
a number of different epidemiological outcome measures, and then proceeds to 
investigate appropriate strategies for statistical modelling. At all stages, 
differences between studies of common diseases and the more familiar rare-disease 
studies are highlighted. The implications of these features of common disease 
studies for the validity of results obtained by using ‘standard’ analytic techniques 
are evaluated. A number of more ‘sophisticated’ analytic techniques are 
compared and contrasted, using criteria specifically proposed for the evaluation 
of statistical models in epidemiology. This evaluation is based to a large degree 
on illustrative analyses, using data used collected in a trial of the impact of 
vitamin A supplementation on the health of young children in Ghana, together 
with data from a rotavirus vaccine trial in Peru.
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Wide-ranging reviews are undertaken of the epidemiological literature on 
common diseases of childhood, permitting the characterisation of the range of 
analytic practices currently encountered. Recent advances in statistical theory are 
also critically described. These insights are combined to produce a series of 
pragmatic recommendations intended as guidance for those working on 
longitudinal studies of common diseases of childhood in the field.
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Chapter 1 Longitudinal studies o f 
common diseases of childhood
1.1 Com m on diseases o f childhood
The 1993 World Development Report (World Bank, 1993) has delivered a strong 
reminder of the dramatic scale of suffering and death attributable to the common 
childhood diseases - pneumonia, diarrhoea, and, to a lesser extent, malaria. In 
1990 alone, lower respiratory infections (essentially pneumonia) resulted in 2.7 
million deaths of children under 5 in resource-starved countries, whilst diarrhoea 
accounted for a further 2.5 million deaths. Another 630,000 children died as a 
result of malaria. Of the other causes of death, only the group of perinatal 
causes approached pneumonia or diarrhoea in the number of deaths for which 
it was responsible.
The degree of suffering caused by these illnesses cannot be measured in terms of 
mortality alone; children living in poor communities are likely to experience 
multiple episodes of diarrhoea and respiratory illness each year, to the extent that 
some of them may spend as much as half the year in a state of ill health. Whilst 
the geographic bounds of malaria are more restricted, those children who do live 
in endemic areas can expea to experience one or more episodes of this illness 
also, either separately or at the same time as an episode of diarrhoea or 
respiratory illness. In order to capture the degree of disability resulting from 
illness as well as mortality, the World Development Report has attempted to 
quantify the total number of ‘Disability Adjusted Life Years’ (DALYs) lost due 
to each cause of morbidity and mortality. They found that in the 0-4 year age 
group, respiratory infeaions accounted for 18.5% and 17.6% (in girls and boys, 
respeaively) of all DALYs lost, and diarrhoea accounted for 16.2% and 15.7%
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respectively. M alaria accounted for a smaller, but still significant, percentage of 
all DALYs lost in  this age group (4.7% in both sexes).
If these illnesses could somehow be eliminated, and assuming unchanging 
mortality from other causes, under-5 mortality rates in resource-starved countries 
would fall by nearly 50%. Furthermore, it is likely that reducing the levels of 
morbidity from these common illnesses would relieve the strain on children’s 
nutritional reserves and immune system, and thus reduce their vulnerability to 
other infections also (Mosley and Becker, 1991). With such enormous gains in 
welfare potentially achievable, the development of effective interventions to 
reduce morbidity and mortality from these illnesses is a humanitarian, economic 
and political imperative.
1.2 L o n g itu d in a l studies o f com m on diseases o f  childhood
In order to develop means of reducing the burden of morbidity and mortality 
from the common childhood diseases, it is first necessary to understand their 
magnitude, distribution and pre-disposing factors. As recently as the 1950s, 
however, methods for the study of these illnesses were still poorly developed. 
It was at this tim e that researchers at the Institute of Nutrition of Central 
America and Panama (INCAP) started to plan a 5-year study of the interactions 
between malnutrition and infectious disease. They envisaged an innovative 
study, in which the health status of a group of young children would be 
repeatedly assessed at regular intervals, explaining that:
"The traditional methods of the cross-sectional nutritional survey 
and the prevalence study of infectious disease do not suffice. ...the 
significance of infectious disease often rests not so much in the 
immediate event as in the number and progression of preceding 
episodes and in their relation one to another. Measurement of the 
postulated synergistic action between infectious disease and 
malnutrition requires their concurrent study by the epidemiological
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method of long-term observation of repeated illnesses as they occur 
under natural conditions." (Scrimshaw et al., 1967).
This type of study, in which repeated observations of the same study subjects are 
prospectively recorded, is referred to as longitudinal. Longitudinal studies have 
proved to be of tremendous value in studying the common childhood diseases 
because these diseases are commonly mild and of short duration, and are thus 
rapidly forgotten by those taking care of the child, with the result that they are 
difficult to study retrospectively (Alam et al., 1989; Martorell et al., 1976). They 
can, of course, be studied cross-sectionally, but this design provides no 
information about the time sequence of risk factors and health outcomes, and 
does not allow the researcher to distinguish between children who spend large 
proportions of their time sick, and others who are normally relatively healthy, 
but just happen to be ill at the time of the survey.
Of course, a prospective study design does not necessarily imply regular contact 
with all study subjects: one alternative is simply to wait for cases to present at 
health facilities. This generally proves to be unsatisfactory in the case of 
diarrhoea, respiratory infections and malaria, because a large proportion of 
episodes remain untreated or are treated in the home. In these circumstances, 
routine home visits by trained interviewers, preferably not less frequently than 
once a week, is the only approach which can be expected to yield sensitive 
estimates of disease incidence. The richness and accuracy of the data which these 
intensive, community-based studies generate has been sufficient to earn them 
a special place in the epidemiologist’s toolbox. It is these studies which form the 
subject of this thesis.
Since the completion of the Guatemalan study described above, the community- 
based longitudinal study has become increasingly popular. Tables 1.1 to 1.3 list 
some of the many community-based, longitudinal studies of childhood diarrhoea,
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acute respiratory infections and malaria that have been carried out in a variety 
of resource-poor countries. The data derived from such studies are of immense 
importance to health policy makers and planners, who need to know the true 
burden of morbidity in the communities for which they are responsible. 
Longitudinal studies can be used to describe this burden in terms of all the usual 
epidemiological measures of illness frequency: incidence, prevalence and duration. 
Because these studies generally involve the continuous collection of data over 
prolonged periods of time, time sequences between risk factors and disease 
outcomes can be unambiguously established, and important seasonal changes in 
disease patterns can be studied. Moreover, they are an ideal study design for 
determining the impact of health interventions delivered at the beginning or in 
the middle of the period of surveillance. In the following sections, a number of 
the most important longitudinal studies of diarrhoea, respiratory infections and 
malaria are discussed in greater detail.
1.2.1 L o n g itu d in a l studies o f diarrhoea
In 1982, Snyder and Merson reviewed the literature on diarrhoea incidence rates 
derived from  community-based studies in developing countries in which 
household visits were conducted at least once every two weeks and surveillance 
was maintained for a minimum of one year. Eighteen such studies were 
identified. In 1992, Bern and co-workers updated this review and were able to 
identify a further twenty-two studies. Many other studies have been conducted 
with less frequent visits (or passive surveillance) and shorter lengths of follow-up.
Table 1.1 presents a selection of eighteen studies which have been central to the 
development of our understanding of the epidemiology of childhood diarrhoea, 
chosen to illustrate the five different types of objectives which have motivated 
the setting-up of longitudinal studies. The community intervention model of the 
early Guatemala study (D8), set up to examine the interactions between nutrition
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and infection, was soon replicated in Narangwal in the Indian Punjab (D9). 
Similar study designs have been used to examine the health impacts of water and 
sanitation improvement projects (D13,D14) and the effects of oral rehydration 
therapy on diarrhoea case-fatality ratios (D15.D16). An early interest in 
establishing the frequency of diarrhoeal disease by age and major population sub­
groups (Dl,D2) soon gave way to a more specific focus on identifying the precise 
aetiological agents associated with disease in the community (D3-D7). 
Prospective observational studies were also used to determine the degree of risk 
associated with various environmental factors, the consumption of poor quality 
water, and poor nutritional status at the beginning of the period of observation 
(D4,D5; D12; DlO.Dll).
More recently, longitudinal study designs have been exploited in individually 
randomised controlled trials. A large number of trials of rotavirus vaccines have 
been conducted in both developed and developing countries, w ith  the best 
examples carried out in Peru and Venezuela (D17,D18). Trials of vaccines against 
other diarrhoeal pathogens, such as cholera and typhoid, have also been 
conducted, but due to the rarity and severity of these illnesses, intensive home- 
based surveillance has not been used. A series of studies of the morbidity 
impacts of periodic, massive dosing with vitamin A have been carried out in 
Ghana, Brazil, India and Indonesia; they have yet to be reported in  detail in the 
medical press. It is expected that in the near future, the effects of other 
micronutrient supplements, such as zinc, will also be evaluated, as well as 
interventions to modify hygiene behaviours.
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1.2 .2 Longitudinal studies o f acute respiratory infections (ARI)
Community-based, prospective studies of acute respiratory infections (ARI) in 
young children have been reviewed by Pio et al. (1985) and Rogers (1991). All 
of th e  ARI-specific studies, as well as the more important general studies of 
childhood morbidity which collected information on respiratory infections, are 
shown in Table 1.2. Prior to the beginning of the 1980s, data on the 
epidemiology of acute respiratory infections in childhood came almost 
exclusively from these general studies, which collected information on a range 
of different morbidities. Some of these studies, such as that carried out in Matlab 
in Bangladesh (listed in Table 1.1: D3), contain only minimal information on 
respiratory infections. Other studies, such as that carried out in San José, Costa 
Rica (R3), are more informative, reporting incidence rates by age and nutritional 
status, separately for acute lower respiratory (ALRI) and all acute respiratory 
infections combined.
D uring the course of the 1980s, a large number of descriptive studies of the 
epidemiology of acute respiratory infections in children were published. Most 
of these (R8-R14) came under the umbrella of the Board on Science and 
Technology for International Development (‘BOSTID’), a series of studies 
coordinated from the US National Academy of Sciences and using similar case 
definitions and methods of ascertainment (Selwyn, 1990). Two of these studies 
(R ll,R 14 ) were birth cohorts, whilst the others included children of mixed ages 
up to  5 years. The studies focused on age- and seasonal patterns in disease 
incidence, and - in contrast to many of the longitudinal studies of diarrhoea - 
contained only limited information on risk factors for disease. One slightly 
different observational study was that conducted in Basse, in the Gambia (R16). 
In th is  study, detailed information on clinical characteristics of respiratory disease 
episodes was collected, with a view to identifying clinical predictors of 
pneumonia.
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Relatively little research has been carried out to test potential interventions 
aiming to prevent acute respiratory infections in children. The vaccine trials 
conducted in Tari, Papua New Guinea (R20) constitute a notable exception. 
Further vaccine trials, and the results of vitamin A and other micronutrient 
intervention studies, are expected in the near future. Research on the health 
impact of indoor air pollution is also anticipated. In the meantime, the focus of 
most national ARI activities has been case-management w ith  appropriate use of 
antibiotics. Studies of the impact of case-management have mostly had ALRI- 
specific mortality as the primary outcome, but some have reported ALRI 
incidence rates in the study population (R17-R18) o r in a representative 
subsample (R19).
1.2.3 Longitudinal studies o f malaria
Because of the need to examine subjects’ blood in order to establish the diagnosis 
of malaria, intensive longitudinal studies have not been w idely used in the field 
of malaria research. Instead, repeat cross-sectional studies have tended to be 
favoured as a means of documenting seasonal variation in malariometric indices. 
A further methodological difficulty with the longitudinal surveillance of malaria 
is that treatment with anti-malarial drugs - an ethical imperative in subjects 
identified as suffering from malaria - usually protects individuals against further 
infection for several weeks at least. Only one study could be identified in which 
no anti-malarial treatment was administered (Miller, 1958): in this study, 10 
children had blood films taken every other day for a period of 71 days. 
Although they were supposedly "protected from mosquitoes", extremely high 
parasitaemias were observed in at least one child. Interestingly, this study 
appears to be almost the only source of information on the incidence of proven 
malaria in children prior to the 1980s.
More recently, several studies have investigated the association between various
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genetic markers and immunological parameters with clinical malaria, and the 
impact on malaria of insecticide-impregnated bed nets. Two alternative
approaches can be identified: in one set of studies (Ml-M2,M5-M6,M9) regular 
home visits were conducted, and blood slides were taken on children presenting 
with a history of fever or measured raised temperature. In four other studies 
(M3-4,M7-8) blood slides were prepared for all study subjects at intervals of 
between twice a week and once a fortnight. Two studies of the efficacy of new 
vaccines against Plasmodium falciparum malaria, included for the sake of 
completeness (M10-11), employed less frequent active case detection (once a 
month) combined with facilitated passive case detection.
More studies of the impact on morbidity of insecticide-impregnated bed nets, and 
of new malaria vaccines are expected in the near future. Together, these studies 
w ill add greatly to our knowledge of the epidemiology of childhood malaria. It 
is likely, however, that repeated cross-sectional surveys w ill remain the research 
tool of choice in the area of malaria epidemiology, and for this reason malaria 
w ill not be a major focus of this thesis.
1.3 O utcom e measures in  longitudinal studies o f  com m on diseases
Unlike cross-sectional studies, longitudinal studies of common diseases provide 
estimates of disease incidence as well as prevalence. Furthermore, this type of 
study facilitates the direct estimation of illness duration, in  contrast to the 
indirect techniques that must be used in cross-sectional studies if information 
from episodes censored by the survey is to be incorporated. When information 
has been collected by means of intensive, home-based surveillance, it is possible 
to estimate all the measures of disease frequency with great reliability in 
longitudinal studies, a situation which contrasts dramatically w ith the rather poor 
recall that can be expected in retrospective studies (see above, Section 1.2).
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Incidence is a measure of disease occurrence. The incidence rate is defined as 
"the number of disease onsets in the population divided by the sum of the time 
periods of observation for all individuals in the population" (Rothman, 1986). 
In the case of common diseases, an individual m ay experience more than one 
disease onset during the course of the period of observation. This is, of course, 
quite different from the situation which applies to rare diseases such as cancer, 
where incidence has generally been taken to refer to  the first appearance of the 
disease in an individual.
Prevalence is a measure of disease status. It may be defined as "the proportion 
of a population that is affected by disease at any given point in time" (Rothman, 
1986). In the case of longitudinal studies of common diseases, measurements of 
disease status are made repeatedly over the surveillance period, and there are thus 
many possible points in time to choose from when estimating prevalence. 
Alternatively, one has the option of focusing on the individual rather than on 
the time point, and calculating the proportion of time that a given individual 
experiences illness. Whilst conceptually similar, this measure is no longer 
prevalence as classically defined.
Duration is related to prevalence, in that the longer the duration of illness 
episodes, the greater the proportion of the population affected by that illness at 
any given point in tim e (assuming incidence remains constant). Once again, 
longitudinal studies of common diseases allow the possibility of examining the 
distribution of episode durations within individuals, as well as between 
individuals, provided that individuals experience more than one episode over the 
period of observation.
The data collected in longitudinal studies of common diseases of childhood are 
rich and complex, and it is perhaps inevitable that a number of difficulties are 
encountered when it comes to choosing between and analysing these various
21
outcome measures. These difficulties relate firstly to the precise defin ition of 
appropriate outcome measures; secondly, to their statistical handling, and 
thirdly to their interpretation. All these areas will be addressed in this thesis.
1.4 A im s  an d objectives o f  the current w ork
This work is driven by a desire to maximise the development potential of 
longitudinal studies of common diseases of childhood. Poorly analysed data 
diminish the benefits that can be obtained from well-conducted, relevant health 
research. Analyses which inadvertently fail to address appropriate research 
questions (as a result, for example, of using an imperfectly understood analytic 
model) are no more useful to policy-makers than data which are not analysed at 
all. Worse still, analyses which result in biased results can lead to inappropriate 
allocation of resources when findings are implemented. Those analyses which 
lead to inefficient estimates can entail the waste of money invested in research, 
since such studies w ill not have the power to demonstrate significant effects. 
Potentially useful interventions could have their implementation delayed until 
more evidence accumulates of their benefit. On the other hand, analyses which 
overstate the precision of the estimates may result in the diversion of resources 
away from other interventions of more securely demonstrated benefit, because 
interventions which do not in reality offer any benefit erroneously appear to 
produce ‘significant’ effects. When any of these problems arises, a significant cost 
is incurred; the costs of these adverse consequences of poor analytic practice need 
to be weighed against the costs of averting such mishaps through dissemination 
of more appropriate methods and training.
The marginal costs of adopting more ‘sophisticated’ analytic techniques to 
safeguard against the potential dangers outlined above may be disproportionately 
large in developing countries. As of 1980, these countries employed just 11% of
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the world’s scientists and engineers and benefitted from just 6% of the world’s 
total expenditure on research and development (Salomon and Lebeau, 1993). 
Since resource-starved countries are also those most directly affected by the 
negative health impact of the common diseases of childhood (accounting for 
99.5% of all DALYs lost due to diarrhoeal disease, 96.8% of all DALYs lost due 
to respiratory infections and 100% of all DALYs lost due to malaria; World 
Bank, 1993), it is crucially important that least-cost solutions to the problems 
besetting the analysis of longitudinal studies of common diseases of childhood be 
identified. Problems which arouse theoretical statisticians, but which do not lead 
to either perceptible bias or significant under- or over-estimation of precision, 
should not, for example, be regarded as sufficiently serious to justify jettisoning 
established and familiar analytic methods. This pragmatic approach to an area 
fraught w ith  methodological difficulties should help ensure that the 
implementation and analysis of longitudinal studies of common diseases of 
chilhood remains accessible to all those who stand to benefit from them.
In the light of these considerations, this thesis aims to:
Identify appropriate outcome measures 
in longitudinal studies of common diseases of childhood, quantify the 
degree to which traditional analytic approaches to the handling of these 
outcome measures may lead to biased, inefficient or spuriously significant 
results, and recommend alternative analytic strategies which are both valid 
and accessible to non-specialist researchers.
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The following specific objectives are addressed:
1. To describe the range of outcome measures for longitudinal studies of 
common diseases of childhood, evaluate alternative possible definitions of 
these measures, and make recommendations for choosing outcome 
measures appropriate to the specific objectives of each study.
2. To identify the statistical features of longitudinal data on common diseases 
of childhood which may set them apart from other, less complex, 
approaches to the study of common morbidities.
3. To describe recent advances in statistical theory which address the specific 
problems encountered in the analysis of data from longitudinal studies of 
common diseases of childhood.
4. To describe current practice in the statistical analysis of longitudinal 
studies of common diseases of childhood.
5. To quantify the degree to which the application of traditional methods of 
analysis developed for the study of rare diseases to the analysis of data 
from longitudinal studies of common diseases of childhood may lead to 
inappropriate conclusions being drawn from the data.
6. To describe appropriate data-handling strategies for large and complex 
longitudinal data sets.
7. To recommend appropriate strategies for the analysis of longitudinal data 
on common childhood diseases, on the basis of a set of standardised 
criteria (see below).
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1.5 Standard criteria f o r  the evaluation o f statistical models fo r  the 
analysis o f  longitudinal data on common diseases o f  childhood
New statistical techniques for the analysis of complex data structures are 
constantly evolving. The descriptions of these models are, for the most part, 
limited to specialist statistical journals, and little effort is devoted to popularising 
novel methods within the ‘main-stream’ of epidemiological research. In the case 
of methodologies for the analysis of longitudinal data on the incidence, 
prevalence and duration of common diseases, few comparative analyses of 
available methods have been published, and even when these are undertaken it 
is often unclear which set of apparently discrepant results is to be preferred, since 
no standard set of [non-technical] criteria by which to judge such methods has 
been proposed. This is problematic, because the criteria used by statisticians to 
judge the technical properties of newly proposed estimators may fail to address 
a variety of questions which may be equally or more important to those who are 
destined to use the methods on the ground, such as the relevance to applied 
research of the underlying conceptual framework. A new set of criteria is 
therefore required.
I propose a list of five criteria by which to judge the appropriateness of statistical 
techniques. These criteria include justification of the technical adequacy of the 
estimators, but also emphasise their flexibility and relevance to applied research. 
Application of these criteria should permit more rational decision-making about 
the benefits of investing in sophisticated statistical methodologies. These 
potential benefits can then be weighed against the costs that such investment 
would incur. Clearly, the various methodologies would need to be regularly 
reassessed as new developments became available. No method of scoring on each 
criterion is proposed at this stage; an element of subjectivity is inevitable in this 
area.
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1.5.1 Five criteria fo r  the evaluation o f statistical procedures
The following five criteria are proposed:
applicability Do these methods address the kinds of research questions 
which epidemiologists actually need to know the answers to?
viability Is the data which is required as inputs for these models 
actually available? If not, does this matter?
utility Do the models permit the usual range of statistical activities: 
viz. estimation, hypothesis testing, model selection and 
identification of outliers?
validity Are the estimators asymptotically correct (‘consistent’) and 
with minimum variance (‘efficient’)? Is this still the case 
when model assumptions are broken (i.e. are they ‘robust’)?
potential for 
wider use
Are the underlying concepts of the model (if not the 
technical details) broadly appealing? Can it be adopted 
without an massive investment of learning time? Are user- 
friendly computer applications available/likely to become 
available?
The first four of these criteria are ordered hierarchically. Clearly, if an analytic 
approach is not able to test the hypothesis which motivated the setting up of the 
research project, it should not be given any further consideration. Some models, 
for example, are unable to handle explanatory variables which vary over time,
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which might be problematic in a study of the association between water source 
and diarrhoea morbidity. On the other hand, some analytic procedures will not 
only provide an answer to the research question at hand, but w ill also estimate 
any number of additional - extraneous - parameters as well. This may create 
unnecessary complexity where a simpler procedure would have been adequate, 
and may be highly undesirable. As for the second criterion, this also needs to 
be evaluated at the very beginning of the analysis phase, for if the necessary 
inputs cannot be provided, the analysis cannot proceed. It will sometimes be the 
case that initial estimates of technical parameters are required as inputs; often, the 
most appropriate values of these parameters will not be known. However, on 
occasions, the choice of these input values has only a minor impact on the final 
results, and this requirement will not therefore be an important constraint.
The third and fourth criteria are technical requirements familiar to statisticians. 
Estimation, hypothesis testing, model selection and identification of outliers are 
all indispensable activities in quantitative research, and a model in which one of 
these options cannot be implemented must be considered seriously handicapped. 
Possible problems with the technical properties of the estimators (which jointly 
determine their valid ity , in the broadest sense) w ill be outlined in Chapter 5. 
These properties are commonly discussed at length in statistical journals, but it 
is important to recognise that for many applications, a small sacrifice in 
efficiency, for example, may be acceptable (especially as it can be compensated 
by increasing the sample size in the field) if it means that a full analysis can be 
conducted by the original research team, without reference to an external ‘centre 
of excellence’. Clearly, no universal rules can be developed for deciding how 
much bias, or loss of precision, may be acceptable in different circumstances. 
Once the implications of using different analytic approaches are known, 
however, investigators can decide for themselves whether the likely gains of 
opting to use a particular technique w ill offset the costs in terms of computing 
facilities and learning time.
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The fifth criterion attempts to capture some of these costs. Some of them, such 
as the profound sense of distrust that new and apparently complex analytic 
techniques tend to give rise to in those confronting them for the first time, are 
extremely difficult to measure. Others, such as the cost and user-friendliness of 
appropriate computer software, can be directly assessed.
1.6 Structure o f  the thesis
This thesis consists of nine chapters. This chapter provides an outline of the 
study context and objectives. Chapter 2 consists of a description of the main 
data sources used. It contains a detailed account of the approach to data quality 
control and data reduction adopted in one of the two large-scale field trials which 
contribute data for this thesis.
The next four chapters focus on event-based analyses. Considerable emphasis is 
given to this area, as it is felt that longitudinal studies are able to make a unique 
contribution to epidemiological understanding through the estimation of 
incidence rates. Chapter 3 examines a number of issues that arise in  the 
definition of illness ‘episodes’. These include conceptual difficulties about exactly 
what we understand - from a physiological viewpoint - by an ‘episode’ of cough, 
malaria, or diarrhoea, and also a more technical discussion aiming to provide 
pragmatic guidelines for the delineation of discrete illness episodes in longitudinal 
data sets. Chapter 4 moves on to describe how these episodes may be used to 
define epidemiological measures of disease frequency - risks and rates -and also 
measures of association - risk and rate ratios. Peculiarities of these measures 
when used to describe longitudinal data on common diseases are highlighted, and 
a defined area of the epidemiological literature on common diseases of childhood 
is examined with a view to identifying which outcome measures are currently 
being used by investigators in the field.
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Chapter 5 sets out in some detail the precise nature of the statistical problems 
that are encountered when attempting to analyse the incidence of common 
diseases of childhood, and reviews three classes of statistical model which have 
been proposed to deal with these problems. These modelling strategies are 
compared and contrasted using the set of standard criteria presented above in 
Section 1.5. A  brief review is also undertaken of the range of analytic methods 
currently encountered in the epidemiological literature on common diseases of 
childhood (using as a case-study the same studies as were examined in Chapter 
4). Following this, Chapter 6 consists entirely of an illustrative analysis of data 
on the incidence of diarrhoea from a large-scale field trial with intensive 
morbidity surveillance. The extent to which ‘standard’ analyses lead to invalid 
conclusions being drawn about epidemiological parameters is evaluated, and 
simple, robust methodologies are proposed and illustrated.
A similar approach is then taken to illness prevalence (in Chapter 7) and episode 
duration (Chapter 8). In these sections, however, greater attention is paid to 
conceptual issues surrounding the interpretation and applicability of the different 
outcome measures. In particular, concept of ‘frailty’ is discussed in Chapter 7. 
Finally, in Chapter 9, the diverse themes of the preceding chapters are drawn 
together, and summary guidelines for the analysis of longitudinal studies of 
common diseases of childhood are presented.
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Table 1.1 Selected longitudinal studies of childhooddiarrhoea in developing countries
Study Location Year Objectives of study Ref
Descriptive epidemiology of diarrhoea; aetiological studies:
Kirkos, Ethiopia Machakos, Kenya Matlab, Bangladesh Pacatuba, NE Brazil 
Bilbeis, Egypt Bakau, Gambia 
Huascar, Peru
1972-731974-77
1978-79
1978-80
1980- 81
1981- 841982- 84
Epidemiology of childhood disease Demogra'ic & disease surveillance Aetiologies; disease & growth 
Environmental conditions, aetiol. Home environment; aetiologies 
Basic epidem' logy and aetiologies 
Aet. and environ'al contamination
D1
D2
D3D4
D5D6D7
Studies of the interaction between diarrhoea and nutrition:
Santa María Cauqué, 
Guatemala 
Narangwal, India 
Mexico City, Mexico Matlab, Bangladesh
1959-64
1970-731984
1988-89
Int'vn: improved medical care vs. 
nutrition supplement vs. control 
Int'vn: medical care vs nutrition Assoc: nutritional status & diarr 
Assoc: nutr. status, CMI & diarr
D8
D9DIO
Dll
Wa t e r  and sanitation:
Matlab, Bangladesh Imo State, Nigeria 
Mirzapur, Bangladesh
1976
1982-861984-87
Assoc: Consumption tubewell water Int'vn: Boreholes & VIP latrines Int'vn: Pumps,latrines & hyg educ
D12D13
D14
Impact of Oral Rehydration Therapy on the course of illness:
Teknaf, Bangladesh Haryana, India 1977-79early
1980s
Efficacy of ORSEfficacy of alternative delivery 
strategies for ORS
D15D16
Vaccine efficacy studies:
Canto Grande, Peru Caracas, Venezuela 1985-61985-87 Efficacy of attenuated RV vaccine Efficacy of rhesus RV vaccine
D17
D18
Notes: Int'vn-intervention study; Assoc>observational study; CMI«cell-mediated 
immunity; RV-rotavirus
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Table 1.2 Longitudinal studies of acute respiratory-infections in children in developing countries
Study Location year Objectives of study Ref
Non-specific studies of childhood morbidity:
Delhi, India Vellore, India 
San José, Costa Rica Dabat, Ethiopia 
Kirkos, Ethiopia
1962-67
1965- 67
1966- 67 1968 
1972-73
morbidity and SES in children 
general morbidity of 110 families 
morbidity and nutritional status morbidity and nutritional status epidemiology of childhood disease
R1R2
R3R4
R5
Basic epidemiology of ARI:
Rural c'ties, Mexico Bana, Burkina Faso 
Ibadan, Nigeria Maragua, Kenya 
Guatemala City, Gu. Montevideo, Uruguay 
Manila, Philippines Bangkok, Thailand Cali, Colombia 
Dubluk/Elka,Ethiopia 
Basse, Gambia
1982- 831983- 841984- 87
1985- 87 
1985-86 1985-87
1985- 871986- 87 1986-88 
1989-91 ?
nationally representative samplesmall rural community
poor urban communityrural community
marginal urban areapoor urban area - birth cohort
poor urban communitypoor urban communitypoor urban area - birth cohort
rural arid lowland communitiesclinical predictors of pneumonia
R6R7
R8
R9
RIORII
R12
R13R14R15
R16
Case-management :
Kathmandu Vly, Nepal Abottabad, Pakistan 
Gadchiroli, India
7
1985-87 
1989-?
Health educ, immun. & antibiotics 
Active case-detection 
Morbidity sub-study
R17 
Ri 8 
RI 9 I
Vaccine efficacy studies:
Tari, P New Guinea 1981-83 Efficacy of pneumococcal vaccine R20
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Table 1.3 Longitudinal studies of childhood malaria indeveloping countries
Study Location Year Objectives of study Ref
Epidemiology and immunology of childhood malaria:
Dinzolo, Congo 
Farafenni, Gambia 
Safo. Mali 
Dielmo, Senegal
1983-84
1988-89
1989
1990
1/week; t temp. -. thick film 
1/week; t temp -» film; immunology 
blood films 1/fortnight; immun'y 
thick films 2/week; temp 1/2 days
Ml
M2
M3
M4
Studies of the impact of impregnated bed nets:
Katchang, Gambia 
Farafenni, Gambia 
Uriri, Kenya
Muheza, Tanzania 
Soma, Gambia
1985
1987
1988
1988-89
1988-90
ACD 1/week; temp., 'fever' -* film 
ACD 1/week; t temp. -• blood film 
ACD 2 /week; 'fever' -» temp.;
weekly thick & thin blood film 
blood slides l/fortnight 
ACD 1/week; t temp. -► blood film
M5
M6
M7
M8
M9
Vaccine efficacy studies:
Vallée du Kou, 
Burkina Faso 
Da Tola, Colombia
1988
1991-92
blood films 1/month + PCD
ACD 1/month + PCD; temp., symp -« 
blood film
M10
Mil
Notes: ACD=active case detection; 'fever'»reported fever; PCD=passive case 
detection; sytnp=symptom; temp=temperature.
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Chapter 2 Data Sources, 
Data H a n d lin g
2 .1  Introduction
The larger part of the arguments in this thesis will be developed with reference 
to an empirical data set describing the morbidity experience of young children 
in northern Ghana over the period 1990-91. These data were collected as part 
of the Ghana Vitamin A Supplementation Trials, two companion, randomised, 
placebo-controlled field trials of the effects of large-dose, periodic 
supplementation with vitamin A on the health and survival of young children. 
From September 1990, three months after the commencement of morbidity 
surveillance in the area, I was resident at the field station in Navrongo, where I 
was employed as statistician for the morbidity study. In the first section of this 
chapter I w ill describe this data set in some detail, w ith particular reference to 
the data quality control and data handling procedures developed by me during 
my time in Navrongo. At the end of this chapter, I w ill describe the other main 
data source from Peru, used for the comparative analysis of episode definitions 
in Chapter 3 and an examination of the duration of diarrhoea episodes in 
Chapter 8.
2 .2  G hana V itam in  A  Supplementation Trials C h ild  H ealth Study
2 .2 .1  O bjectives o f  the study
The Ghana Vitamin A Supplementation Trials Child Health Study, henceforth 
known as Ghana VAST - CHS, was one of four large-scale field trials of the 
effect of periodic, massive-dose vitamin A supplementation on the health, as
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distinct from mortality, of young children to be carried out in developing 
countries in the late 1980s/early 1990s. Vitamin A is a naturally occurring 
compound which it has long been known is crucially important for the 
maintenance of epithelial integrity and function in humans (Wolbach and Howe, 
1925; Zile et al., 1981). More recently, it has become clear that vitamin A exerts 
a number of other effects on the immune system (Ross, 1992). A severe form 
of vitamin A deficiency, known as xerophthalmia, leads to poor vision in dim 
light (‘night blindness’), reversible opacities on the surface of the eye (‘Bitot’s 
spots’), and finally, irreversible damage to the cornea, and blindness (Sommer, 
1982).
Although the value of vitamin A treatment in measles was demonstrated as early 
as 1932 (Ellison), it was a series of findings in Indonesia in the early 1980s which 
aroused new interest in the vitamin in the broader scientific community: Alfred 
Sommer and co-workers (Sommer et al., 1983) showed that children with night 
blindness or Bitot’s spots suffered mortality rates over the following 3 month 
period that were around 4 times higher than those of children without signs of 
vitamin A deficiency. This finding was rapidly followed by an intervention 
study in the same area, which showed that massive-dose vitamin A 
supplementation was able to reduce the mortality rate in children aged 12-71 
months by 34% (Sommer et al., 1986). These results, which were confirmed in 
1988 by a food fortification study also conducted in Indonesia (Muhilal et al., 
1988), and later by other supplementation studies carried out in the south of 
India (Rahmathullah et al., 1990) and Nepal (West et al., 1991; Daulaire et al., 
1992), suggested that the detrimental effects of vitamin A deficiency must be 
affecting many organs other than the eye, and must be occurring at levels of 
deficiency not previously recognised as posing a significant threat to health. Two 
further supplementation studies conducted in the north of India (Vijayaraghavan 
et al., 1990) and Sudan (Herrera et al., 1992) failed to identify any beneficial 
impact of vitamin A supplementation on mortality.
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In an attempt to determine whether the same reductions in childhood mortality 
could be delivered in an African context, a trial of the effects of massive-dose, 
periodic supplementation with synthetic vitamin A on childhood mortality 
(Ghana Vitamin A Supplementation Trials Child Survival Study) was set up in 
Navrongo, northern Ghana, in early 1989. The companion Child Health Study 
was established the following year in an adjacent area. The aim of this study was 
to determine the mechanism by which vitamin A was achieving such impressive 
impacts on child survival, by documenting in great detail any effects on the 
incidence, duration and severity of a range of childhood illnesses, principally 
diarrhoea and respiratory disease. In addition to elucidating the mechanisms by 
which vitamin A supplementation was able to  achieve its mortality-saving effects, 
it was hoped that this study would provide information about additional gains 
of vitamin A supplementation arising from the reduction of the morbidity 
burden in young children. The most important results from the two Ghana 
VAST trials have been published in the Lancet (Ghana VAST Study Team, 1993).
2 .2 .2  The study area
The Child Health Study was carried out in Kassena-Nankana District, an 
administrative sub-division of the Upper East Region of Ghana (see map, Figure 
2.1). The Upper East Region of Ghana shares a common border with Burkina 
Faso to the north, and has many ecological and cultural features in common with 
that country. The climate is sub-Sahelian, w ith  an annual average of 852 mm of 
rain (1981-90, Irrigation Company of the Upper Regions) falling in a single rainy 
season, which lasts approximately from M ay until September. The bulk of the 
agricultural activity in the region is concentrated in this period, when sorghum, 
millet, groundnuts and beans are grown for household consumption. During the 
remainder of the year, the climate is extremely arid, with relative humidity 
falling to 20% in March/April. Agriculture is not possible during this period, 
except for those with access to a dry-season vegetable garden. These are usually
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irrigated from hand-dug wells, although a small area of the district is irrigated 
commercially, using water channelled from a large man-made reservoir.
Three different ethnic groups live in the district: the Kassena, the Nankana and 
the Bulli. All of these are Voltaic peoples, closer to the Moré of Burkina Faso 
than to the Akan peoples of southern and central Ghana. All three groups live 
in dispersed settlements, or ‘compounds’, of between 1 and 50 or more 
inhabitants (median = 8). Although families living in the same compound share 
bonds of kinship, each ‘nuclear’ household is to a large degree economically 
independent, leading to large discrepancies in living standards within compounds. 
The only substantial sized town in the district is the capital Navrongo (20,000 
inhabitants), which has two secondary schools and a teacher training college, as 
well as a medium-sized district hospital. Four other health centres are scattered 
throughout the district, none of them in the area where the Child Health Study 
was carried out (see below, Section 2.2.3).
In general, the health situation in the district is extremely poor. Indirect 
estimates of child mortality derived using the Preceding Birth Technique (Brass, 
1985) to analyse data collected in the baseline survey of the study suggest that in 
the year 1987, the (period) risk of dying by age five (5q0) was around 173/1000. 
The major causes of death in young children, as identified by the Ghana VAST 
Child Survival Study, 1989-91, are shown in Table 2.1. Acute gastroenteritis and 
chronic diarrhoea/malnutrition together account for nearly one third of all 
deaths of infants and children in the area. Episodes of diarrhoea are frequent, 
with the average child experiencing 5 episodes each year. Although access to 
potable water is high, with 72% of families getting their drinking water from a 
closed system borehole in the dry season, it is likely that much of this water 
becomes contaminated during storage, and the animal pounds which surround 
83% of compounds undoubtedly provide a rich reservoir of enteric pathogens. 
Hygiene practices are poor, and 78% of mothers in the study area have never
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attended school.
The burden of parasitic diseases is very heavy, with malaria highly prevalent in 
young children at all times of year (prevalence ranging from 53% in the dry 
season to 85% in the rainy season), and responsible for one quarter of all deaths 
in childhood and infancy. Schistosomiasis and filariasis are common in older 
children. Respiratory infections appear to account for a somewhat lower 
percentage of all infant and child deaths than is commonly observed in 
developing countries (WHO, 1993). It is possible that transmission of respiratory 
pathogens is reduced by the custom of sleeping on the roofs of the dwellings 
rather than inside rooms, except during the rainy season, when the prevalence 
of respiratory symptoms goes up.
Immunisation coverage was poor at the outset of the study, with only 25% of 
children aged 12-23 months having received the full schedule of vaccines (children 
without a health card available for inspection assumed not fully vaccinated). 
Measles occurs in approximately biennial epidemics, w ith a cumulative incidence 
of 13% in 4-year olds (this of course excludes those children who have died, and 
is therefore undoubtedly a gross underestimate of the true incidence). In general, 
nutritional status is very poor, w ith  38% of children under five more than 2 
standard deviations below the median weight-for-age of the United States 
National Centre for Health Statistics reference population (US Public Health 
Service, 1976). Vitamin A deficiency is widespread; 74% of children were 
severely or moderately deficient at baseline, with serum retinol levels below 0.7 
/xmol/L.
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2.2 .3  The study population
The Child Health Study was carried out in an area of 198 km2, to the south of 
Navrongo town (see map, Figure 2.2). This area was divided into four sub­
zones. In three of these sub-zones, all children born on or after the 1st January, 
1986 were recruited into the study. On completion of the population census in 
these areas, it became clear that the sample size obtained would not be adequate 
to evaluate all of the study hypotheses, and the fourth sub-zone was added. In 
this fourth sub-zone, all children born on or after 1st January, 1988 were 
recruited into the study. This was to provide relatively greater amounts of 
follow-up time in the age group 0-23 months, where the bulk of morbid events 
were expected to occur. In all, 1206 children had been registered into the study 
by the first day of the baseline clinical examinations, which took place in April 
(subzones 1 and 2) and June (subzones 3 and 4) of 1990.
Dosing with vitamin A/placebo, along with the initiation of regular weekly 
morbidity surveillance, took place two months after the baseline clinical 
examination. A full timetable of the study is shown in Figure 2.3, and it can 
be seen that activities in subzones 3 and 4 were staggered two months behind 
those in sub-zones 1 and 2. Once regular home visits had begun it was possible 
to identify all new births and new arrivals into the study area, and these children 
continued to be enrolled into the study until the last dosing points in June 
(subzones 1 and 2) and August (subzones 3 and 4) of 1991. A total of 740 
children were enrolled into the study from the first day of the baseline clinical 
examinations until the end of the study. The total number of child-weeks of 
follow-up in each age group is shown in Table 2.2.
It should be noted that children did not enter the vitamin A supplementation 
trial until they were first eligible for dosing, and that no children were eligible 
for dosing until they reached the age of 6 months or over. The number of
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children in the vitamin A supplementation trial is therefore less than the number 
of children in the morbidity study as a whole, and the age structure of the child- 
weeks of follow-up is different. Analyses in this thesis are based on all children 
enrolled into the study, rather than the subset who participated in the vitamin 
A trial.
2 .2 .4  Data collection procedures
Three different types of data were collected during the course of the Child 
Health Study: baseline demographic, socio-economic, nutritional and previous 
medical histories; prospective surveillance of morbidity; and repeated measures 
of time-dependent covariates (risk factors).
The baseline data were collected by means of questionnaires administered in the 
home prior to the beginning of the study. Some of the data, such as sex, birth 
order, and exposure to measles, can be viewed as fixed covariates relating 
specifically to the index child. Another set of data, including the educational 
level of the child’s mother and her knowledge of oral rehydration therapy are 
household- rather than individual-level covariates. 24% of study mothers had 
more than one child in the study. A third set of data, collected on a separate 
form, relates to characteristics of the residential compound, such as possession of 
animals or ‘luxury’ items, or presence of animal faeces in the living area.
Current morbidity was assessed in a number of different ways. Between the first 
and the last dosing points in each sub-zone, all children were visited weekly in 
their homes, and a detailed morbidity questionnaire was administered (Figure 
2.4). The presence of 21 signs or symptoms was enquired about over each day 
of the preceding week, using a locally understood terminology that was identified 
prior to the start of the study with the help of a consultant anthropologist. For 
example, seven distinct diarrhoeal illnesses were enquired about, and four
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different respiratory complexes. In order to help the respondent (usually the 
child’s mother) remember the child’s health status on each of the preceding 7 
days, a pictorial illness diary was left with the child’s caretaker each week. She 
was then asked to mark on the diary each day whether the child had some form 
of diarrhoeal illness, a respiratory illness, another illness, or had been in good 
health. The diary was then used as an aide-memoire during the course of the 
morbidity interview.
In addition to the daily presence or absence of the listed signs and symptoms, a 
number of simple observations of the child’s health status were made by the 
fieldworker each week. These included measuring the child’s temperature and 
breathing rate, and listening for signs of respiratory distress. A history of 
consultations with health service providers (both allopathic and traditional) was 
taken, and on occasions when diarrhoeal illness was reported during the week, 
a detailed assessment of illness severity was undertaken.
In the advent of severe illness of any kind, or the presence of warning signs such 
as raised breathing rate, fieldworkers were instructed to refer children to one of 
the mobile clinics provided by the project in the study area. Since the clinics 
visited two different sections of the study area on alternate weeks, referrals were 
only possible on 2/10 visit days (the day of the clinic, and the day before). For 
those study subjects living nearer to Navrongo town, another clinic was provided 
once a week in the district hospital. In addition to those children referred to the 
clinics by fieldworkers, a larger number of children presented spontaneously to 
the clinics. Severely sick children were admitted to Navrongo hospital and kept 
under daily surveillance by the study paediatrician.
45
Once every four weeks, a different set of fieldworkers would visit all the children 
in their homes to update information on the most important time-dependent 
covariates. These included feeding mode, sleeping patterns and potential sources 
of air pollution, source of drinking water, weight and mid-upper arm 
circumference (these latter intended as additional outcomes for the vitamin A 
trial). A small number of variables, such as length and vitamin A/placebo dosing 
status, were only updated at the 4-monthly dosing rounds, and one variable, 
vaccination status, was only updated a single time at the end of the study. These 
data can be combined with the morbidity data in risk factor analyses.
2 .2 .5  D ata qu ality control
Data quality control measures were instigated both in the field and in the 
computer centre. Field measures included scheduled and unscheduled supervisory 
visits to fieldworkers in the field, blind re-interviews with the children’s carers 
and random checks on study households, and weekly meetings of all field staff. 
Due to the high ratio of supervisory to lower-grade staff (one deputy supervisor 
for every four fieldworkers) an intensive surveillance of field operations could be 
maintained at all stages of the study.
In the computer centre, all data were entered twice in order to minimise 
typographic errors. Following the completion of data entry, a series of 
computerised checks was run to ensure that only permitted values of each 
variable had been recorded (‘range checks’) and that no inconsistent responses 
had been recorded within each questionnaire (‘consistency checks’). Consistency 
of response from one period to the next was verified on a number of key 
variables - such as breastfeeding and anthropometric status - by scrutiny of the 
full sequence of records for any unexpected transitions, such as the resumption 
of breastfeeding after a child had been fully weaned, or weight gain of more than 
one kilogram in the course of a single month. Such inconsistencies resulted in
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the retrieval of the original records, discussion with the fieldworker concerned, 
and, in the case of breastfeeding queries, a detailed interview with the child’s 
mother in an attempt to establish the true course of events.
Probably the most innovative element of the data quality control measures 
developed in the computer centre was the elaboration of simple performance 
indicators based on elements recorded each week on the morbidity questionnaire. 
By tabulation of these indicators, comparisons could be made between 
fieldworkers, and those whose performance was poor relative to the average (or 
suspiciously good) could be singled out for re-training and surveillance by 
supervisory staff. Indicators which proved particularly useful included the 
proportion of visits on which the study child was recorded absent and the 
prevalence of a number of common complaints such as cough or fever. 
Disaggregation of fieldworker-specific prevalence rates by day since previous 
interview revealed that whilst some fieldworkers were recording similar 
prevalences over each day of the week (as should be the case), others appeared 
not to be probing adequately about events occurring earlier in the week, and 
were thus recording substantial increases in disease prevalence towards the end 
of the week. There were also important differences between fieldworkers in the 
frequency with which whole weeks of illness (suggestive of a failure to establish 
day of onset and day of recovery) were recorded.
Continuous variables, such as measured breathing rate or axillary temperature 
also provided rich grounds for the examination of between-fieldworker 
differences. The proportion of ‘failed readings’ was especially useful in 
identifying technical problems with use of the instruments (or simply inadequate 
performance), and proportions above or below critical cut-offs were also useful 
in establishing systematic observer bias. Measures of variability for these 
variables proved to be as informative as measures of location, with substantially 
below-average spread, and uniform rather than Normal-shaped distributions
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suggestive of falsification of data. Use of these measures of fieldworker 
performance ensured high quality data and established good communication 
between the field operations and the computer centre: supervisory staff 
participated in the interpretation of these data and frequently suggested 
alternative measures of performance. In this way, analysis was integrated with 
data collection from an early stage, and was rapidly established as an interactive 
process.
2 .2 .6  D ata reduction
Due to  the complex nature of the data set, considerable difficulty was 
encountered in reducing the data to a format appropriate for calculating measures 
of incidence and prevalence. Essentially, two very different approaches may be 
adopted to the organisation of data sets of this type, with each of them 
characterised by a number of distinct advantages and disadvantages. The first 
option is to create files in which each day of observation, for each individual 
participating in the study, has a separate record, with the various signs and 
symptoms being recorded as a set of discrete variables. This format is 
particularly advantageous when it comes to prevalence-type analyses, since the 
denominator is simply the total number of records (usually excluding missing 
values), and the numerator can be obtained very straightforwardly by running 
frequencies on the relevant variables. Obtaining summary statistics on each 
study individual, such as the number of days with a particular symptom, is also 
relatively straightforward using analytic packages which permit ‘aggregate’ 
functions (summarising over common values of an identifier variable). Obtaining 
episode-type data is, however, awkward with this arrangement of data, since 
many w idely used analysis packages are not good at scanning multiple records 
simultaneously (this is necessary to determine whether an episode has really 
ended, o r is just interrupted by, say, one day without symptoms). Furthermore, 
this arrangement of the data results in enormous data sets (half a million records,
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in the case of the Ghana VAST Child Health Study), which are extremely 
cumbersome to manipulate, especially if they need to be sorted.
A second option is to concatenate all the data for one individual over the whole 
observation period, creating a single long string variable. C learly this can only 
be done for one sign/symptom at a time. If, therefore, it is desired to create 
complex variables representing combinations of signs or symptoms, these must 
be created before concatenation. The resulting files are much more manageable, 
since they only have as many records as there are individuals in the study, but 
multiple files are generated (one for each sign/symptom). This is the approach 
that was adopted in the Ghana VAST Child Health Study. It has the 
disadvantage that a further set of programs must then be written (in a 
programming language, as opposed to using a standard analytic package) to read 
the morbidity strings and generate summary measures of prevalence and 
incidence. However, the generation of illness episodes is relatively simple, since 
looking backwards and ahead to other days in the string presents no problem. 
Moreover, visual inspection of individuals’ morbidity patterns over time becomes 
possible, a procedure the usefulness of which should not be underestimated. In 
spite of this, the disassociation of information on different signs/symptoms is 
undesirable from many points of view, and this approach should probably only 
be considered when the amount of information collected is so large that other 
approaches are not feasible.
Whatever approach is adopted to the organisation of the morbidity data, there 
are bound to be specific problems which arise during the course of the data 
processing as a result of the particular design features of each study. It is 
important to think carefully about the implications of each possible resolution 
of these problems, and to take pragmatic decisions to facilitate the analysis. An 
example of such a problem arose in the Ghana VAST study when children 
moved from one ‘sub-zone’ to another within the same ‘zone’ (see map, Figure
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2.2). Since within each zone, fieldwork in one sub-zone was staggered one week 
behind fieldwork in the other sub-zone, this could result in children having more 
or less than the full year of follow-up. This was undesirable both from the point 
of view of assessing the impact of vitamin A supplementation, which had to be 
over the same period of time since dosing for all children, and from a 
programming perspective. The final week of follow-up was therefore eliminated 
from those children with 53 rather than 52 weeks of follow-up, and four children 
who moved zones (and were therefore dosed at 2- or 6- month intervals, rather 
than the normal four months) were excluded from the analysis altogether.
2 .3  The L im a  R otaviru s Vaccine T rial
A second data set is used in Chapter 3 to explore issues in the definition of 
episodes of illness, and again in Chapter 9 to examine the duration of episodes 
of diarrhoea. These data were kindly contributed by Dr Claudio Lanata of the 
Instituto de Investigación Nutricional, Lima, Peru in order to permit comparative 
analyses with the Ghana VAST Child Health Study data described above.
The Peru study was a randomised, placebo-controlled trial of a single dose of the 
Rhesus or Rhesus-Human reassortant rotavirus vaccines conducted between 
August 1987 and October 1990 in a shanty town on the outskirts of the capital, 
Lima. The primary objective of the study was to determine whether either of 
the two vaccines, administered to 800 children at two months of age, could bring 
about a reduction in the number of diarrhoea episodes associated with rotavirus 
over the following two-year period. A secondary objective was to determine 
whether the vaccines could bring about a reduction in all-cause diarrhoea over 
the same period.
Field methods were broadly similar to those described for the Ghana study, 
although home surveillance was more frequent. Field workers interviewed the
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mothers/carers of study children in their homes twice every week and recorded 
data on the total number of stools each day and the number of liquid/semi-liquid 
stools, as well as on a number of other clinical features of the illness, including 
the hydration status of the child. Stool samples were taken for laboratory 
analysis when diarrhoea (defined as 3 or more liquid/semi-liquid stools in a 24- 
hour period) was reported. Severely sick children were referred to a clinic for 
attention and specific antibiotics were provided for culture-proven, treatable 
diarrhoeal illness. However, clinic attendances do not form a major outcome for 
this study. Also, given the more specific focus of th is study on diarrhoeal disease 
compared to the Ghana study, there is a more limited array of risk-factor data: 
only breastfeeding data were regularly updated, in  this case on a daily basis. 
Baseline socio-economic and demographic data were collected at the time each 
child was enrolled into the study.
Quality control measures were similar to those used in Ghana. A system of 
incentives and penalties for fieldworker performance was developed to encourage 
high quality returns. Specially designed data entry systems (using Turbo-Pascal) 
were developed, giving rise to individual child-day records. The derivation of 
episode counts forms the basis of the discussion in  Chapter 3.
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Table 2.1 Ghana VAST Child Survival Study:Causes of death in all study children
Number 
of deaths %of total
Deaths with established cause:
Malaria 276 25 3%Acute Gastroenteritis 274 25 1% i
I  Chronic Diarrhoea or Malnutrition 75 6 9%I Acute Lower Respiratory Infection 203 18 6%Measles 151 13 8%Injury 25 2 3%Meningitis 14 1 3%Other 73 6 7%
Cause not known 326
Total 1417
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Table 2.2 Ghana VAST Child Health Study:
Total child-weeks of follow-up by age and sex'
Age group (months)
Males Females Total
0- 5 4172 4312 84846-11 4866 5402 1026812-17 4685 5156 984118-23 4693 4921 961424-35 8847 9168 1801536-47 7480 6512 1399248-59 4710 4716 942660- 515 701 1216
Total 39968 40888 80856
* Including weeks temporarily absent or in hospital, 
permanent losses to follow-up. but excluding
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Figure 2.1 Map of Ghana, showing the Upper East Region
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Figure 2.2 Map of Kassena-Nankana District, showing the Ghana VAST study areas
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Figure 2.3 Ghana VAST Child Health Study: Timetable of Events
Figure 2.4 Morbidity questionnaire used in
VAST Child Health Study
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Chapter 3  E v e n t  A n a ly s is  (I): 
D e f in in g  E p iso d es
3 .1  Introduction
Despite the fact that all researchers analysing longitudinal studies of common 
diseases must confront this problem at some point, the question of how to define 
an episode of a frequently occurring illness such as diarrhoea has attracted 
surprisingly little attention in the epidemiological literature. In experimentally 
induced infections, episodes of illness can generally be clearly identified: 
symptoms begin shortly after administration of the pathogenic challenge, increase 
in severity as the infection becomes established, and then - in most cases - decline 
as an effective immune response is mounted. This is illustrated in Figure 3.1, 
which shows results from a volunteer study (Satterwhite et al., 1978) in which 
mean stool volume was measured each day following administration of a 
pathogenic dose of Escherichia coli. In this study, group C was challenged with 
a large dose of a highly virulent strain of the pathogen, and experienced 
markedly increased stool volume on days 2, 3 and 4 of the experiment, compared 
to the other three groups who received smaller inocula or a less virulent strain. 
Similar patterns are described for other diarrhoeal pathogens (see, for example, 
Music et al., 1970).
Such clearly defined patterns of sickness and recovery cannot be expected in 
community-based studies. Exposure to pathogens in the community is not a 
discrete, time-limited event; instead, children in developing countries grow up in 
the midst of a reservoir of multiple pathogens. Diarrhoeal pathogens are 
commonly present in the water these children drink, the food they eat and in 
animal faeces which they come into contact with around the home (Black et al., 
1989). Table 3.1 presents a list of organisms known to cause diarrhoea in
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children in developing countries. Other infections and non-infectious events are 
also suspected to be associated with diarrhoea in young children: Plasmodium 
falciparum malaria (Harinasuta & Bunnag, 1988); food allergy, especially to cow’s 
m ilk , eggs, fish, peanuts or soya (Helbling, 1994), and - more controversially - 
personal or familial stress (Dutton et al., 1985). It should not therefore surprise 
us if  children living in contaminated environments are exposed to several distinct 
challenges in the course of only a few days or weeks. This would naturally 
produce a more complicated symptomatology than that described in volunteers 
exposed to a single, controlled dose.
It is also important to note that, contrary to what may be achieved in volunteer 
studies, other variables are not generally ‘held constant’ when a child becomes 
sick with diarrhoea. Indeed, active steps are usually taken to manage the child’s 
illness. Some of these actions may have a palliative effect though they fail to 
achieve a complete cure. However, even in the absence of deliberate 
manipulations of the child’s environment, day-to-day fluctuations in the severity 
of symptoms are to be expected in the course of any illness. Thus the child may 
experience a few days with milder symptoms before returning to frank illness. 
In diseases such as shigellosis, relapses are known to occur, even after an 
apparently radical cure has been affected (see, for example, Gilman et al., 1981). 
When patients with shigellosis are not treated with antibiotics, carriage of the 
pathogen may persist for periods approaching three months (DuPont et al.,
1969), and changes in the child’s nutritional/immune status may be sufficient to 
induce relapse.
The net effect of these complexities of community infection is that individual 
children’s symptom histories may be difficult to interpret confidently in terms 
of discrete episodes of illness. Figure 3.2 depicts the diarrhoea morbidity 
experience of a single child in the Lima rotavirus vaccine study described in 
Section 2.3. It is far from clear how many ‘episodes’ of diarrhoea this child
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experienced in April 1989 - it may be that the whole month made up a single 
aetiological episode of illness, with only low-grade symptoms on most days. On 
the other hand, it is possible even that the peak occurring on the 7th and 8th 
days of the month could have been aetiologically distinct from the symptoms 
recorded a few days earlier. Only DNA serotyping of pathogens can provide 
definitive answers to these questions. Since such a solution is wholly impractical 
in the majority of community-based studies, I attempt in this chapter to provide 
pragmatic guidance on appropriate algorithms for defining the beginning and end 
of diarrhoea episodes. In the final section of the chapter, I discuss the biological 
plausibility of the conclusions that emerge, and extensions to other common 
diseases of childhood.
3 .2  Previous attem pts to define an ‘episode’  o f  diarrhoea
The standard approach in defining episodes of diarrhoea has been to specify a 
minimum number of diarrhoea-free days which must intervene between days 
with symptoms before it can be considered that these periods of diarrhoea 
represent genuinely distinct episodes. It has been shown, however, that there is 
little consensus on what should be the minimum number of symptom-free days 
between distinct ‘episodes’ of diarrhoea (Baqui et a l., 1991). Some studies have 
required only two symptom-free days between episodes, whilst others have 
required as many as 14 symptom-free days.
The urgent need for some standardisation of the definition of an episode of 
diarrhoea was clearly demonstrated in the article by Baqui and co-workers, which 
showed that altering the number of symptom-free days required to signal the 
break between one episode and the next from 1 day to 7 days can reduce the 
apparent total number of episodes by as much as one third, and that estimates 
of the incidence of ‘persistent’ diarrhoea (episodes of more than 14 days’ 
duration) are also dramatically affected. Similar conclusions were reached some
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years earlier in an analysis of diarrhoea data from the Gambia by Pickering et al. 
(1987). Baqui and colleagues note that the greatest change is seen when varying 
the number of diarrhoea-free days between episodes from one to three, and that 
"increasing the requirement for a new episode from three to seven diarrhoea-free 
days provided very similar measures of diarrhoeal incidence". They therefore 
conclude that "using fewer than three diarrhoea-free days could possibly over­
estimate the overall diarrhoeal incidence".
This conclusion appears to be based on the assumption that it would be unlikely 
for a child to experience a new episode of diarrhoea within a day or two of 
recovering from a previous episode. No biological or mathematical justification 
for this assumption is presented. In order to determine whether such an 
assumption might be justified, we decided to model the occurrence in time of 
diarrhoea-provoking ‘trigger’ events, as described in Section 3.3. When this is 
done, it becomes possible to compare observed distributions of illness in time (or 
more precisely, the distribution of intervals between days of illness) with the 
distribution expected under the assumptions of the model. If, in any particular 
study, the observed distribution of intervals follows the expected distribution 
closely, it can be concluded that it would not be appropriate to combine in the 
analysis periods of illness following each other in rapid succession. On the other 
hand, if there is a large excess of observed over expected symptom-free intervals 
of - for example - one or two days’ duration, such short intervals as these should 
probably not be considered sufficient to define a new episode of diarrhoea.
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3 .3  A  theoretical m odel o f  diarrhoeal illness
Because of the large number of different possible causes of diarrhoeal illness in 
young children, the concept of a ‘trigger event’ is central to the development of 
a theoretical model. A trigger event is defined as any event provoking the 
appearance of diarrhoea symptoms in the child. In many cases, the trigger event 
w ill consist of an incident infection w ith  a diarrhoeal pathogen, but other 
possibilities, such as a change in the ch ild ’s ability to contain a pre-existing 
infection, or a non-specific trigger event such as malaria, are not excluded 
provided that they are causally associated with symptoms of diarrhoea in the 
immediately ensuing period of time.
The central assumption of the model is that, in the experience of each child, 
trigger events are randomly distributed in time. This assumption is reasonable 
if it is accepted that the trigger events result from encounters between the child 
and other persons, objects or externally conditioned events, each one of which 
may be defined in probabilistic terms (see Section 3.6). It implies that by chance 
alone, a susceptible individual may encounter several trigger events in rapid 
succession. When this happens, a new period of symptoms may start before the 
previous illness has resolved. Etiologically distinct periods of symptoms will 
overlap in time and only one ‘episode’ of illness will be observed.
The model is developed in a number of stages. In the simplest version, it is 
assumed that all individuals will encounter trigger events at the same constant 
rate over time (X). This results in a Poisson process (Whittle, 1976), in which 
time intervals between successive trigger events are distributed with an 
exponential probability density function,
f(x) -  X .e^
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where x represents the length of the interval between trigger events. Based on 
this simplistic assumption, a data set is generated representing the morbidity 
experience of 10,000 children monitored over a period of 365 days.
In subsequent stages of the model development, three potentially important 
determinants of the distribution in time of periods of diarrhoeal illness and the 
intervals between them are added sequentially:
(1) The distribution of the duration of symptoms of diarrhoea following a 
trigger event. This might be expected to influence the proportion of 
trigger events occurring in the course of a pre-existing period of illness.
(2) Inter-individual variation in the rate at which trigger events are 
encountered. Since important characteristics of the child such as his/her 
age, housing conditions, nutrition etc. are known to influence the rate of 
diarrhoeal illness, the initial assumption of homogeneity of incidence rates 
is clearly unrealistic.
(3) Seasonal variation in the rate at which trigger events are encountered. 
This may be considerable in some environments.
Parameters for development of the model are derived from the two empirical 
data sets from Ghana and Peru described in the previous chapter. Many 
alternative parametrisations of the model are of course possible; some of these are 
discussed in Section 3.4.3 following the development of the primary model.
In the simplest version of the model, individuals experience trigger events at a 
rate of 9 events per child per year. Because some trigger events can be expected 
to occur during the course of a pre-existing period of diarrhoea symptoms, this 
would normally be equivalent to a somewhat lower episode incidence rate,
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probably close to 8.5 episodes per child per year. This episode rate, whilst 
corresponding fairly well to those found in both the Peru and the Ghana studies, 
is clearly at the upper end of the range of diarrhoea incidence rates reported in 
empirical studies from developing countries (Bern et al., 1992). The implication 
of the use of lower rates is also considered in Section 3.4.3.
As the second stage in the development of the model, allowance was made for 
the duration of symptoms following a trigger event. Examination of the two 
empirical data sets reveals that the numbers of consecutive days of diarrhoea had 
an approximately negative exponential distribution, a curve with a negative slope 
which is initially steep but asymptotically approaches zero. This curve is fully 
defined by a single parameter, X ^; the larger the value of Xdu,, the steeper the 
initial slope. In the Peru study, the mean number of consecutive days of three 
or more liquid/semi-liquid stools was 2.6, and the distribution was well 
approximated by a negative exponential distribution with Xdur=0.67 (grouping all 
durations of 15 days or more and comparing observed versus expected 
distributions resulted in a x2 statistic of 0.53 on 14 d.f.). In the Ghana study, the 
distribution of durations was heavily influenced by heaping, on 7 and 14 days, 
but a similar pattern was apparent. It is therefore assumed that the duration of 
symptoms may be represented by a negative exponential distribution, with a 
parameter of Xdur«0.67, as estimated from the Peruvian data.
The third stage in the development of the model involved relaxing the 
assumption that the underlying rates of diarrhoeal illness would be the same for 
all children. In order to permit different ‘children’ in the simulated population 
to have different trigger event rates, the distribution of rates in the population 
is assumed to follow a Gamma distribution, a flexible family of curves 
commonly used to model skewed, continuous variables restricted to the positive 
range (Rothschild & Logothetis, 1986). A scaled-up Gamma distribution with 
parameters 1.5 (shape), 0.5 (scale) and a multiplying factor of 3 is used to model
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the between-child variation. This provides a degree of skew in the underlying 
rates intermediate between those observed in the two empirical data sets, with 
a mean rate of 9.0, as before.
Finally, the effect of seasonal variation in diarrhoea incidence is allowed for. 
This might be expected to increase the proportion of trigger events separated 
from the preceding event by relatively short intervals. Although many 
alternative seasonal patterns could be considered, the final version of the model 
incorporates a two-season split, with a mean rate of 5.4 trigger events/year in the 
first half of the year and 12.6 in the second half of the year. This 2.3-fold 
increase slightly exceeds the contrast observed in the Ghana data, in an area with 
a marked climatic change from dry to wet season. The data from Peru showed 
very little seasonality. Whilst the choice of contrast is arbitrary, it is felt 
unlikely that seasonal variation would exceed this level in many environments.
3 .4  Results fro m  the sim ulation m odel
3 .4 .1  The Basic M odel
The simplest version of the model, in which trigger events are determined by a 
simple Poisson process, is illustrated in Figure 3.3. In this figure, the 
distribution of intervals between consecutive trigger events is shown by a 
continuous line (the duration of symptoms following each trigger event is not 
considered at this stage). It is apparent from this figure, though perhaps not so 
intuitively, that the shorter the interval between trigger events, the more 
frequently it may be expected to occur. The most frequently encountered 
interval between one trigger event and the next is, therefore, an interval of one 
day or less.
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It should be noted at this point that the length of the period of observation may 
be expected to have a substantial effect on the proportion of all intervals 
observed between one trigger event and the next that are of short duration. This 
artefact arises because long intervals are more likely than short intervals to be 
censored by the end of the observation period. Thus, while 7.9% of all closed 
intervals are of 3 days duration or less (under the Poisson model) when the 
period of observation is 365 days long, 11.5% of all such intervals would have 
been of this length had the period of observation been limited to only 90 days.
3 .4 .2  A llo w in g  fo r  the duration o f  sym ptom s
When each trigger event is assigned a duration (randomly generated from a 
negative exponential distribution, as described above), it can be shown that 6.3% 
of all non-initial trigger events occur during the course of a pre-existing period 
of illness, and so would not be detected in a community study. Similarly, in the 
model, only a single period of symptoms is observed, starting with the first 
trigger event and ending when the child is no longer experiencing symptoms 
resulting from either of the tw o events.
The distribution of intervals between periods of diarrhoea symptoms (trigger 
events plus their associated durations) is shown by the bars in Figure 3.3. It can 
be seen that the distribution of intervals is not appreciably altered by the 
additional assumption that each trigger event is associated with a number of 
subsequent days of symptoms during which time the impact of new trigger 
events cannot be detected. Even lengthening the durations considerably does not 
alter the relative distribution of intervals between periods of symptoms. This is 
a property of the Poisson distribution.
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3.4 .3 A llo w in g  fo r  inter-child varia tio n  in illness rates a n d  seasonality
Figure 3.4 shows the distribution of the number of periods of diarrhoea 
experienced by each child in the two empirical data sets (Peru: one year of 
follow-up only; two alternative definitions of diarrhoea [see below, Section 3.4.4]) 
and in the simulation model when allowing for clustering of diarrhoeal illness 
within children. The distribution obtained from the model lies between the 
three observed distributions.
Table 3.2 shows the model distribution of intervals between periods of diarrhoea 
when clustering, and clustering plus seasonality, are added to the basic model. 
The distribution of intervals when neither clustering nor seasonality are present 
is also shown for comparison. With both clustering and seasonality incorporated 
into the model, 11.3% of all non-initial trigger events occur during the course of 
a pre-existing period of diarrhoea. Allowing for clustering of diarrhoea illness 
appears to substantially increase the proportion of short intervals expected, such 
that 12.6% of periods of diarrhoea are preceded by three or less symptom-free 
days, as opposed to only 8.0% without clustering. Allowing for seasonality 
produces a smaller increase in the expected proportion of short symptom-free 
intervals (9.3% of periods of diarrhoea are preceded by three or less symptom- 
free days with seasonality but no clustering, and 14.1% when both seasonality 
and clustering are present).
This approach allows us to calculate the sensitivities of alternative definitions of 
an episode, relative to the situation in which a single symptom-free day defines 
a new episode. The sensitivity of a particular definition is estimated as the 
proportion of all non-initial ‘episodes’ (separated by at least one day from 
previous periods of illness) that remain distinct (i.e. are not merged with previous 
‘episodes’) under the new definition. Table 3.3 shows the sensitivities of three 
alternative definitions of an episode - break periods of two, three and seven days
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without symptoms - assuming a range of different incidence rates and within- 
child clustering. The results demonstrate that under the assumptions of the 
model, requiring 7 days o r more free of symptoms between episodes would lead 
to up to one fifth or even a quarter of genuinely distinct periods of illness being 
combined in the analysis in situations of high incidence or high within-child 
clustering. The alternative definitions considered are associated with sensitivities 
above 90%, regardless of the incidence rate or degree of clustering.
3 .4 .4  Com parison w ith  em pirical data fro m  Peru an d Ghana
The distribution of intervals between periods of one or more consecutive days 
of diarrhoea in the two empirical data sets is shown in Figure 3.5. The data 
from Peru are presented for each of two alternative definitions of diarrhoea: 
under definition A, diarrhoea is defined as three or more liquid/semi-liquid stools 
in a 24-hour period. Under definition B, however, two liquid/semi-liquid stools 
in a 24-hour period also constitute diarrhoea providing that three or more stools 
were reported on both the previous and following days. It can be seen that there 
is pronounced heaping on intervals of one day duration in the Peru data set 
(definition A) and on intervals of seven and fourteen days in the Ghana data set. 
In the Ghana data set, the observed heaping seems to be an artefact of the data 
collection system, which was based on once-a-week home visits. It was noted for 
several of the most common conditions enquired about, and does not appear to 
be linked to the definition of diarrhoea.
Heaping in the Peru data set, on the other hand, virtually disappears with the use 
of the more flexible definition of diarrhoea (definition B). This suggests that 
many of the apparent single-day intervals should in fact be viewed as days of 
milder symptoms occurring during the course of a longer illness episode. If 
definition B is in fact the appropriate one, then these results may be used to 
derive a measure of the specificity of the single day cut-off to define a new
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episode of diarrhoea when diarrhoea is defined according to the standard 
algorithm (definition A). In this case, the specificity is lower than desired, at 
around 90%. The specificity of a two-day cut-off is, however, likely to be 
acceptably high.
3 .5  Conclusions fro m  the sim ulation m odel
Using a simple conceptual framework to develop a model of the distribution 
over time of diarrhoea symptoms in young children, the following principal 
findings emerge:
a) The true incidence of trigger events cannot, in practice, be observed, since 
many such events may occur when the child is already experiencing a period of 
diarrhoea occasioned by a previous trigger event. Where within child clustering 
of diarrhoea and seasonality are important, our model suggests that over 10% of 
all trigger events could be missed in this way.
b) With a high incidence of trigger events and clustering of çUarrhoeal illness in 
a subset of high-risk children, many periods of diarrhoea resulting from 
genuinely distinct trigger events are separated from each other by intervals of 
only a few days. In such circumstances, as many as 10-15% of all periods of 
diarrhoea may be preceded by just three diarrhoea-free days or less. The choice 
of the minimum number of days required to define a new episode may, 
therefore, have a considerable impact on the reported incidence of diarrhoea.
c) In a contrasting situation, with no clustering, and a lower incidence of trigger 
events - say, five trigger events per child per year - only around 5% of all periods 
of diarrhoea would be preceded by three or less symptom-free days. In these 
circumstances, the choice of the minimum number of days required to define a 
new episode w ill have much less impact on the reported incidence of diarrhoea.
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d) The model may be used to highlight irregular patterns in the distribution of 
interval durations in  empirical data. If the assumptions of our model are 
approximately correct, then these irregularities must be due either to deficiencies 
in the data collection instruments or to the occurrence of occasional symptom- 
free days in the course of ongoing episodes.
Examination of the tw o data sets from Peru and Ghana confirms the usefulness 
of the simulation model as an analytic tool. In broad terms, the hypothesised 
exponential distribution of interval durations is observed, but major disturbances 
are apparent. In the Peru data, a very large excess of single-day intervals between 
periods of illness is observed. It is possible to show that this is the consequence 
of single days of m ilder symptoms intervening in the midst of ongoing episodes. 
In addition to a slight excess of single-day intervals, there is a marked excess of 
seven- and fourteen-day intervals in the data from Ghana. It appears that in this 
study, the method of weekly recall employed led to an overestimate of the 
number of whole weeks that were completely free of diarrhoea. In this instance, 
examination of the observed distribution of intervals between periods of illness 
has highlighted important areas for further investigation.
e) In general, the model endorses the recommendations of previous studies, 
which have found that two or three days without symptoms w ill - in most 
circumstances - m ark the beginning of a new episode of diarrhoea. However, a 
definition in which an interval of just two symptom-free days is sufficient to 
mark a break between distinct episodes may be more appropriate in areas of high 
incidence rates and clustering. The development of a simple theoretical model 
may also help to suggest more appropriate definitions of diarrhoea itself than 
those currently in use. This is seen in the data from Peru, where a minor 
adjustment to an accepted definition of diarrhoea eliminates a substantial 
anomaly in the observed pattern of intervals between days of illness.
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3 .6  Biological plausibility o f the m odel assumptions
The primary assumption of this model is that trigger events are randomly 
distributed in time. This would clearly not be the case in a classic single-source 
epidemic; the model is thus only appropriate for endemic diseases, or for 
situations in which there are so many different pathogens producing sim ilar 
symptoms that even if each one of them occurred in epidemics, the overall effect 
would be of endemic illness. In the case of diarrhoeal disease in young children 
in developing countries, we have shown that large numbers of different 
pathogens (and non-pathogens) are capable of triggering symptoms of illness, and 
that these pathogens (and non-pathogens) are widely distributed in the child’s 
immediate environment. The random model is therefore probably justified. 
Indeed, it will be shown in Section 5.2.2 that for individual children (but not for 
populations), a Poisson model of disease occurrence over time appears adequate. 
In fact, there is some empirical evidence to suggest that the within-child 
variability of disease occurrence over time is slightly less than would be expected 
under the Poisson model. This ‘under-dispersion’ could be partially accounted 
for by the fact that new trigger events occurring during the course of an existing 
episode are not directly observed (the so-called ‘dead-time’ effect; see McCullagh 
& Nelder, 1989, p.193).
One important factor which could potentially invalidate the assumption of 
randomly distributed trigger events is the occurrence of altered susceptibility to 
infection as a result of a prior infection. It is indisputably the case that 
experience of a particular diarrhoeal pathogen confers at least partial protection 
against infection by that pathogen for a period of many months, if not years (see, 
for example, Levine et al., 1979). However, it is also clear that immunity is to 
a large degree serotype-specific. Given the large number of different diarrhoeal 
pathogens present in the environment, it appears unlikely that acquired 
immunity to a specific serotype would appreciably alter a child’s morbidity
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experience over a defined period of time. This supposition is borne out by the 
observation that rotavirus vaccine trials which have significantly reduced the 
incidence of rotavirus, the leading cause of childhood diarrhoea in many 
communities, have nonetheless failed to impact on all-cause diarrhoea (e.g. Lanata 
et al., 1989).
Recent advances in the epidemiology of persistent diarrhoea further support the 
conclusions of the simulation study. Baqui and co-workers (1992) in Bangladesh, 
and Lanata and co-workers (1992) in Peru have analysed sequences of stools from 
children with persistent diarrhoea identified in the community. Both groups 
found that few children had the same class of pathogen identified at different 
time points w ithin a single episode of ‘persistent’ diarrhoea. This unexpected 
finding suggests that rapid reinfection with pathogens common in the population 
is a reality in these highly contaminated environments, at least for a vulnerable 
sub-group of children.
3 .7  Extensions to other com m on illnesses
Figure 3.6 shows the respiratory morbidity of a group of children from the 
Ghana vitamin A study. Each child’s morbidity experience is shown by a single 
line, with Is o r Os representing the presence or absence of cough during each of 
54 consecutive weeks. Theoretically, similar methods to those described for 
diarrhoea could be used to determine appropriate definitions of an episode of 
cough, especially since there are many potential triggers of respiratory illness in 
young children. However, it can be seen that some children suffer from almost 
continuous respiratory illness over the entire period of follow-up. Even in less 
extreme cases, it is difficult to know whether one should reasonably talk of 
‘episodes’ of ARI lasting 3-6 months. In this case, measures of disease prevalence 
or burden are probably more informative. These will be discussed in Chapter 
7. As for low er respiratory infections such as pneumonia, these are so rare as to
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ensure that rapid re-infection will always be an extremely unlikely event.
Malaria infections also present specific problems for the analyst wishing to define 
discrete episodes. Due to the cycling of the fever and parasitaemia, it  is expected 
that the child will be without symptoms at many points during the biological 
episode (see, for example, James et al., 1932). Because of this cycling, a 
computing algorithm incorporating a long break period between episodes is 
clearly demanded on clinical grounds alone, even if this entails combining some 
genuinely distinct episodes in the analysis. Because of continuous exposure to 
mosquitoes and the existence of a number of different strains of malaria, the 
random distribution assumption is probably justified, although th is assertion 
requires verification.
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Table 3.1 Pathogens demonstrably associated with
diarrhoea in children in developing countries
Campylobacter jejuni 
Cholera
Cryptosporidium spp. 
Enteropathogenic Escherichia coli 
Enterotoxigenic Escherichia coli 
Giardia lamblia 
Rotavirus 
Salmonella spp.
Shigella spp.
Sources: Black et a l . , 1989; Molbak et a l . , 1994; Ogunsanya et al ., 1994; 
Taylor & Echeverria, 1993; Sima Huilan et a l . , 1991.
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Table 3.2 Distribution of durations of intervals betweendays of diarrhoea - simulated data.
Duration of No clustering Clustering Clusteringinterval No seasonality No seasonality Seasonality(days) % n % n V n
1 2.7 2052 4.4 3231 5.0 35922 2.7 2057 4.3 3141 4.7 33663 2.6 1975 3.9 2843 4.4 31154 2.5 1876 3.7 2673 4.1 29175 2.5 1856 3.5 2574 3.8 26986 2.5 1889 3.4 2497 3.6 25507 2.3 1743 3.1 2288 3.4 24398 2.3 1743 3.1 2252 3.1 22469 2.3 1737 2.9 2122 2.9 206710 2.2 1629 2.7 1941 2.8 200011 2.0 1535 2.4 1776 2.5 179412 2.1 1554 2.5 1789 2.3 164813 2.1 1545 2.3 1697 2.3 163414 1.9 1440 2.2 1602 2.1 149715 1.9 1399 2.0 1462 2.0 142916 1.9 1443 2.1 1513 1.9 137017 1.8 1384 1.9 1412 1.8 129518 1.7 1301 1.8 1326 1.8 128419 1.7 1266 1.7 1232 1.6 116620 1.6 1219 1.6 1173 1.6 1119
21 + 56.7 42666 44.2 32171 42.3 30266
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Table 3.3 Sensitivities of different definitions of an 'episode' under a variety of assumptions
on incidence and within-child clustering of trigger events.
Incidence :
No. of symptom- 
free days required to 
define new episode None*
Extent of within-child clustering 
Medium1 High1
LOW 2 days 98.7% 98.2% 97.8%
(3 trigger events 3 days 97.5% 96.5% 95.7%
/child/year) 7 days 93.0% 90.3% 88.2%
MEDIUM 2 days 98.4% 97.2% 96.2%
(6 trigger events 3 days 96.7% 94.3% 92.5%
/child/year) 7 days 90.6% 84.2% 79.9%
HIGH 2 days 97.3% 96.1% 94.9%
(9 trigger events 3 days 94.5% 92.2% 90.1%
/child/year) 7 days 84.5% 78.8% 73.6%
Notes : *) No extra-Poisson clustering (sickest 10% of the children experience 16% of the illness) 
t) 10% of the children experience 25% of illness. ♦) 10% of the children experience 33% of illness.
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Figure 3.1 Stool volume in adult volunteers
following a pathogenic dose of E . coli (Satterwhite et a l ., 1987)
Mean itool volume by group for day of study.
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Figure 3.2 Four months' diarrhoea morbidity, child 39, Lima, Peru
No o f  Csemi-3 I i q u i d  s t o o l s  per 24h
Date 0 9 8 9 }
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Figure 3.3 Frequency distribution of intervals between trigger events (simulation data)
L e n g t h  o f  I n t e r v a l  f i n  d a y s }  
E D w ith  random d u ra t io n  * w ith o u t d u ra tio n
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Figure 3.4 Frequency distribution of diarrhoea in children - Ghana, Peru and simulation data
Percentage  o f  a l l  c h i l d r e n  in  s tu d y  (cumu la t  i ve])
No. o f  p e r io d s  o f  d ia r r h o e a  e x p e r ie n c e d  
'^ 'G h a n a  “""P eru  (A J  " ' 'P e ru  f B )  "*"Slmu la t  ion
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Figure 3.5 Frequency distribution of symptom-free intervals between periods of diarrhoea
D u r a t io n  o f  i n t e r v a l  ( d a y s }
P e r u  ( d e f i n i t i o n  A j l p e r u  ( d e f i n i t i o n  Ghana
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Figure 3.6 Presence of cough over 54 consecutive weeks in 
children in northern Ghana
Weeks with 
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Chapter 4 Event Analysis (II): 
Rates, risks, and measures of association
4 .1  Measures o f  disease frequency
In the previous chapter, methods were proposed for defining an ‘episode’ of 
diarrhoea, respiratory illness or malaria. Once such episodes have been 
identified, it then becomes possible to compare individuals, or groups of 
individuals, by counting the total numbers of episodes observed over a defined 
period of time. Specifying the time period concerned is important since - in 
most circumstances - the number of illness episodes observed will be proportional 
to the length of the observation period.
Classically, two alternative measures of disease frequency (or incidence) are 
recognised for non-recurrent illnesses. Both include - structurally or by reference 
- a tim e element. The first, known as incidence density, or, more loosely, as the 
(average) incidence rate, is calculated by dividing the total number of new cases 
over a defined period of time by the amount of observation time accrued by the 
population at risk over the same period. Individuals may cease to contribute 
observation time by getting the disease or dying; moving out of the study area 
or refusing to participate; undergoing medical procedures which make them 
incapable of experiencing the outcome, or reaching the end of the study 
(Kleinbaum et al., 1982). Incidence rates are expressed per unit of person-time.
The second measure is referred to as cumulative incidence, and is defined as the 
proportion of all individuals entering the study who experience the disease 
outcome within a defined period of time. The public health relevance of this 
measure stems from the fact that it may sometimes be interpreted as the 
probability of a disease-free individual developing a given disease over a specified
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period of time, conditional on their not dying of something else first (referred 
to as the conditional risk of disease). This interpretation is strictly speaking only 
valid when all individuals are followed up for the same length of time 
(Kleinbaum et al., 1982). However, if the cohort is fixed and there is little 
attrition during the follow-up period, cumulative incidence provides a good 
estimate of average risk. If there is significant attrition of the initial cohort, the 
morbidity experience of those lost to follow-up cannot be known, and 
cumulative incidence may provide a biased estimate of average risk. The same 
applies when individuals are entering the study cohort at different times, a 
situation referred to as a ‘dynamic’ population. Actuarial (life-table) methods are 
available to estimate risk in these circumstances (see Lee, 1992).
For longitudinal studies of common diseases, rates are again an important 
measure of disease frequency. Since these diseases are recurrent, it is no longer 
appropriate, however, to define the incidence rate as the number of new cases of 
disease in those previously unaffected. Rather, the numerator of the rate may be 
estimated - as for non-recurrent diseases - as the total number of new cases over 
a specified period of time. The correct way to calculate the denominator (total 
observation time) has become a matter of some controversy: some researchers 
prefer to use the total follow-up time for the study population, whilst others 
prefer to subtract the duration of the disease, and others still subtract the 
duration of the disease and a further period beyond the end of the episode when 
the subject is considered not at risk of a further episode. These different 
approaches can be related to the discussion of trigger events presented in Section 
3.3: by dividing the total number of new cases by the total observation time, the 
average incidence of observed episodes is derived. Using this approach, an 
individual who is observed to suffer from 7 episodes of diarrhoea during a year 
of observation w ill be classified as experiencing an incidence rate of 7 per year. 
On the other hand, by dividing the total number of new cases by the total 
observation time minus the 'dead time’ when no new episodes can be observed
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(duration of illness plus duration of symptom-free interval required to define to 
new episode, see Chapter 3), an estimate of the true incidence of trigger events 
is obtained, based on the assumption that trigger events will continue to 
accumulate at the same rate whilst individuals are sick as they do when they are 
healthy. Thus, an individual who experiences 7 episodes, each of 3 days’ 
duration, will be classified as experiencing an incidence rate of 7.74 (—7/330 x 
365) per year, w ith the excess of 0.74 episodes per year representing the number 
of trigger events that are likely to have remained unobserved because they 
occurred during the time the child was already ill. Subtracting just the summed 
duration of illness from the total observation time is an unhappy compromise 
between these two approaches, because by not including the disease-free days 
required to define a new episode, the proportion of the total observation time 
during which new trigger events could have in reality occurred but could not be 
discerned in the study is underestimated.
The fundamental difference between these two measures of incidence needs to 
be carefully considered before any analyses are conducted: for the purposes of 
descriptive epidemiology, the incidence of observed episodes may be of greater 
interest, since this shows how often children experience bouts of illness from a 
given disease, with all the physiological consequences that may entail. When, 
however, the protective efficacy of a new intervention designed to interrupt 
transmission is being evaluated, the estimated incidence of trigger events may be 
a more appropriate measure. There is no guarantee, of course, that the true 
incidence of trigger events is adequately estimated by this method. In particular, 
if the duration of symptoms associated with consecutive trigger events ‘overlap’ 
(see Section 3.3), then this method will underestimate the true incidence of 
trigger events, since the true incidence of trigger events during the observed 
periods of illness w ill be higher than predicted.
The risk of being affected by disease over the follow-up period can also be
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estimated in longitudinal studies. In this case, only the first occurrence of disease 
in each subject is considered. With common diseases, most subjects will 
experience the disease outcome within a fairly short period of time. This is 
shown in Figure 4.1, which depicts the relative cumulative incidence of at least 
one episode of diarrhoea in 493 children with at least 51 weeks of follow-up in 
the study of childhood morbidity in northern Ghana described in Chapter 2. 
One half of these children had experienced an episode of diarrhoea within three 
weeks of the beginning of the study, and two-thirds had experienced an episode 
within 45 days. In such situations, risk becomes a rather uninformative measure 
if the time referent is longer than a few months. In addition, all the information 
on non-initial episodes is wasted. As in studies of non-recurrent illnesses, 
cumulative incidence may give a biased estimate of average risk when a dynamic 
cohort design is used, or rates of attrition from the initial cohort are high.
4 .2  Measures o f  association
Epidemiological measures of association can be derived from both rates and risks. 
Both absolute measures (such as the difference between two-rates) and relative 
measures (such as the ratio of two rates) may be derived, but two distinct factors 
favour the use of relative measures: firstly, they ‘fall out’ naturally from several 
commonly used statistical models for rates, such as Poisson regression (see 
Section 5.2.1); secondly, it has been shown that relative measures often provide 
clearer indications of the strength of epidemiological associations, and - when 
appropriate - causality (Cornfield & Haenszel, 1960).
The incidence density ratio (or simply, relative rate) is derived by dividing the 
incidence density in  a group exposed to some variable of interest by the 
incidence density in  the unexposed group. The time dimension of a single 
measure of incidence density drops out when the relative measure is used, so that
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the density ratio is dimensionless; furthermore, the total observation time is 
assumed to be prior-determined by the design of the study, so that all statistical 
variability is ascribed to the variation in the episode counts (see Section 5.2.1). 
The cumulative incidence ratio (or simply, relative risk) is derived by dividing the 
cumulative incidence in a group exposed to some variable of interest by the 
cumulative incidence in the unexposed group. The measure is also dimensionless, 
but refers to a specific time interval. Both the number of individuals 
experiencing disease, and the number of subjects observed are relevant in 
determining the statistical variability of this measure.
In longitudinal studies of common diseases of childhood, the interpretation of the 
relative rate w ill again depend on the w ay that the denominators of the rate have 
been calculated. Table 4.1 shows the results of a simulation in which both the 
incidence of trigger events and the duration of symptoms were assumed to vary 
with the age of the child. Mean incidence rates were assumed to fall linearly 
with age from 8 trigger events per child-year at 12 months to 4 trigger events per 
child-year at age 60 months. Between-child heterogeneity was allowed for as 
described in Section 3.2 (a chi-squared distribution with 3 degrees of freedom was 
used to generate individual-level trigger event incidence rates). Episode durations 
were randomly generated from a negative exponential distribution. Geometric 
mean durations were assumed to fall linearly from 2.36 days at age 12 months 
to 1.42 days at age 60 months. A uniform distribution of starting ages was 
assumed, with 10,000 individuals and 365 days of observation.
This simulation analysis shows that incidence rates calculated on the basis of 
observed episodes of illness are substantially affected by the choice of 
denominator. In the youngest age group, for example, the reported incidence 
rate is 12% larger (7.65 per child-year vs. 6.84 per child-year) when days of illness 
(plus the two-day symptom-free margin) are excluded from the denominator. 
Estimated rate ratios, comparing each group to the ‘corner’ group, are also
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slightly affected by the choice of denominator. This is because duration of illness 
acts as a confounder of the relationship between age and incidence, because 
duration is associated with age and is also taken into account in the calculation 
of incidence when the ‘dead-time’ approach is adopted. The confounding effect 
of duration is not large, perhaps because there was not a very large differential 
in average durations between the youngest and oldest age groups in this example.
It is important to note that although the estimates derived using observed 
episodes and denominators that exclude time ill and the 2-day symptom-free 
margin are closer to the actual incidence of trigger events than those derived 
when total observation time is used in  the denominator, they are not the same 
as the ‘real’ incidence of trigger events. In order for them to be the same, it 
would be necessary to subtract from the total observation time the sum of the 
durations associated with each trigger event; since periods of symptoms overlap, 
it is not possible to determine the duration associated with each trigger event 
separately, and the total time ill is not equal to the sum of these durations.
The relative risk is not a suitable outcome measure for longitudinal studies of 
common diseases of childhood. Because the risk of disease rapidly approaches 
unity in all groups, the relative risk measure also varies over time, approaching 
unity as the time referent increases. The relative rate, on the other hand, is 
constant over time (see Rodrigues and Kirkwood, 1990). The relative risk is also 
wasteful of information when the follow-up period is long enough to allow a 
substantial proportion of the study population to experience more than one 
episode, since non-initial episodes are ignored. Where there is substantial 
attrition of the initial cohort, relative cumulative incidence is liable to be biased 
as an estimator of relative risk, since the disease outcome of those lost to follow­
up is unknown. This poses a problem when a) rates of attrition are not the same 
between different exposure groups, or b) rates of attrition are balanced, but the 
prognosis of those lost to follow is differentially affected by exposure group.
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4 .3  A  review  o f  current practice in the epidem iological literature
In order to identify the range and quality of current practice regarding the choice 
and calculation of outcome measures in longitudinal studies of common diseases 
of childhood, I undertook a comprehensive review of a defined area of the 
epidemiological literature: trials of potential vaccines against enteric diseases, 
carried out (and reported) since 1980. This area was chosen because vaccine trials 
are necessarily characterised by prospective designs, and - since the intervention 
is intended to protect the individual from infection with the disease - the 
outcome is invariably reported as some form of incidence rate. Vaccine trials 
also have the advantage of being characterised by a clearly defined entry point, 
making calculation of time-at-risk a relatively simple procedure. A considerable 
number of such trials have been conducted to date, with a focus on three 
different gastro-intestinal pathogens: rotavirus, cholera and typhoid (see reviews 
by Black [1993] and Holmgren & Svennerholm [1990]). This chapter will 
concentrate on rotavirus (RV) vaccine trials, since cholera and typhoid are not 
common events even in areas where these diseases are endemic.
4 .3 .1  Methods
All references to rotavirus vaccine trials were sought by a search of Medline® 
1988-93, using the terms VACCINE plus either DIARRH* or ROTAVIRUS. 
Only reports of vaccine efficacy (as opposed to immunogenicity or 
reactogenicity) were retrieved. The bibliographies of all articles retrieved were 
then reviewed to identify any further vaccine trials carried out since 1980 and 
not previously indicated in the Medline® search. A total of 19 distinct RV 
vaccine trials were identified (of which four from bibliographies and review 
articles only). The studies are listed by alphabetic order of the first author in 
Table 4.2. All the papers were successfully located.
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4.3 .2  Results
Rotavirus vaccine trials have now been carried out in a wide variety of different 
settings, by 12 different groups of investigators and using substantially different 
study designs (Table 4.2). The studies differed markedly with respect to the 
number of children enrolled - some were clearly inadequate in this respect, since 
it is unlikely that any clinical trial could demonstrate a significant difference 
between treatment groups with only 13 children per group (#11). Recruitment 
procedures also differed considerably from trial to trial, with seven trials enroling 
at a single point in time, so that all children were in the trial and ‘exposed’ to 
the risk of diarrhoea (RV or other) for exactly the same period of time. At the 
other end of the spectrum, one trial (#12) employed rolling recruitment, so that 
the length of time ‘exposed’ would have varied from 0 to 17 months depending 
on each child’s sequential order of enrolment. In the eight trials where 
recruitment was rolling prior to the onset of the season of RV infections 
(‘RPOS’), time exposed to the risk of RV infection would be the same for all 
children, but time exposed to the risk of any diarrhoea would not (unless 
episodes of diarrhoea were recorded only during the RV season). Conversely, 
in those trials where rolling recruitment led into a fixed length period of follow­
up (‘R/FPFU’), all children are similarly exposed to the risk of all-cause 
diarrhoea unless there is very marked seasonal variation in diarrhoea incidence, 
but length of exposure to the risk of RV diarrhoea depends on the timing of the 
follow-up period with respect to the RV season. All but one of the RV vaccine 
trials recorded the impact on all-cause diarrhoea as well as on RV-specific 
diarrhoea, but due to the important interactions between study design and 
between-subject variations in  time-at-risk, the two outcomes will be considered 
separately.
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4.3.2.1 Aetiology-specific vaccine efficacy
Table 4.3 shows some important features of the 19 trials with respect to RV- 
specific outcomes. The trials have been re-ordered so that trials with similar 
design features appear together. This is to highlight the close dependence that 
exists between study design and choice of outcome measure.
The most homogenous group of studies in terms of presentation of results are 
those in which enrolment was staggered over the period of time immediately 
preceding the onset of the RV season (the ‘RPOS’ group). In 7 of these studies, 
surveillance was maintained over a single RV season (5-7 months). In the 
remaining study (#19), two consecutive seasons were considered, but findings 
were presented for each of the two seasons separately. Only three of the eight 
studies present data on losses to follow-up (due to death or out-migration) during 
the study period. In two of these three studies, however, the losses reported are 
substantial, amounting to nearly one-quarter of those initially recruited. At least 
five studies in this group have restricted their analysis of vaccine efficacy to those 
children who completed the study. This introduces a potential for serious bias - 
known as attrition bias (Dwyer & Feinleib, 1991) - if (a) rates of loss were 
different in the two groups, or (b) rates of loss were the same in the two groups, 
but the treatment group-specific prognoses of those children lost to follow-up 
were different from children remaining in the trial. Since no information is 
presented on the characteristics of those children lost to follow-up in these 
studies, the possibility of serious bias cannot be dismissed.
In all the studies in this group, the primary outcome was the cumulative 
incidence of RV diarrhoea over the duration of the season, a measure which has 
been denoted Cl (cumulative incidence). With significant attrition of the initial 
cohort, this measure may not provide an accurate estimate of an individual’s risk
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of RV illness over the follow-up period (see above, Section 4.1). If, however, it 
can be assumed that the losses to follow-up are balanced between the two 
treatment groups, then the ratio of these measures in each of the two treatment 
groups should provide an unbiased measure of effect equivalent to the risk ratio. 
Smith, Rodrigues and Fine (1984) have shown, however, that this is not the 
appropriate measure of vaccine efficacy when the risk of disease is not small and 
the model of action of the vaccine is that it reduces the probability of illness in 
all vaccinees by a constant proportion. This is because all study subjects may be 
expected to get the disease if surveillance is maintained for long enough, so that 
C l approaches un ity  in both groups over time, and the apparent vaccine efficacy 
diminishes. In th is situation, the rate ratio, rather than the risk ratio, provides 
the appropriate estimate of vaccine efficacy. This model of action (all vaccinees 
experience a reduced probability of illness) appears to be appropriate for RV 
vaccines, which, it has been suggested, prevent severe but not mild illness 
(Vesikari, 1993). The alternative model of action is that the vaccine prevents 
disease completely in some subjects, but is ineffective in others. In these cases, 
the risk ratio provides the appropriate measure of vaccine efficacy.
In the studies w ith  simultaneous enrolment, or rolling recruitment but a fixed 
period of follow-up (the ‘R/FPFU’ group), cumulative incidence-based analysis 
has tended to be adopted in the studies with relatively short periods of follow-up, 
and person-time based analysis in studies with longer follow-up periods (and, in 
general, a greater proportion of study subjects lost to follow-up). In study #6, 
it is not clear whether the analysis is based on all children vaccinated or only on 
those completing follow-up, and no rates or statistics are presented. In study 
#10, the outcome analysed is the proportion of all diarrhoea episodes with RV 
present in the two groups, which appears to be a statistically valid approach since 
the incidence of diarrhoea did not differ between treatment groups. In public 
health terms, however, the proportion of diarrhoea episodes attributable to 
rotavirus is of no interest if the overall incidence remains unchanged.
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In the one study where a rolling recruitment procedure was adopted (#12), two 
different analyses were performed. Firstly, the proportion of cases in the placebo 
and treatment groups was compared. This risk-type measure is conceptually 
rather unsatisfactory in a population where some individuals were under 
surveillance for a matter of days and others for 17 months, since children with 
very short follow-up times will appear in the denominator but in reality have 
little chance of inclusion in the numerator. The ratio of these proportions in the 
two treatment groups will be sensitive to the number of subjects w ith  short 
follow-up periods, and will be biased if the average follow-up time per individual 
is not the same in each treatment group, or the rate of disease is related to the 
period of follow-up. Furthermore, the inflated denominators will very slightly 
inflate the precision of the effect estimate (if analysed as a risk ratio), though this 
effect is likely to be negligible.
The second analysis performed in this study focused on the average duration of 
time elapsing between vaccination and disease in the different treatment groups. 
This analysis is highly efficient in that it utilises all the information available 
about the relationship between exposure and outcome, and individuals whose 
follow-up is censored still contribute information for the length of tim e they 
were under surveillance.
4 .3 .3 .2  Non-specific vaccine efficacy
Data from 18 of the 19 trials relating to the analysis of the impact on all-cause 
diarrhoeal illness are presented in Table 4.4. It should be noted that for all but 
one of the ‘RPOS’ group, diarrhoea surveillance commenced immediately post­
vaccination for each study subject, with the result that time at risk varied 
considerably for individuals within each study. Numbers of episodes recorded 
are substantially larger than for the cause-specific outcome, and in this table the
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number of diarrhoea episodes is shown for both treatment groups. Four studies 
had more than one treatment arm (#19, #9, #10 and #12).
Only six studies quoted any measure of disease frequency in their results. In 
three instances (#9, #10, #12), the outcome measure chosen was the average 
incidence rate, IDR. Two authors chose to use the formula in which the total 
number of episodes is divided by the total time under observation (#9, #10), 
whilst the other author seems to have used the ‘time at risk’ formulation 
(denominator = observation time - duration of illness - symptom-free margin). 
In study #11, the cumulative incidence of diarrhoea over the duration of the study 
period was the outcome measure reported, and the risk of non-RV diarrhoea was 
presented in study #4. In all the other studies the outcome measure used, either 
explicitly or otherwise, was the total number of diarrhoea episodes divided by 
the number of children entering the trial. This measure has no commonly 
accepted epidemiological interpretation, and is a poor proxy for the incidence 
density rate, IDR. However, provided that the average length of follow-up is 
similar between treatment groups, the ratio of these rate-like measures in the two 
treatment groups will be equivalent to the true rate ratio, and the precision of 
the effect measure will also not be affected.
4 .4  Discussion
Both risk (as estimated by cumulative incidence) and rate (as estimated by the 
incidence density rate) are important outcome measures in studies of non­
recurrent or rare diseases. It is clear, however, that cumulative incidence has 
severe limitations as a measure of the frequency of common diseases of 
childhood, because it rapidly approaches unity with time referents longer than - 
say - one month, in the case of diarrhoea in areas with incidence rates of the 
order o f 7 episodes per child per year. This has the highly undesirable effect that
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the epidemiological measure of association derived by dividing the cumulative 
incidence in a group exposed to a particular risk factor b y  the cumulative 
incidence in the unexposed group also approaches unity as the length of the time 
referent increases, regardless of the magnitude of the true effect. Relative rates, 
on the other hand, are time invariate, and are also not prone to bias as a result 
of attrition of the initial cohort.
There is little evidence to suggest, however, that the limitations of cumulative 
incidence, especially when applied to a dynamic population, are appreciated by 
those actually carrying out applied research in the area of common diseases of 
childhood. Inspection of the 19 rotavirus vaccine trials carried out since 1980 
reveals that the use of cumulative incidence is widely favoured. The problem of 
unequal lengths of follow-up is overcome by restricting analysis to those study 
subjects who completed the follow-up period. Post hoc exclusion of study 
subjects from the analysis may not, however, be a desirable solution to this 
problem, since it introduces an important risk of bias. Where it is done, it is 
essential that the reader be informed of the number of subjects involved, and 
whether or not they are equally divided between treatment groups. 
Furthermore, depending on the mode of action of the vaccine,-risk estimates may 
lead to inappropriate measures of vaccine efficacy, as discussed above.
Estimation of incidence density rates in studies of common diseases is sensitive 
to the choice of denominators: whether or not the duration of illness and 
symptom-free margin are subtracted from the total observation time. Relative 
rate measures are also somewhat sensitive to the choice of denominator. Whilst 
there is no clearly ‘correct’ approach in this case, it appears that subtracting the 
illness duration and symptom-free margin produces a measure with no 
straightforward intuitive interpretation, since it represents neither the frequency 
of observed bouts of illness, nor the ‘true’ frequency of trigger events. Since 
analysis of disease duration must focus on observed bout lengths rather than the
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duration of symptoms associated with each trigger event (the latter being 
unobservable), the principle of internal consistency would suggest that analyses 
of disease frequency should also focus on observed bouts, unless there are strong 
a priori reasons for not doing so. It may be noted that the calculation of 
stratum-specific follow-up time is far more complex when the duration of illness 
and symptom-free margin needs to be subtracted. These considerations suggest 
that total observation time should generally be used in the denominators of 
incidence rates.
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Table 4.1 Trigger events, observed bouts of illness, and illness incidence rates calculated
by three different methods in a simulated data set
Age Group 
(months)
Total no. 
of trigger 
events
Total
observation
time
(months)
Trigger event 
incidence 
rate (yr'1) + 
R R s
Total no. 
of observed 
episodes
Observation 
time less 
'dead time* 
(months)
Obs. episode 
incidence 
rate (yr'1) 
(1) + R R s
Obs. episode 
incidence 
rate (yr'1) 
(2) + R R s
12- 2683 3922.01 8.21 2235 3507.33 6.84 7.65
18- 7346 11626.33 7.58 ( 0 . 9 2 ) 6265 10434.43 6.47 ( 0 . 9 5 ) 7.20 ( 0 . 9 4 )
24- 9140 15302.98 7.17 ( 0 . 8 7 ) 7921 13870.36 6.21 ( 0 . 9 1 ) 6.85 ( 0 . 9 0 )
30- 8416 15195.76 6.65 ( 0 . 8 1 ) 7427 13958.36 5.87 ( 0 . 8 6 ) 6.38 ( 0 . 8 3 )  1
36- 7453 15054.10 5.94 ( 0 . 7 2 ) 6720 13998.79 5.36 ( 0 . 7 8 ) 5.76 (0.75)
42- 7032 14877.33 5.67 ( 0 . 6 9 ) 6434 13949.27 5.19 ( 0 . 7 6 ) 5.34 ( 0 . 7 0 )
48- 6270 14713.37 5.11 ( 0 . 6 2 ) 5810 13918.47 4.74 ( 0 . 6 9 ) 5.01 (0.65)
54- 5926 14736.73 4.83 ( 0 . 5 9 ) 5498 14018.01 4.48 ( 0 . 6 5 ) 4.71 ( 0 . 6 2 )
60- 5333 14571.39 4.39 ( 0 . 5 3 ) 5035 13938.27 4.15 ( 0 . 6 1 ) 4.33 (0.57)
TOTAL 59599 120000.00 5.96 53345 111593.29 5.ÎÎ 5.74
Notes: (1) Incidence rate calculated using total observation time in the denominator
(2) Incidence rate calculated using total observation time minus 'dead time' in the denominator
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Table 4.2 Rotavirus vaccine trials -Basic details and design features
F P. Investigator Country Vaccine n1 Recruitment’
l. Bernstein (1990) USA WC3 103 RPOS (3 months)
2 . Christy (1988) USA MMU
18006
88 RPOS (4 months)
Clark USA
3. (1988) WC3 55 RPOS (4 months)4 . (1990) WI79-9 39 RPOS (? months)
5. De Mol (1986) Rwanda RIT 4237 123 Simultaneous
6 . Georges-Courbot C. Afric. WC3 235 R/FPFU(1987) Republic
7. Gothefors (1989) Sweden MMU
18006
51 ± Simultaneous
8 . Hanlon (1987) Gambia RXT 4237 83 RPOS (11 I 
months)
9. Lanata (1989) Peru RIT 4237 100 R/FPFU
10. Perez-Schael Venezuela MMU 151 R/FPFU
(1990) 18006
11. Rennels (1986) USA MMU
18006
13» RPOS (2 months)
12. Santosham (1991) USA RIT 4237 107 Rolling
Vesikari Finland
13. - a (1984) RIT 4237 92 Simultaneous14 . -  b (1985) RIT 4237 160 RPOS15. - c (1990) RIT 4237 121 * Simultaneous16 . - d (1991) RIT 4237 128 ± Simultaneous17. - e (1990) RIT 4237 122 ± Simultaneous18 . - f (1990) RRV-1 100 ± Simultaneous
19. - g (1992) DxRRV
a n d
DSlxRRV
120 RPOS
N o t e s ■
1. Number of children in placebo group.
2. Recruitment procedure. Codes«
RPOS - rolling recruitment prior to onset of rotavirus season
(in parentheses, period over which recruitment is staggered) 
R/FPFU - rolling recruitment with fixed period of follow-up
3. Only 10 children were actually followed up for diarrhoea incidence.
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Table 4.3 Rotavirus vaccine trialsRV-specific outcomes
# Recruitment Time at Losses to No. of Measure ofrisk Follow-up Episodes Incidence ;
(1) (2) (3) placebo placebo (4)
5 . Simultaneous 4 months ? ■p (5) -
7 . ± Simultaneous 2x4 mon.s none 17 Cl =0.333 [i]
13 . Simultaneous 5 months 6.3% [e] 18 Cl =0.196 [q]
15. ± Simultaneous 32 months 22% 24 IDR=0.088 [q]
16 . ± Simultaneous 28 months 16.3% 25 IDR=0.115 [q]
17. ± Simultaneous 24 months 13% 16 IDR=0.077 [q]
18. ± Simultaneous 17 months ? 16 Cl =0.160 [i]
1. Rolling POS 7 months ? 25 Cl =0.250 [q]
2. Rolling POS 6 months ? 17 Cl =0.193 [i]
3 . Rolling POS 5 months ? [e] 14 Cl =0.255 [q]
4 . Rolling POS 1 season ? [e] e Cl =0.205 [q]
8 . Rolling POS 1 season 23.3% [e] 34 Cl =0.410 [q]
11 . Rolling POS 6 months 23.1% [e] 3 Cl =0.300 [i]
14 . Rolling POS 6 months 4.6% [e] 27 Cl =0.169 [i]
19. Rolling POS 19 months ? 9 + 9“’ Cl =0.075 [6]
6 . Rolling /FPFU 9 months 12.3% [?] 59 Cl =0.251 [i] I
9. Rolling /FPFU 18 months 12.8% 35 IDR=0.276 [i]
10. Rolling /FPFU 12 months 19.7% 7 (5) % RV+—9.9%
12 . Rolling 0-17 mo.s 3.3% 9 IDR=0.072 [i]
(1) Recruitment procedures. Codes«RPOS Rolling recruitment prior to onset of RV seasonR/FPFU Rolling recruitment with fixed period of follow-up(2) For RPOS group, time-at-risk is arbitrarily defined as the interval between the last vaccination and the termination of the study.(3) Losses to follow-up calculated where information available.[e] indicates that the children lost to follow-up were excluded from the analysis as presented.(4) Cl is the cumulative incidence of RV diarrhoea over the follow-up period. IDR is the average incidence rate of disease over the follow-up period. [q] indicates that the rate is quoted in the article, [i] indicates that it is implicit.(5) In these studies, there was incomplete ascertainment of aetiologies.(6) Number of episodes in each season. Rate is per season.
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Table 4.4 Rotavirus vaccine trials 
All diarrhoeal illness
# Recruitment Time at No. of No. of Measure ofrisk Episodes Episodes Incidence
(1) vaccine placebo placebo (2)
5 . Simultaneous 4 months ? ? c/N-0.98 tq]
7 . ± Simultaneous 2x4 mon.s 75 79 c/N-1.55 [i]
13 . Simultaneous 5 months 15 28 c/N-0.30 [q]
15 . ± Simultaneous 32 months
' 181 171 c/N=0.70 [i]17. ± Simultaneous 24 months .
16. ± Simultaneous 28 months 72 76 c/N-0.59 [i]
18. ± Simultaneous 17 months 37 52 c/N=0.52 [i]
1. Rolling POS 7-9 mon.s 153 179 c/N-1.74 [i]
K) Rolling POS 6-10 mon.s 59 58 c/N-0.66 ti)
3 . Rolling POS 5-9 mon.s 12 35 c/N=0.64 [i]
4‘ Rolling POS ?-10 mon.s 18 20 c/N=0.51 [3]11. Rolling POS 6-7 mon.s 4 14 c/N-1.40 [i]Cl =0.80 [i]
14 . Rolling POS 6 months 27 42 c/N=0.26 [i]
19. Rolling POS 9-22 m.s 48,37 70 c/N-0.58 [i]
6 . Rolling /FPFU 9 months 514 479 c/N=2.56 [4]
9. Rolling /FPFU 18 months 1051,11921 189 1343 . IDR=10.6 [q]
10. Rolling /FPFU 12 months 294,48 290 IDR=2.24 [q]
12 . Rolling 0-17 mo.s 397,404 383 IDR.3.9 tq]
Notas :
(1) Recruitment procedures. Codes-RPOS Rolling recruitment prior to onset of RV seasonR/FPFU Rolling recruitment with fixed period of follow-up(2) c/N is the number of diarrhoea episodes per child enrolled in the study Cl is the cumulative incidence of diarrhoea over the follow-up period IDR is the average incidence rate of disease over the follow-up period [q] indicates that the rate is quoted in the article, [i] indicatesthat it is implicit in the data quoted in the article.(3) The cumulative incidence of non-RV diarrhoea is quoted in the text.(4) A tabulation of number of episodes per child (grouped data) ispresented.
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Cumulative incidence of diarrhoea
in 493 children with 51 weeks of follow-up
in northern Ghana
relative cumulative incidence of diarrhoea
0 28  56  84  112 140  168  196  224  252  280  308  336  364
days from start of study
Figure 4.1
Chapter 5 Event Analysis (III): 
Statistical issues and methods
5 .1  Introduction
In the previous chapter, different options for the choice of outcome measures in 
longitudinal studies of common diseases of childhood were discussed, and the 
advantages of the incidence rate were highlighted. As stated in that chapter, 
estimation of the incidence rate involves counting the total number of new 
episodes over a specified period of time, and dividing that number by the total 
observation time accruing to the study population over the same period. This 
measure is referred to by Kleinbaum et al. (1982) as the incidence density rate-, it 
can be viewed as the average value, over the duration of the time band, of a more 
fundamental measure of disease frequency, termed the instantaneous rate of illness, 
X, which cannot itself be measured because it is constantly changing. The 
instantaneous rate (also sometimes called the ‘force of morbidity’) is considered 
to be the ideal outcome measure for studies "attempting to relate disease 
occurrence to genetic and environmental factors in a framework of causation" 
(Breslow and Day, 1980). It may be defined for a particular individual (X,; i 
varies from 1 to n), a particular time period (Xf; t varies from 1 to m), a group 
of individuals, or the whole study population.
Methods for analysing illness rates are well developed for outcomes which can 
occur only once (Breslow and Day, 1987). In this situation, when an individual 
has once experienced the relevant outcome, they cease to be considered at risk 
and contribute no further observation time. With recurrent diseases, on the 
other hand, individuals are not eliminated from the ‘at risk’ group after 
experiencing the disease outcome (except when a restrictive ‘first-occurrence’ 
analysis is undertaken, which involves discarding information on all non-initial
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episodes). The possibility that certain individuals may contribute more than one 
outcome over the period of observation give.* this type of data a dimension that 
is missing in non-recurrent disease data.
In this chapter, I investigate more closely the features of longitudinal count data 
on the incidence of common diseases, using as an example data on diarrhoea 
morbidity drawn from the Ghana VAST Child Health Study described in 
Chapter 2. Episodes are defined as proposed in Chapter 3. Having outlined 
some of the salient statistical features of such data, and the problems that these 
features give rise to, I then review three alternative methodologies that have been 
developed by statisticians over recent years to overcome some of the difficulties 
encountered. This involves the application of the criteria for the evaluation of 
statistical models proposed in Section 1.5. I then identify the analysis strategies 
actually pursued by the researchers conducting the trials of rotavirus vaccine 
efficacy described in Section 4.3, highlighting areas where these fail to address 
issues outlined earlier in the chapter. To aid the reader, a G L O S S A R Y  of the 
technical terms and symbols used in this chapter is provided as Appendix A.
5 .2  Statistical featu res o f longitudinal data on com m on diseases
5 .2 .1  Notation
Longitudinal data on common diseases of childhood may be conceptualised in 
terms of a two-dimensional matrix: the columns of this matrix represent calendar 
time, with the total period of observation divided into m equal-length segments 
(or bands). The rows of the matrix represent each of n study subjects. The 
values in each cell correspond to the number of illness episodes observed for 
individual i and time band t, conventionally shown as y„ (mxn realisations of a 
random variable KJ. Dividing yu by the length (in units of time) of time band
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t gives an estimate of X,„ the time- and subject-specific rate of illness per unit 
time:
Time periods (f)
1 2 3 4 ... m-4 m-3 m-2 m-1 m
1 V i i y t2 y 2j y  l.ml y ,m
s
u
2 y 22 y 22 y 2m
b 3 y3i y 3m
j 4
e
c
... y,<
t n-3
s n-2
(0
n-1 y n -l,m
n y nl y n2 yn j % yn,m-l y nm
In all of the following discussions, the unit of time is taken to be one time band; 
the estimated rate per unit of time, X,„ is therefore the same as the observed 
number of episodes, yir
If the length of follow-up is assumed to be invariate, the analysis of rates focuses 
on the sampling variability of the observed number of episodes, y„ (Breslow & 
Day, 1987). Following the usual notation for Generalised Linear Models 
(McCullagh & Nelder, 1989), the expected value of Yit is denoted E(YJ, and its 
variance is given by:
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Var(yi[) = <t>.v,
where vit is a specified variance function and <t> is a dispersion parameter that may 
or may not be known.
The mean, E(YJ, is related to a linear transformation of a series of p explanatory 
variables (given the vector notation x j ,  multiplied by their respective regression 
coefficients 0. The linearising transformation is referred to as the link function. 
Thus, we can say that the mean, E(YJ, is related to the linear predictor 
yit = 0 xit by the link function g{E(YJ} = rjlt, with inverse h = g 
Denoting the response vector by Y, the mean therefore satisfies
£(Y) -  ¿(X 0)
As is apparent from the matrix shown above, the variability of Yit can be divided 
into two components: that which is accounted for by differences between study 
subjects (between-subject variability) and that which is accounted for by within- 
subject differences from one time period to the next (within-subject variability). 
In the following two sections, each of these sources of variation is described in 
greater detail.
5.2.2 W ithin-subject variability
Figure 5.1 illustrates the morbidity experience of sixteen children followed for 
the entire length of the study. In this figure, each 3 mm-high solid block 
represents a new episode of diarrhoea: child A019, for example, experienced one 
episode in the first time period, three in the second, two in the third and so on. 
For each child, the average number of incident episodes of diarrhoea per four
A
weeks of follow-up, \ , is shown in the penultimate column, and the variance of
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this episode count over the 13 4-week periods is shown in the final column. 
Casual inspection suggests that the variance tends to be close to the mean rate. 
This is what would be expected if, at the level of the individual, episodes were 
distributed randomly in time and thus conformed to a Poisson model (Whittle,
1970).
In Figure 5.2, the mean 4-weekly episode count for each child for whom a full 
52-weeks of morbidity data were collected is plotted against the variance of the 
13 observations for that child (n = 271). Also shown is the straight line 
representing the relationship variance = mean episode count. Although there is 
some scatter about this line, and although this variation increases as the mean 
episode count increases, there does appear to be an approximately linear 
relationship between these two parameters. There is some indication that the 
variance may not increase quite as rapidly as the mean episode count: using the 
method of Ordinary Least Squares to calculate the regression coefficients for the 
line best describing the relationship between these two parameters, and 
constraining the intercept to take the value 0, since this is fixed a priori, the 
relationship can be described by the equation:
Va  ^ — 0.84 x \
A
Where A, represents the average number of episodes per 4 weeks of observation 
for child *'. The calculated standard error of the slope estimate (0.022) cannot be 
relied upon because of the increasing scatter around the regression line 
(‘heteroscedasticity’), but there is at least a suggestion that the true slope is less 
than one. This situation, known as under-dispersion, implies that at the level 
of each individual, disease rates are slightly less variable from month to month 
than would be expected under the random occurrence model. One plausible 
explanation for this slight departure from the Poisson model is that trigger events 
are randomly distributed in time, but that those occurring during the course of
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an existing episode fail to be recorded, most frequently when the true incidence 
is high (see Chapter 3). This situation is equivalent to the ‘dead-time’ 
experienced by Geiger counters following the arrival of a radioactive particle, as 
described by McCullagh & Nelder (1989) in their discussion of commonly 
encountered departures from the Poisson model.
5 .2 .3  Between-subject variability
N ot only do the number of episodes vary at the individual level from month to
A
month, but the average rate, also varies from individual to individual. Figure
5.3 shows the total number of episodes of diarrhoea experienced by each of the 
271 children over the 52-week study period (solid bars). The distribution is 
h ighly skewed to the right, so that whilst many children experienced only a few 
episodes over the year, a few experienced over 20. The mean number of episodes 
per child was 6.23, with a variance of 33.8.
Even if the underlying propensity of each child to diarrhoea had been the same, 
there would still have been some random between-child variability in the number 
of episodes observed over the study period. The resulting distribution would, 
under these circumstances, follow the Poisson distribution, which, with a mean 
of 6.23 is almost symmetrical and has a variance of 6.23. The distribution 
expected under the null hypothesis of no heterogeneity in underlying disease 
rates is shown by the hatched bars in Figure 5.3. There is far more variability 
in the observed total episode counts than would be expected under this 
unrealistic null hypothesis. This situation is referred to as over-dispersion 
(McCullagh & Nelder, 1989). Some of this variability w ill be explained by 
measured individual-level covariates such as age and socio-economic status. Other 
important covariates will either have been measured imprecisely, or not measured 
at a ll. The impossibility of including all predictors in the systematic component
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of the model will thus leave a portion of the between-child variability 
unexplained.
Because of this heterogeneity in individuals’ underlying propensity to illness, 
disease rates measured at different points in time on the same individual will tend 
to be more similar than disease rates measured at different points in time on 
different individuals. That is to say, there is within-subject correlation between 
disease incidence rates in different time periods. Table 5.1 shows - for the 271 
children with complete morbidity records - unadjusted correlations between 
diarrhoea episode counts in each combination of the thirteen different time 
periods. In this case, there is some suggestion that the correlations may decrease 
somewhat as the time interval between the two observations increases, a situation 
which may be modelled as as stationary correlation.
This correlation cannot be ignored in the analysis. To do so would result in the 
overestimation of the precision of all effect estimates. The reason for this is as 
follows: when determining the precision of either stand-alone or effect estimates, 
assumptions are made about the relationship between the sample variance, s2, and 
the population variance, o2. It can be shown that, provided that each member 
of the sample is equally likely to be selected,
where otJ represents the covariance between any two observations of the outcome 
variable (Dwyer & Feinleib, 1991). ‘Standard’ analyses then proceed on the 
assumption that a,;=0 whenever i^ j  (i.e. zero covariance between different 
elements). This allows the second half of the right-hand side of the equation to 
be ignored, greatly simplifying the analysis. The existence of within-subject 
correlation, however, invalidates this simplifying assumption, leading to the
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underestimation of all standard errors which include the element a2 (that is, the 
standard errors of all effect estimates) if the correlation is not explicitly modelled.
Although the principal effect of within-subject correlation is to produce bias in 
the estimated precisions, it is important to note that with categorical outcomes 
effect estimates themselves are biased when correlations are ignored (Dwyer & 
Feinleib, 1991). This is a result of the relative down-weighting of multiple 
episodes occurring to the same individual that occurs when correlation is taken 
into account. The extent of this bias is investigated in the following chapter.
5 .3  Statistical m odels fo r  correlated, categorical data
Considerable efforts have been devoted to tackling the problems of correlated 
response data when the response variable is continuous, and can be assumed to 
come from an underlying Normal distribution. Both Analysis of Variance 
(ANOVA)-type methods and regression models have been developed for such 
situations. However, the assumption of Normality, common to both these 
procedures, is wholly inappropriate for the distribution of numbers of disease 
episodes recorded over a specified period of time. This is because episode counts 
can only take whole integer, positive values; tend to show a highly skewed 
distribution, and are characterised by greater variability at higher average levels.
Unfortunately, models for correlated, categorical data are as yet less developed. 
In this section, I discuss three regression-type approaches to the analysis of such 
data that have been proposed over recent years. These approaches are the 
conditional or transition models widely favoured in econometric modelling 
(Gujarati, 1988), and established for at least the last fifteen years in the area of 
respiratory health; ‘multi-level' models, developed much more recently in the 
field of education (Goldstein, 1987); and a family of marginal models, especially
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the semi-parametric Generalised Estimating Equations which have recently been 
developed in the Johns Hopkins University School of Public Health, Baltimore 
(Liang & Zeger, 1986). All of these models are described, and then, in Section 
5.5, critically assessed using the criteria developed in Section 1.5.1.
5 .3 .1  C onditional models
One of the most intuitively appealing approaches to the problem of serial 
(between one time period and the next) correlations in longitudinal data has been 
the explicit inclusion of variables describing a subject’s previous state as 
predictors in models seeking to explain his/her subsequent state. Such models 
are termed conditional models because the response variable is not the vector of 
outcomes y as it stands, but rather the probability of observing a particular value 
yit given that the same individual had a known set of outcome(s) in previous time 
period(s). This may be expressed as:
Because the response variable is not simply the vector of outcomes Y, these 
models have a quite different interpretation to other models more widely used 
in health research: the focus is on individual-level change over time rather than 
on net population-level differences between sub-groups. As indicated by Ware 
et al. (1988), such models do not address questions such as ‘How does the 
prevalence of asthma change with age?’; instead, they answer questions such as 
‘Does the frequency of reported wheezing in  children free of wheezing a year 
earlier vary according to the age of the child?’. Because of this subject-specific 
focus, these models are sometimes termed ‘transition models’. It has been 
suggested that this focus might be appropriate for estimating from observational 
data the likely health impact of proposed interventions (Dwyer & Feinleib, 1991).
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Two crucial issues arise when fitting models of this type. The first relates to the 
number of previous states that need to be included in the model in order to fully 
capture the autoregressive structure. For example, an early paper on the 
relationship between asthma and air pollution (Korn and Whittemore 1979) 
included a variable relating to subjects’ asthma status on the preceding day as a 
predictor of asthma attacks on the index day. This is known as a first-order 
autoregressive model. The effects of health status on days further removed from 
the index day (known as ‘higher order dependencies’) are not explicitly included 
in the model. Ware et al., on the other hand, show that their model of changes 
in children’s wheezing status from one year to the next is significantly improved 
by including the response at t - 2, a second-order autoregressive model. 
Obviously, if the individual’s history over two previous time periods has to be 
included in the model, then the first two observations cannot be used in the 
outcome matrix, as the relevant previous information does not exist. Such a 
limitation is wasteful and has serious implications for studies in which data is 
only collected on a limited number of occasions.
Secondly, there is an assumption in this kind of modelling that transition 
probabilities are independent of time. This means that changes in state from 
time t • 2 to time t - 1 are assumed to occur with the same probability as 
between times t - 1 and t. Since violations of this assumption (and the existence 
of high-order dependencies) make these models difficult to fit (Markus, 1979, 
quoted in Ware et al., 1988), less restrictive variants of the basic procedures have 
been sought. One example is a quasi-likelihood approach recently developed by 
Zeger and Qaqish (1988). Estimation techniques can be complex for 
autoregressive models, since there is a danger that correlations between 
explanatory variables and the random error can induce bias and inconsistency in 
the estimators. Missing data can be particularly troublesome, and observations 
must be evenly spaced in time.
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W ith the notable exception of the area of wheezing and air pollution, conditional 
models have not been widely used in research on common diseases of childhood. 
Generally, epidemiological research has focused on identifying disease differentials 
between distinct population sub-groups, and conditional models are ill-suited to 
address these questions. Furthermore, autoregressive models may fail if 
exposures affect subjects’ initial state as well as their transitions between states 
(Stram et al., 1988), a scenario that frequently arises in epidemiological studies.
5 .3 .2  ‘M ulti-level* models
Another area which offers exciting prospects for the analysis of longitudinal data 
in the future is what has been termed ‘multi-level’ modelling. This approach is 
being pioneered by Goldstein and colleagues at the Institute of Education in 
London (see Goldstein, 1987). This type of model explicitly recognises that units 
of observation at one level are grouped within units at the next higher level; in 
theory, at least, any number of hierarchical levels can be defined, so that one can 
envisage analyses in which multiple observations on each subject constitute the 
basic unit of analysis, with subjects themselves as the second level, families as the 
third, communities as the fourth and so on. Covariates can be included at each 
level of the analysis, and can be fixed or random. A major goal of this type of 
analysis as it is currently being developed consists of estimating how much of the 
variability in the outcome corresponds to each of the various levels in the 
hierarchy.
The underlying ideas of multi-level modelling are illustrated with an example 
relating a continuous outcome (such as weights of young children) measured on 
multiple occasions to two sets of occasion-specific and child-level covariates. The 
example is adapted from Goldstein (1987). Let the subscript i refer to the child 
and the subscript t to one of n, multiple observations on each child. There are
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thus a total of n observations. In an extension of the previously used notation 
for Generalised Linear Models, xlt is a vector of occasion-specific covariates, and 
z, is a vector of child-level covariates. The basic model is thus:
yit = a0 + a, + /3xIt + yz, + e„
where ag is the grand mean (the intercept term for the reference, or comer, 
individual), and a, is an individual-specific intercept term for child i. The 
random term elt is independently distributed within each child i with an expected 
value of zero and constant variance, o2.
In multi-level modelling, the individual-specific intercept, a„ is treated as a 
random variable with expectation of zero and constant variance, a 2, and the 
model is rewritten as:
y,, = a + /3xit + yz, + (a, + e j
This model includes elements from both levels in both its fixed and random 
parts. Goldstein (1986) has developed methods for estimating the parameters a, 
0, y , o2 and o 2 by Iterative Generalised Least Squares (IGLS). The approach is 
extremely flexible, and permits modelling of random coefficients as well as 
random intercepts; this in turn allows for variance heterogeneity to be 
introduced into the model by means of random coefficients with zero expected 
values. In the case of discrete data, the squares of the random variables can be 
introduced into the model as additional random terms if this is desirable to 
improve the fit of the linearising transformation (Goldstein, 1991).
With these models, epidemiologists may be able to address issues that they had 
no means of addressing previously - particularly exciting is the prospect of being 
able to determine where ‘unexplained variance’ in disease rates actually arises,
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whether at the individual, household or community level. However, this very 
flexibility may constitute an important barrier to the widespread adoption of 
these techniques: highly sophisticated decision-making is necessary to decide 
which random terms should be included in the model and at which levels; 
whether coefficients should be treated as fixed or random; whether linear 
constraints among parameters need to be incorporated, and how parameter 
estimates should be interpreted. Multi-level models may open the door to a new 
realm of epidemiology, but admittance, it appears, will be highly restricted!
Multi-level models have been developed most extensively for normally distributed 
outcomes. Although procedures have been outlined for other types of outcomes 
- log linear models in  particular (Goldstein, 1991) - there is relatively little 
experience with their use and computer applications are still being refined. 
Other computational procedures, such as the Penalised Quasi-Likelihood of 
Breslow and Clayton (1993), are also being developed, but they appear to offer 
little advantage over the multi-level IGLS procedure currently implemented in 
the software package ML3.
5.3 .3  M arginal m odels
Whereas in multi-level modelling the amount of variance attributable to the 
higher-level clusters is of direct interest, in marginal models the focus is on 
population-averaged associations between covariates and outcome, with response 
correlation treated either as known or as a nuisance parameter. It is often said 
that marginal models fail to take advantage of repeated measurements on each 
study subject, or the fact that the effects of covariate changes within subjects on 
the response are directly observable (Ware et al., 1988; Neuhaus, 1992). Very 
often, however, it is precisely questions relating to the population-averaged 
associations between covariates and outcomes that epidemiologists wish to
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address. Correlations in response variable are not a focus of interest in 
themselves, but rather they arise unavoidably as a result of the longitudinal 
methodology required for the accurate estimation of disease incidence.
Several different forms of marginal models have been developed. These range 
from fully parametric models in which both the within-individual variation in 
the outcome and the between-individual variation in mean incidence rates are 
fully described, to semi-parametric methods in which specification of the form 
of the association between the mean outcome and the covariates as well as of the 
mean-variance relationship is combined with ‘working assumptions’ about 
response correlation. Surprisingly perhaps, fu lly parametric models are poorly 
developed for count data; the wealth of different models for binary data (many 
of which, such as the beta-binomial and Normal-binomial models, have been 
implemented in highly accessible computer software) stands in contrast to the 
rather limited experience with mixtures such as the negative binomial 
distribution (see, for example, Lehmann et al., 1991). Two major disadvantages, 
however, weigh heavily against further investment in these models: firstly, only 
individual-level (as opposed to occasion-specific) covariates can be modelled, and 
secondly, the models are only appropriate when all pairs of responses measured 
on the same individual at two different times are equally correlated.
A much more promising advance has been the development of a semi-parametric 
approach by Liang and Zeger (1986). This approach incorporates ‘working 
assumptions’ about the correlations between pairs of outcomes for the same 
subject into estimating equations for the regression parameters (the so-called 
Generalised Estimating Equations [GEE], from which the method has taken its 
name) and into another set of equations for estimating the variances of the 
estimators. These formulae exploit the independence across subjects when 
estimating the variance of the regression estimators, and have the remarkable 
advantage of yielding consistent estimates of /3 and var(/3) even when the
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arecorrelation structure has been mis-specified! These ‘robust’ estimates 
maximally efficient only when the correlation structure is right,
but the cost of totally mis-specifying the correlation structure is unlikely to 
exceed 5-10% in many circumstances (Liang and Zeger, 1986). Unequal numbers 
of observations on different individuals, and very high correlations among 
repeated observations would be expected to cause a drop in efficiency when the 
correlation structure was incorrectly specified. It is important to note that the 
semi-parametric method will always be somewhat less efficient than 
corresponding parametric methods (Stukel, 1993). This is an example of the 
‘price of ignorance’ of the true variance structure.
The Generalised Estimating Equation approach is still relatively new, and is not 
without difficulties. One of these is that in order for the underlying assumptions 
to hold, missing data must be totally independent of previous outcomes. It 
should be added that, whatever the structure of the missing data, its very 
existence poses substantial problems for the analyst trying to use current 
computer applications of the GEEs. Secondly, although Wald tests (a form of 
significance testing involving only the parameter estimate and its standard error) 
may easily be performed for all variables included in the regression, there is as 
yet no robust device for hypothesis testing (a naive likelihood ratio test has been 
derived by Rotnitzky and Jewell, 1990). Such a development will be crucial if 
full benefit is to be gained from this methodology. On the other hand, the 
methodology remains highly attractive because of the ready interpretability of 
the parameters derived, and its apparent ability to ‘absorb’ extra-Poisson 
variability (over-dispersion) without requiring accurate estimates of the covariance 
structure, or sacrificing the consistency of the estimates.
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5 .4  Statistical methods adopted in rotavirus vaccine efficacy trials
In an attempt to verify to what degree an understanding of the statistical 
peculiarities of longitudinal data on common diseases has permeated the 
epidemiological literature, the 19 rotavirus vaccine trials described in Section 4.3 
were reviewed with respect to the analytic approaches adopted. Since all-cause 
(as well as RV-specific) diarrhoea is a recurrent illness, failure to control for 
correlation in the outcome might be expected to lead to exaggerated estimates of 
the significance of treatment group differences (see above, Section 5.2.3). As 
discussed in Section 4.3.2.1, 13 studies focused on the cumulative incidence of one 
or more episodes of RV diarrhoea over the study period, thus bypassing the issue 
of multiple episodes occurring to the same individual altogether. Of the 
remaining six studies, one (#5) presented no data on the frequency of RV illness 
at all, and two (#9, #16) used unspecified chi-squared type tests, which do not 
account for within-subject correlation, and thus overstate levels of significance in 
treatment-group comparisons when used in this context.
Two further studies (#15, #17) analysed their data using repeated measures 
analysis of variance. No details are given in the paper as to how this procedure 
was carried out, but it may be assumed that the total variation in  RV diarrhoea 
incidence was partitioned as follows:
Between subjects variation 
Treatment group
Subjects within groups (individual differences)
Within subjects variation 
Time period
Treatment x time period interaction 
Individual differences x time period interaction
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This scheme differs from that which would apply in a no repeated measures two- 
w ay analysis of variance in just one important respect: instead of a single 
‘ residual’ variance category, the within-cell variation is divided into two distinct 
parts, one relating to the subjects-within-groups effect, and the other to the 
interaction between individual differences and the time period effect. The 
appropriate denominator for the F-test for the treatment group effect is the 
subjects-within-groups variance (M S^ w grou(J ,  whereas under a no repeated 
measures factorial design it would be the residual variance (MSrcsidull) (Winer,
1971). These features of repeated measures ANOVA lead to a relatively 
conservative estimate of the F-statistic associated with the between-subjects main 
effect (treatment group). In order for repeated measures ANOVA to give valid 
results, however, a number of conditions must be met. The first of these is that 
the variation due to subjects-within-groups should be homogenous over each level 
of the main between-subjects effect (i.e. in the vaccine and placebo groups). As 
mentioned above in Section 5.3, where the response variable consists of count- 
type data (such as the number of illness episodes), the variance within each group 
is likely to be proportional to the mean (McCullagh & Nelder, 1989). 
Homogeneity of variance could not therefore be expected where vaccines are 
effective in reducing illness episodes.
The last study (#12) used a log rank test to examine treatment-group differences 
in  the average duration of time elapsing between vaccination and disease. This 
test is highly efficient in that it utilises all the information available about the 
relationship between exposure and outcome, and individuals whose follow-up is 
censored still contribute information for the length of time they were under 
surveillance. Standard techniques do not, however, permit the analysis of non­
initial events.
In the analysis of all-cause diarrhoea, chi-squared (or exact binomial) tests were 
again preferred by most authors. Two studies made some attempt to incorporate
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information on clustering of disease: in study #11, the Mann-Whitney U test 
(Mann & Whitney, 1947) was used to evaluate whether the numbers of children 
with 0,1,2,3... episodes of diarrhoea were similarly distributed in the two groups. 
This test is perhaps better suited to circumstances in which the response variable 
takes a broad range of different values, since the study subjects cannot easily be 
ranked if the response variable (here, number of illness episodes) takes the same 
value in a substantial proportion of cases. In study #6, a tabulation of number 
of episodes per child was presented but no test was carried out to evaluate the 
difference between vaccine and placebo recipients. Although neither approach 
incorporates information on follow-up time, they m ay offer important insights 
supplementing the standard techniques which focus on differences in mean rates.
5 .5  Conclusions
There are important differences between the conceptual framework for the 
analysis of incidence rates in longitudinal studies of common diseases, and that 
which applies in the case of rare diseases. This is because, in the case of common 
diseases, the outcome measure varies across two dimensions: person-to-person, 
and within subjects from one time period to the next. The degree of within- 
subject correlation is clearly substantial, and there are strong theoretical reasons 
for believing that it should not be ignored.
These considerations have not gone unnoticed in the statistical literature. Indeed, 
considerable advances have been made over the last decade in statistical methods 
for the analysis of longitudinal count data. Three possible approaches have been 
reviewed, and some of their major features are summarised in Table 5.2. The 
last section of this table shows how these three approaches compare on the 
criteria for evaluating statistical models proposed in Section 1.5.1. Conditional 
models score highly on user-friendliness, validity and ability to offer all the usual
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statistical options, but they are unlikely to be widely used by epidemiologists 
studying common diseases of childhood primarily because the focus of the 
questions they address is different from the classic ‘risk factor’ approach in 
epidemiology, but also because they are difficult to fit and require uncomfortable 
assumptions about stationarity of transition probabilities over time. Multi-level 
modelling is an exciting development which is likely to add considerably to our 
understanding of the common diseases of childhood if applied intelligently. 
Furthermore, these models make no special demands in terms of input data, and 
again offer all the usual statistical options. The level of sophistication required 
to use these models is, however, very great, and there is no prospect of their 
routine use to overcome problems of response correlation in longitudinal studies. 
The GEE approach, on the other hand, appears much better suited to this 
purpose. It is highly applicable, requires only a limited selection between 
different options in terms of specific inputs, and is generally simple to use. 
Further empirical validation of the robustness of the variance estimates is, 
however, required.
A review of rotavirus vaccine trials carried out since 1980 suggests that, in this 
area at least, most epidemiologists carrying out longitudinal studies of common 
diseases in the field are unaware of the statistical peculiarities of the data they are 
working with. Chi-squared tests remain the analytic technique favoured by most 
authors, even though they take no account of correlation in the outcome, and 
are thus liable to overstate the precision of treatment group comparisons. Where 
an attempt is made to incorporate information on clustering of disease, the 
methods adopted are often unsuitable - either because they are premised on 
assumptions which are unquestionably violated, or because they are essentially 
techniques for significance testing which do not permit the estimation of 
epidemiological measures of effect. Over half of these studies did not even 
attempt to assess the impact of rotavirus vaccine on all-cause diarrhoea (or else 
did not specify the analytic technique used), perhaps in part because of the lack
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of a generally accepted, valid and accessible methodology for the analysis of this 
kind of data. Given these difficulties, it is clearly important to establish just how 
far the nature of the data being analysed is likely to render the established, 
‘traditional’ forms of analysis invalid. This task is undertaken in the following 
chapter.
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A p p e n d i x  A: Gloss a r y
{} refers to usage specific to this Chapter.
• autoregressive. A series of observations wherein the value of 
each distribution is partly dependent on the values of those which 
have immediately preceded it.
• bias. A systematic (i.e. non-random) distortion of a statistical 
result.
• conditional. Refers to the sub-distribution obtained in a set of 
variables A when the values of another set of variables B are held 
constant, given that sets A and B have a joint frequency 
distribution.
• consistent estimator. An estimator which converges in 
probability, as the sample size increases, to the parameter of which 
it is an estimator.
• correlation. Interdependence between quantitative data. Commonly 
measured by the Pearson product-moment correlation coefficient, r, 
which at the population level is denoted p.
• covariate (=explanatory variable, predictor variable; x) . 
Variable whose differing values are reflected in changes in the 
outcome variable (see below).
• efficient estimator. An estimator with a small variance relative 
to other possible estimators.
• marginal distribution. The unconditional distribution of single 
variables, or groups of variables, in a multivariate distribution.
• mean rate (=average rate) . The mean number of events per unit 
time period, averaged over several time periods. {Since in this 
Chapter a unit of time has been defined as one time band (see 
below) , the mean rate is equivalent to the mean number of events per 
time band.
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• outcome (=response; y) . Variable of interest which varies in 
accordance with the values of other 'explanatory' variables (x) . 
{in this case, the number of incident episodes of illness over a 
defined period of time}.
• over-dispersion. Data are said to be over-dispersed if the 
variance is greater than the theoretical value assuming 
independence. Since, for the Poisson distribution, var(Y)=E(Y), 
data are said to be over-dispersed if var (Y) =<t>E (Y) , where <j>, the 
dispersion parameter, is greater than one.
• parametric model. Regression model in which the shape ('moments' ) 
of the underlying theoretical distribution is fully described.
• rate, instantaneous (=force of morbidity; X). Number of new 
events {in this case, incident episodes of illness; y) per unit of 
time. At, where the unit of time is infinitesimally small. Usually 
approximated by the incidence density rate (IDR), the number of 
events divided by the person-time-at-risk.
• subject (i). Individual {child}.
• systematic. The part of a linear model which is not captured by 
the 'random' error term(s) . Generally refers to the covariates 
which have 'fixed' effects on the outcome.
• time band (t). Period of time of defined length, over which the 
illness rate is presumed invariate.
• under-dispersion. Data are said to be under-dispersed if the 
variance is less than the theoretical value assuming independence. 
Since, for the Poisson distribution, var(Y)=E(Y), data are said to 
be under-dispersed if var (Y) =<t>E (Y) , where <t>, the dispersion 
parameter, is less than one.
• £ . Summation symbol.
Some of these definitions are adapted from:
Marriott, FHC. A dictionary of statistical terms (5th edition). Harlow, UK: Longman Scientific and Technical, 1990.
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Table 5.1 Unadjusted within-child correlations of diarrhoea incidence between consecutive 
4-week periods
Previous Time Period
-1 -2 -3 -4 -5 -6 -7 -8 -9 -10 -11 -12
1 -
2 .29
3 .23 .26
T 4 .36 .29 .27im 5 .31 .41 .29 .24e
6 .25 .21 .28 .33 .24p
e 7 .26 .24 .30 .25 .20 .19
ri 8 .33 .22 .24 .30 .28 .23 .25od 9 .36 .42 .32 .26 .34 .22 .26 .22
10 .27 .24 .18 .20 .26 .23 .21 .24 .20
11 .21 .26 .23 .21 .25 .22 .27 .29 .14 .25
12 .40 .25 .29 .36 .32 .22 .08 .23 .23 .13 .16
13 .45 .31 .27 .27 .20 .20 .17 .15 .26 .26 .13 .21
Av. Correl'n .31 .28 .27 .27 .26 .22 .21 .23 .21 .21 .15
• 2 1
Table 5.2 Features and advantages/disadvantages of three 
different approaches to the analysis of longitudinal count data
Conditional
Models
Multi-Level
Models
Marginal Models 
(GEEs)
Application to categor'al data Various Goldstein(1991) Zeger S, Liang (1986)
Model output Probability of outcome Y at time t, conditional on value of Y at time 
t - 1  and covariates
Fixed and random 
covariate effects; variance components
Fixed effects;estimated 
correlations ; overdispersion parameter
Type of correlation that can be modelled
Autoregression Equi-correlation; autoregression (by 
invoking macro)
Equi-correlation; (non-)stationary correlation; 
autoregression; user-specified
Fittingtechnique Maximumlikelihood ML; REML; general quasi- likelihood
Quasi- likelihood
Computerapplication Standard stat. software ML3 SAS/IML; S+; SPIDA
Crucialassumptions
Transition probabilities are independent of time; no higher order dependencies
Strict hierarchy in 
data structure; independence among level-1 units once 
higher level effects accounted 
for; Normality of higher-level 
residuals
Missing data independent of previous outcomes; 
weighted average of est'ed correlation 
matrices converges to a fixed matrix
APPLICABILITY ** ***** *****
VIABILITY ** ***** * * * *
VALIDITY **** ? i **★
UTILITY ***** **** **
POTENTIAL **** ** ★ **★
Notes :
1. Some problems with estimators for non-linear regression in existing software application (ML3); expected to be resolved in next release.
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Figure 5.1 Within-child variability in diarrhoeaincidence
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Figure 5.2 Within-childincidence: variability in diarrhoea
Note.
Relationship between mean 4 -weekly episode 
count and its variance over 13 time periods
VARIANCE
MEAN NUMBER OP INCIDENT EPISODES PER 4-WEEK PERIOD
Symbols represent number of cases with values defined by point (A*10, B=ll, C-12 etc.).
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Figure 5.3 Between-child variability in diarrhoea incidence, northern Ghana
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Chapter 6 Event Analysis (IV) 
Illustrative Analysis
6 .1 Using the Generalised Estim ating Equations algorithm s
In Chapter 5 it was shown that a number of relatively new statistical techniques 
are available to tackle the problems inherent in correlated response data. One 
of the most promising of these is the Generalised Estimating Equation (GEE) 
approach of Liang and Zeger (1986). The overview of analytic approaches 
adopted in rotavirus vaccine efficacy trials, presented in Section 5.4, indicates, 
however, that these ideas are still a long way from achieving widespread 
acceptance in the world of applied epidemiology. In this chapter, an illustrative 
analysis is conducted using the GEE approach. The specific issues that are likely 
to arise during the course of such an analysis are dealt with in some detail, as are 
the practical implications of relying on more familiar analytic techniques which 
do not take account of within-child clustering of disease.
A computer algorithm for the iterative derivation of the GEE estimators has 
been developed by Karim (1988). It is implemented in SAS Macro language, and 
is invoked from SAS/IML (the matrix algebra module of SAS). The use of this 
macro should present little difficulty to anyone familiar with SAS, although the 
module is sensitive to inadequacies in the raw data file, and the error messages 
generated are generally unhelpful. A similar implementation is available in 
SPIDA (Statistical Package for Interactive Data Analysis; Statistical Computing 
Laboratory, NSW, Australia). Although this package is distinctly more user- 
friendly than SAS, and possibly also faster, only rather small data sets can be 
analysed due to limited file-size specifications.
Whichever implementation is used, the data file is organised as a series of
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multiple records for each individual, with each record corresponding to one time 
band. The number of new illness episodes recorded during the course of each 
time band is designated as the y-variable, and the various fixed and time- 
dependent covariates are noted as x-variables. If any of the covariates need to be 
modelled as factors, then dummy variables must be created by the user. The l in k  
function is specified as an option by the user: in the case of event analysis, the 
link w ill normally be logarithmic (as in Poisson regression). The relationship 
between the mean response and its variance is also specified from a number of 
options. Again, for event analysis the analogy w ith classic Poisson regression is 
maintained, and the variance is specified as equal to the mean response. It should 
be noted, however, that one of the features of the GEE approach is that an extra 
‘over-dispersion’ or ‘scale’ parameter is estimated as part of the variance function, 
so that in reality this assumption only indicates that the variance of the y- 
variable is proportional to, rather than equal to, its mean.
The cluster of records corresponding to a single study subject is identified by an 
ID variable indicated by the user. Within each cluster, the form of the 
correlation expected between different time bands must also be specified. This 
is referred to as the ‘working’ correlation matrix. The appropriate specification 
of the form of this within-subject correlation is discussed at length in Section 6.2, 
since little practical guidance has been given on this issue in previous discussions 
of the method. The following section (6.3) discusses the appropriate width of the 
time bands for this type of analysis, since it m ight be believed that that the 
choice of time banding could affect both the magnitude of the effect estimates 
themselves and their precision. Section 6.4 deals with the issue of differing 
lengths of follow-up, and the final section (6.5) brings together the findings of the 
previous sections to present a unified schema for the analysis of correlated 
episode data.
The example used in this chapter is drawn from the Ghana Vitamin A
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Supplementation Trials Child Health Study described in Chapter 2. The 
incidence of diarrhoea (as defined by the child’s carers) is related to the child’s 
age and source of drinking water (time-dependent covariates), and the place 
where the adults of the compound go to defecate, as well as the presence of 
animal (other than poultry) faeces in the compound (treated as fixed covariates). 
It should be noted that the output obtained when running the GEE analysis 
includes two different sets of estimates of the precision of the covariate effects: 
the first of these, referred to as ‘naive’ standard errors, are calculated on the 
assumption that the working correlation matrix is a true representation of the 
underlying process. The second set, referred to as ‘robust’ standard errors, 
include an allowance for the possibility that the working correlation matrix has 
in fact been mis-specified.
6 .2  Specifying the fo rm  o f  the within-subject correlation
In order to analyse longitudinal data on common diseases using the GEE 
procedures, it is necessary to make assumptions about the form of the correlation 
in the outcome variable. Although a number of different options are available, 
essentially the choice is between exchangeable/equi-correlation', which implies that 
all observations on a given individual are correlated with all other observations 
on that individual to the same degree, and stationary correlation, which implies 
that the degree of correlation is determined by the length of the time interval 
separating the two observations (so that a pair of observations separated by only 
a short time interval w ill be more highly correlated than a pair of observations 
separated by a long time interval). Sometimes it is additionally assumed that 
when the time interval separating two observations is longer than a specified 
number of time bands, the correlation between them will be effectively zero. 
This is referred to as - for example - stationary-5 correlation, when the limiting 
number of time bands is five.
138
Unfortunately, the choice of appropriate correlation structure is not wholly 
straightforward. Although the presence of within-subject correlation can be 
detected by examining the crude correlations between the number of illness 
episodes experienced by the same individual in different time bands, thic 
procedure w ill exaggerate the degree of the correlation since it fails to take into 
account important, measurable, individual-level determinants of disease (such as 
socio-economic status) which remain fixed throughout the period of observation. 
A preferable method of determining the degree of within-subject correlation 
between one time band and another is to examine the correlations in the 
regression errors after fitting a suitable model which includes the most important 
covariates. This can in fact be done using the GEE procedures, and the results 
for the diarrhoea data, adjusting for AGE, DRINKING WATER SOURCE, ADULT 
DEFECATION and PRESENCE OF ANIMAL FAECES in the compound are shown in 
Table 6.1. It appears that all pairs of observations are correlated, but that the 
correlations gradually become weaker as the time intervening between the two 
observations increases. Average correlations above 0.2 are seen for pairs of 
observations separated by no more than four time bands. It should not be 
assumed that the observed correlation matrix is a ‘true’ representation of the 
underlying process, since it is of course influenced by sampling variability.
The implications of ignoring the within-subject correlation are illustrated in 
Table 6.2. In this table, the results of analysing the data using the GEE 
algorithms are compared to results obtained using Poisson regression, with each 
time band treated as an independent observation. In setting up the GEE analysis, 
zero correlation (iindependence) was specified as the working correlation matrix - 
this means that the ‘naive’ standard errors should be approximately the same as 
those obtained from standard Poisson regression, and the difference between the 
naive and robust standard errors may be interpreted as a measure of how much 
the precision of the estimates is exaggerated when the correlation is ignored.
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It may be seen from the table that the effect estimates (the beta coefficients) are, 
as expected, unaffected by the choice of Poisson regression versus GEE modelling 
using an independence working correlation matrix. The naive standard errors 
derived from the GEE procedures are all 7.6% larger than those derived by 
means of Poisson regression: this is because the GEE model assumes only that 
the variance of the dependent variable is proportional to its mean (as opposed to 
the Poisson model, which stipulates that the variance is equal to the mean). 
Under the GEE procedure, all calculated standard errors are then inflated by (the 
square root of) a ‘scale parameter’ which is estimated iteratively. This is a minor 
difference, however, compared to the discrepancy between the naive standard 
errors, which are calculated on the assumption that the specified working 
correlation matrix is correctly specified, and the robust standard errors, which 
make no such assumption. In this example, the robust standard errors are 
between 1% and 73% larger than the naive standard errors (median, 34% larger). 
There is no clear pattern as to which variables show the largest (or smallest) 
discrepancies between the naive and robust standard errors.
Table 6.3 shows naive and robust estimates of the coefficient standards errors 
using GEE methods with a) exchangeable, and b) stationary-5 working 
correlation matrices. In both cases, the discrepancies between the robust and 
naive estimates are much less than those seen when an independence working 
correlation matrix was used: with exchangeable correlation, the robust standard 
errors are between 13% smaller and 15% larger than the naive standard errors 
(median, 3% larger), whilst with stationary-5 correlation, the robust standard 
errors are between 4% smaller and 10% larger than the naive standard errors 
(median, 5% larger). The robust standard errors are to all intents and purposes 
the same, regardless of whether the working correlation matrix is specified as 
exchangeable or stationary-5. They are, however, considerably smaller than 
those estimated when the working correlation matrix is specified as zero- 
correlation (independence). This is because the zero-correlation matrix is such
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a poor representation of the true situation that the robust standard errors are 
estimated very inefficiently.
Table 6.4 compares the effect estimates derived under the three alternative 
specifications of the working correlation matrix. Significant effects are 
highlighted in bold. It may be seen that the effect estimates are only minimally 
affected by the choice of working correlation matrix. In this example, the 
conclusions that would be drawn from the analysis are identical for all three 
specifications of the correlation matrix.
6 .3  D eterm ining the appropriate width fo r  the tim e bands
A fundamental practical issue that must be resolved in the analysis of 
longitudinal studies is the appropriate length of each period of observation, or 
time band. To some degree this is determined by the design of the data 
collection procedures, since the time bands cannot be shorter than the shortest 
interval for which disease outcome data are recorded, or longer than the total 
observation period. Within these limits, however, the length of the time bands 
which form the units of analysis m ay be freely determined at the outset of the 
analysis phase.
At one extreme, each child’s total experience can be summarised in a single 
record; this procedure makes no attempt to model the within-subject element of 
the variability in the outcome, and extra-Poisson variability is manifest as 
overdispersion (see Section 5.2.3). At the other extreme, each day’s experience 
can be dealt with separately, and day-to-day correlations can be modelled; this 
has the disadvantage of generating enormous data files, and in the case of a study 
with one year’s follow-up involves the inversion of a 365x365 matrix in order 
to solve the Liang-Zeger Generalised Estimating Equations, a task beyond the
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scope of most desk-top computers. A reasonable compromise would seem to be 
to divide the total observation period into something between 3 and 30 shorter 
bands, but the implications of the exact choice have not been clearly spelled out.
6 .3 .1  Effects on estimates
Table 6.5 shows the (exponentiated) regression coefficients from the same 
analysis described previously, using 5 different options for the length of the time 
bands. These vary from 26 bands of 2 weeks’ duration, to a single band of 52 
weeks’ duration. Since information on the time-dependent covariates was 
collected once every 4 weeks in this study, individuals are classified according to 
the value observed in the first 4-week period of a time band whenever the time 
band is longer than 4 weeks. This mimics the situation which would arise if the 
data on the time-dependent covariates had only been collected once per time 
period (that is, once every 13 weeks for the 13-week banding, once every 26 
weeks for the 26-week banding, etc.). When data on time-dependent covariates 
are collected more frequently than once per time period, various other strategies 
are possible. These are discussed in Section 6.3.3. For the two-week time bands, 
the same covariate value was matched to two consecutive morbidity records.
Obviously, the intercept term is highly sensitive to the length of the time band. 
Also unsurprisingly, it is seen that effects of the time-invariate variables (WHERE 
THE ADULTS DEFECATE, and the presence of ANIMAL EXCRETA in the 
compound) are unaffected by the choice of time banding. The effects of the 
time-dependent variables, on the other hand, are altered by the choice of 
banding: the estimated AGE pattern of infection is moderately distorted even 
when the observation period is divided into 4 13-week periods, such that an 
accelerated fall-off in risk appears after 18 months. The pattern is radically 
different when a single band of 52 weeks’ duration is used. This is because age
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is strongly related to the outcome, and children move rapidly from one age 
group to the next; therefore, if the child’s age is defined only once every 3 
months, or even less frequently, a significant amount of misclassification of 
exposure group will occur. Misclassification will also occur with other time- 
dependent variables, such as WATER SOURCE, which may explain some of the 
fluctuations in the observed effect of this covariate.
Although it is not apparent in Table 6.5, it can be shown that the failure to reset 
the AGE GROUP variable at frequent intervals can lead to important residual 
confounding by age. This is demonstrated in Table 6.6, which shows the 
relationship between sleeping patterns and ALRI in children aged 0-5 months at 
the beginning of the one year follow-up (the example is again drawn from the 
Ghana vitamin A data set). In these children, sleeping inside appeared to be 
protective against ALRI (RR—0.58; P<0.05). However, when they were 
reclassified according to the age at which they actually experienced the episode 
of illness and the effect of sleeping pattern was adjusted for age, the protective 
effect of sleeping inside was no longer significant (Mantel-Haenszel RR = 0.74; 
P > 0.05).
The implication of this finding is that variables which are not related to the age 
of the child and which are not subject to seasonal variation - such as WHERE THE 
ADULTS DEFECATE - m ay be analysed using methods which do not require the 
division of the observation period into multiple time bands. Parametric negative 
binomial regression, described briefly in Section 5.3.3, is one such approach. 
Another even simpler approach involves using ordinary Poisson regression, and 
allowing for the over-dispersion by inflating the calculated standard errors by a 
scale factor equal to the square root of the residual deviance divided by the 
residual degrees of freedom (Aitkin et al., 1989). On the other hand, those 
variables which are related to the age of the child must be analysed by methods 
which permit the frequent resetting of the AGE variable, if residual confounding
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by age is to be avoided. Table 6.7 shows which of the variables collected during 
the baseline phase of the Ghana Vitamin A study were associated with the age 
of the child: it can be seen that the majority of the individual-level variables were 
in fact related to the age of the child. Thus, parametric methods which do not 
permit the modelling of time-dependent covariates are likely to be of only 
limited use in the field of the epidemiology of common diseases of childhood.
6 .3 .2  Effects on precision
Table 6.8 shows the estimated precision of the regression coefficients with time 
bands of 2, 4, 13, 26 and 52 weeks’ duration. The estimates for the first four 
situations are derived using the GEE approach, whilst the single time band 
estimate is derived using ordinary Poisson regression with the standard errors 
inflated as described above (Section 6.3.1). The estimated degree of within-subject 
correlation (under the assumption of equi-correlation) is shown in the lower 
section of the Table, together with the scale parameter for the variance function. 
These latter parameters are of interest because they show that sparse data (which 
is the result of dividing the observation period into very short time bands) can 
make it difficult to detect within subject correlation, a finding which I have 
verified using simulated data.
This table shows that the precision of the time-invariate effects is unaltered w ith  
increasingly long time bands, but the precision of the time-dependent variable 
(WATER SOURCE) is decreased, presumably due to increasing misclassification of 
exposure with longer time bands. Somewhat surprisingly, the precision w ith 
which the AGE effects are estimated is increased w ith longer time bands. One 
possible explanation for this phenomenon is that it reflects a problem with using 
discrete age ‘groups’ to model what is essentially a continuous evolution of risk  
at different ages. Under the discrete age-group model, a child passing from one
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age group to another is assumed to experience an immediate transition to a 
different level of risk; in reality, however, that child will continue to experience 
much the same level of risk that they experienced a few days earlier. With very 
short age bands, it will frequently occur that the same child w ill contribute to 
more than one risk-set during the course of the period of observation, and the 
variability of disease experience within each age-group will thus be increased 
(leading, of course, to less precise estimates of the effects of each age group). The 
same problem would not be expected to arise if a polynomial function of age 
were used rather than discrete age-groups; ease of interpretability would, 
however, be sacrificed.
Where discrete age-groups are used, the results of Table 6.8 suggest that it may 
be preferable to avoid extremely fine time-bandings. In this case, the criterion 
for the choice of the width of the time bands should be to ensure that they are 
as wide as possible without incurring significant misclassification of exposure 
status. Table 6.9 illustrates the degree of misclassification that might be expected 
in a selection of time-dependent variables studied in the Ghana vitamin A trial 
if consecutive months of observation were combined into longer time bands. It 
is assumed that exposure status was correctly ascertained when the data was 
collected on a 4-weekly basis, and that if longer time bands were to be created, 
the value observed at the beginning of each time band would be assumed to 
apply for the entire duration of that time band. It can be seen that when two 
months of observation are combined, most variables are mis-classified in the 
second half of the time band in around 10% of all cases. The exceptions to this 
are the variable describing where the CHILD SLEEPS each night, which is highly 
occasion-specific, and that describing whether or not any COOKING was done in 
the compound, which may be considered a fixed characteristic of the compound. 
When longer time bands are created, the degree of misclassification becomes even 
more marked, to the extent that serious bias is likely to occur in the analysis.
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6.3.3 Conceptual fram ework and analytic approach fo r occasion-specific 
covariates
The fact that variables such as where the CHILD SLEEPS are highly occasion- 
specific raises certain problems in the analysis. Two quite different conceptual 
models can be distinguished: under the first model, as soon as the child is 
exposed to sleeping indoors (or outdoors, depending on which is considered to 
be the high-risk category), his/her risk of a negative outcome would increase. 
In this case, the variable would need to be measured very frequently, and 
transitional models, described in Section 5.3.1, would probably be the most 
appropriate analytic approach. These models are examined further in Section 
7.4.1, where they are applied to the analysis of illness prevalence. On the other 
hand, if the conceptual model is that those children who most frequently sleep 
indoors (or outdoors) will also experience more than average morbidity, then it 
may be appropriate to summarise the various measurements of the covariate over 
a time band of at least several months. F igure 6.1 shows the distribution of the 
percentage of occasions on which each child was reported to be sleeping in a 
room, as opposed to outside, for children with at least 12 assessments of this 
variable during the year’s follow-up in the Ghana VAST Child Health Study. 
Considerable variation was noted in the proportion of occasions on which 
children slept inside. This variable did not, however, appear to be correlated 
with any of the 21 signs/symptoms enquired about in the weekly morbidity 
interviews. Alternative summary measures for other variables might involve 
classifying children according to the ‘best’ or ‘worst’ category recorded over all 
the occasions on which the variable is measured.
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6.4 Differing lengths o f follow-up
So far, all analysis has been conducted using data for the sub-group of children 
who were under observation for a full year. These children present less 
difficulties in the analysis than children with incomplete follow-up because the 
exact form of the period-to-period correlations can be estimated empirically. 
However, in many studies a substantial minority - or even a majority - of study 
participants are not observed for part of the follow-up period. This is especially 
the case in studies with continuous enrolment, and studies where subjects drop 
out o f observation by virtue of out-migration, death or voluntary withdrawal. 
Temporary absences from the home also result in incomplete follow-up. There 
are good a priori reasons for believing that children with shorter periods of 
follow-up may differ systematically from those with longer periods of follow-up, 
both in terms of important covariates such as age, and in terms of their 
morbidity experience.
In the Ghana VAST study, many children contributed less than the full year of 
observation. Separate analyses, shown in Table 6.10, have been carried out for 
four different groups of children: those with no more than one week of missing 
data (51-52 weeks of observation), those with 44-50 weeks of observation, those 
with between 1/2 year (26 weeks) and 43 weeks of observation, and those with 
less than 1/2 year of observation. In each case, the total surveillance period has 
been divided into 13 4-week bands, and observations are only included for a 
given individual when at least three weeks’ data are available to estimate the 
number of new diarrhoea episodes occurring during the course of a time-band. 
Equi-correlation is assumed and the estimated degree of within-subject correlation 
is shown, as well as the number of observations contributing to each group’s sub­
analysis.
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The consistency of the findings from the four different sub-groups of children is 
remarkable. The age effects appear slightly different for the group with the 
shortest duration of follow-up, but on closer inspection it can be seen that only 
the rates in the youngest age group are different from the other analyses, with 
the relative intensities of disease in the other age groups m irroring the results 
based on children with longer durations of follow-up. The effects of the 
different sources of drinking water are also more marked for the children with 
the shortest follow-up times. This may be due to sampling variability, but could 
also reflect differences in the age/seasonal make-up of this group, suggesting that 
possible interaction between drinking water source and age and/or season could 
be investigated in the final model.
\
Table 6.11 shows the final estimated effects, combining data from all the children 
in the study. Exchangeable correlation is assumed, to overcome the difficulty of 
including children with incomplete data. Since the age structure of the group of 
children with shorter lengths of follow-up is substantially different from that of 
children with longer lengths of follow-up, it is important to bear in mind that 
combining data for all children introduces a risk of confounding by AGE if this 
variable is not included in all subsequent analyses. Duration of follow-up was 
also associated with seasonality in this study, since new recruits o n ly  contributed 
data during the latter part of the study. Although seasonal effects may be of 
little interest in themselves, there are clearly reasons to believe that SEASONALITY 
could potentially confound the association between AGE and DIARRHOEA, or 
between WATER SOURCE and DIARRHOEA. Table 6.11 demonstrates that 
adjusting for seasonal effects does in fact have a quite substantial impact on the 
regression coefficients for AGE, though less so for WATER SOURCE. There is only 
a very small (and entirely negligible) loss of precision associated with 
incorporating the 14 dummy variables for SEASONALITY into the model.
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6 .5  Conclusions
In this chapter it has been shown that strong period-to-period correlations in 
diarrhoea incidence can be detected in a typical empirical data set, even after 
adjusting for important covariates such as age. Ignoring this correlation w ill lead 
to substantial over-estimates of the precision of the covariate effects, but is 
unlikely to produce any serious bias in the estimates. The over-estimate of the 
precision of the covariate effects is sufficiently large (on average, around 34%) to 
render ‘standard’ techniques inappropriate. Therefore more elaborate analytic 
techniques are required.
Several different methods are available to adjust for within-subject correlations. 
This analysis illustrates that the optimum method is determined to an important 
degree by the type of covariate that is being studied. The GEE method, which 
has several theoretical advantages and is conceptually close to traditional Poisson 
regression, has been shown to give good results. By ‘re-setting’ the AGE variable 
in each time band, the effects of time-dependent covariates which are associated 
with the age of the child can be modelled without the danger of residual 
confounding by AGE. When covariate values change extremely rapidly with 
time, however, and it can be assumed that the exposure w ill have an immediate, 
non-cumulative effect on the outcome, conditional models - described in Sections
5.3.1 and 7.4.1 - offer an alternative, perhaps preferable, choice of analytic 
strategy. When an immediate, non-cumulative effect cannot be assumed, 
summary measures of exposure, combining information from more than one 
occasion, may be more informative. At the other end of the spectrum, some 
covariates are time-invariate and unrelated to the age of the child: this implies 
that there is no need to split the total observation into smaller bands, and the 
over-dispersion in the outcome can probably be quite adequately modelled using 
relatively simple parametric methods such as negative binomial regression, or
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even ordinary Poisson regression with the standard errors inflated by a scale 
factor easily calculated from the residual deviance. The range of recommended 
strategies is illustrated in Table 6.12.
When using the GEE model, exchangeable correlation between different time 
bands can safely be assumed. This simplifying assumption has a negligible impact 
on the precision or accuracy of the effect estimates, and makes it possible to 
include individuals with incomplete follow-up in  the analysis. The appropriate 
width of time banding is indicated in Table 6.12. Two alternative situations are 
envisaged, one giving rise to time bands of 1-2 months’ duration, and another 
giving rise to bands of 4-6 months’ duration. This assumes incidence rates s im i la r 
to those observed in our study for diarrhoea, and would obviously need to be 
adjusted for more/less frequent outcomes. It is imperative that the AGE variable 
is reset for each time band in order to avoid important residual confounding by 
age, as well as biased estimates of the effects of AGE itself. Data can be included 
from children with incomplete follow-up, but it is highly likely that 
SEASONALITY will have to be introduced into the model as a potential 
confounder, especially if a dynamic cohort design has been used, or there is 
substantial attrition from the initial cohort.
Use of an appropriate analytic tool does not obviate the need for a well thought 
out analytic strategy. Many important issues relating to the choice of variables 
to include in explanatory models are unfortunately beyond the scope of this 
discussion, but need to be resolved before attempting to fit any regression model. 
Regrettably, the SAS/IML implementation of the Generalised Estimating 
Equations is cumbersome and highly sensitive to programming errors, and thus 
not suitable for exploratory analyses. The SPIDA implementation does include 
a routine for choosing the best subset of explanatory variables to include in the 
final model, however, this implementation cannot be used with very large data 
sets. One way of minimising the required recourse to the SAS macros might be
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to conduct initial analyses in a user-friendly application of Poisson regression 
such as EGRET, treating each time-band as an independent observation. This 
will result in substantial over-estimates of the precision of all the effect estimates, 
but w ill enable variables not associated at all with the outcome variable to be 
weeded out before the final model is fitted in SAS/IML using the Generalised 
Estimating Equation algorithms.
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T a b l e 6 . 1 Within-subject correlations, adjusted for main covariate effects
time band (t - i)
-l -2 -3 -4 -5 -6 -7 -8 -9 -10 -11 -12
1 -
2 .72
3 .34 .35
T 4 .38 .47 .47i
m 5 .36 .37 .31 .27
e
« .21 .30 .24 .31 .18
B 7 .21 .16 .21 .25 .22 .20an 8 .25 .22 .23 .23 .20 .23 .15d
9 .32 .27 .26 .25 .29 .21 .34 .23
t
10 .22 .18 .14 .19 .17 .18 .05 .14 .12
11 .14 .19 .15 .14 .18 .19 .18 .13 .14 .14
12 .21 .15 .21 .26 .18 .18 .13 .19 .22 .15 .10
13 .33 .18 .16 .23 .20 .18 .18 .10 .16 .20 .11 .17
Average
Correlation
.31 .26 .24 .24 .20 .20 .17 .16 .16 .16 .11 .17 i
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Table 6.2 Regression coefficients and standard errorsfrom Poisson and GEE (with independenceworking correlation matrix) models
ß SK(/S)
Poisson/GEE Poisson GEE Naive GEE Robust
Constant - . 26 .110 .119 .152
Aga:0-5 -6-11 . 12 . 121 .130 .15212-17 . 02 . 120 .129 . 15418-23 - . 04 .118 .127 . 16024-35 - . 35 .113 . 122 . 16036 + - . 77 . 114 .123 .169
Water Source:Borehole -Open well . 08 . 047 . 050 . 077Other - . 02 .102 . 109 . 151NK - . 34 . 176 . 189 .191
Adults defecate:In fields -In designatedtoilet area - .21 . 046 . 049 .085 !Elsewhere - . 72 .150 .161 .268
Animal excreta
in compound . 12 . 054 . 058 .100
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Table 6.3 Standard errors from the GEE model using 
exchangeable and stationary-5 working correlation matrices
SE (0)
Exchangeable Stationary-5correlation correlation
Naive Robust Naive Robust
Constant .132 . 141 . 136 .142
Age:0-56-11 .120 . 138 . 136 . 14612-17 .126 . 144 .145 •13918-23 .135 . 145 .146 . 14624-35 .136 . 148 .142 .14936 + .146 .163 . 146 .157
Water Source:Borehole Open well . 065 .061 . 061 . 064Other .122 .121 . 114 .125NK .163 . 154 . 154 .158
Adults defecate:In fields In designatedtoilet area .094 . 085 . 079 . 085Elsewhere .308 .271 .247 .264
Animal excreta in compound .111 .097 .093 . 097
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Table 6.4 Regression coefficients from the GEE modelwith three alternative specifications of theworking correlation matrix
exp(/J)
Independence Exchangeable Stationary-5
Constant 0.77 0.80 0.83
Aga:0-5| 6-11 1.13 1.13 1.0512-17 1.02 1.03 1.01 118-23 0.96 1.03 1.0024-35 0.70 0.72 0.7036 + 0.46 0.41 0.46
Hatar Sourca:
1 Borehole Open well 1.09 1.06 1.00Other 0.98 1.02 0.98
i NK 0.71 0.80 0.78
Adults defecate:In fields In designatedtoilet area 0.81 0.79 0.7 9Elsewhere 0.49 0.47 0.51
Animal excreta In compound 1.13 1.11 1.10
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Table 6 .5 Regression coefficients from the GEE model with time bands of varying lengths
exp(/S)
26 bands (x2 weeks) 13 bands (x4 weeks) 4 bands (xl3 weeks)
2 bands (x26 weeks) 1 band(x52 weeks) |
Constant 0.43 0.80 2.80 5.50 11.81.
Agsi0-56-11 0.99 1.13 0.99 1.06 0.8612-17 0.94 1.03 0.92 0.88 0.7518-23 0.90 1.03 0.86 0.79 0.6724-35 0.75 0.72 0.66 0.64 0.5336+ 0.49 0.41 0.39 0.40 0.47
Natar Source: Borehole 
Open well 1.03 1.06 1.05 1.01 0.92Other 1.01 1.02 0.90 0.91 1.19 !NK 0.81 0.80 0.64 0.82 “
Adults dafecate:In fields In designated toilet area 0.79 0.79 0.80 0.81 0.81Elsewhere 0.45 0.47 0.46 0.48 0.50
Animal excreta 
in compound 1.11 1.11 1.12 1.10 1.08
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Table 6.6 Residual confounding by age in children 
classified as aged 0-5 months at the beginning 
of the one-year follow-up period
Actual age at time Sleep Sleep ---- 1of ALRI episode: inside outside Ratio \
AgesO-5 mo.
episodes: 36 11 0.58
c h i l d r e n : 137 74
Age = 6 -11 mo.
episodes: 11 24 1.71
c h i l d r e n : 196 251
Age = 12 -17 mo.
episodes: 10 4 0.19
c h i l d r e n : 78 164
All ages
episodes: 57 39 0.58
c h i l d r e n : 411 489 | 0.38,0.86
Mantel-Haenszel Rate Ratio= 0.74 (0.49-1.13)
158
Table 6.7 Associations with age of the child among the 
full set of covariates examined in the Ghana 
study
Variables clearly associated with the age of the child:
★ Vaccination status
★ History of measles or hospital admission
★ Consumption of vitamin A rich foods and breastfeeding
★ Anthropometric status; vitamin A status
★ Sleeping patterns
★ Child's defecation practices
★ Source of drinking water and use of soap; 
certain handwashing practices
★ Knowledge, attitudes and practices re. ORS
★ Mother's age and parity; presence of younger sibling
Variables associated with the age of the child in this 
data set, but unlikely to be associated in other data 
sets:
★ Maternal education
★ Twin
★ Household possessions and access to dry season farm
Variables not associated with the age of the child:
★ Sex of the child
★ Birth order
★ Survival status of the preceding child
★ Father's education
★ Household ownership of livestock and design of compound
★ Exposure to smoke pollutants
★ Certain handwashing practices
★ Adult defecation and refuse disposal practices
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Table 6.8 Robust SEs from the GEE model with time bands of varying lengths
26 bands 
(x2 weeks)
13 bands 
(x4 weeks)
4 bands 
(xl3 weeks)
2 bands 
(x26 weeks)
1 band 
(x52 weeks)
Constant .155 .141 .109 .096 .106
Ages
0-5
6-11 .150 .138 .109 .095 .138
12-17 .161 .144 .123 .109 .160
18-23 .158 .145 .114 .107 .130
24-35 .155 .148 .116 .108 .125
36+ .160 .163 .133 .124 .129
Hater Source:
Borehole 
Open well .061 .061 .066 .072 .088
Other .122 .121 .117 .196 .241
NK .161 .154 .164 .194 -
Adults defecate:
In fields 
In designated 
toilet area .087 .085 .084 .086 .087
Elsewhere .266 .271 .263 .260 .283
Animal excreta in 
compound .098 .097 .097 .098 .104
Estimated within- 
subject corral. .130 .224 .407 .521 -
Scale parameter 0.96 1.19 1.92 2.77 1.93
Table 6.9 Numbers (and percentages) of time-bands in which the exposure variable is partially 
misclassified when the value observed at the beginning of the time band is assumed 
to be correct for the entire duration of that time band
||
length of tine bands -> 2 months 3 months 4 months
fraction of time band for which 
individuals are misclassified for 
exposure status ->
1/2 1/3 2/3 1/4 1/2 3/4 f |
Exposure variable:
Breast feeding 802/8877
( 9 . 0 * )
530/5567
( 9 . 5 * )
336/5567
( 6 . 0 * )
417/4117
( 1 0 . 1 * )
266/4117
( 6 . 5 * )
191/4117 
( 4 . 6 * )  :!
Wasted (weight-for-age s -2 z-scores^ 766/8639
( 8 . 9 * )
531/5485
( 9 . 7 * )
268/5485
( 4 . 9 * )
370/4064
( 9 . 1 * )
249/4064
( 6 . 1 * )
145/4064
( 3 . 6 * )
Sleeping pattern 3680/8874 
( 4 1 .  S t )
2013/5570
( 3 6 . l t )
1350/5570
( 2 4 . 2 * )
1193/4115
( 2 9 . 0 * )
1108/4115
( 2 6 . 9 * )
791/4115 ! 
( 1 9 . 2 * )  j
Father smokes 786/8869
( 8 . 9 * )
505/5565 
( 9 . I t )
256/5565
( 4 . 6 * )
422/4113
( 1 0 . 3 * )
157/4113
( 3 . 8 * )
151/4113
( 3 . 7 * )
Source of drinking water 1172/8876
( 1 3 . 2 * )
692/5570
( 1 2 . 4 * )
483/5570
( 8 . 7 * )
485/4115
( 1 1 . 8 * )
317/4115
( 7 . 7 * )
263/4115
( 6 . 4 * )
Cooking in compound 218/8871
( 2 . 5 * )
117/5568
( 2 . 1 t )
74/5568
( 1 . 3 * )
111/4114 
( 2 . 7 *  )
25/4114
( 0 . 6 * )
44/4114 '
( 1 . 1 * )
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Table 6.10 Regression coefficients from the GEE model: 
separate models fitted for 4 sub-groups of 
children according to their length of followup
exp (0)
duration of
observation --
>
*51 weeks 
n=4862
44-50 weeks 
n-6717
M yr-43 wks 
n-2926
sM year 
n=1041
Constant 0.80 0.76 0.78 0.61
A g e :
0-5
6-11 1.13 1.10 0.96 1.2612-17 1.03 1.03 1.10 1.2618-23 1.03 0.94 0.99 1.0824-35 0.72 0.72 0.70 0.79
36 + 0.41 0.51 0.47 0.57
Water S o u r c e:
Borehole 
Open well 1.06 0.96 1.00 1.19Other 1.02 0.93 0.84 1.30
NK 0.80 0.85 0.98 0.74
Adults defecate:
In fields 
In designated 
toilet area 0.79 0.97 0.98 1.03
Elsewhere 0.47 0.84 0.77 0.68
Animal excreta in
compound 1.11 1.05 1.15 *
Estimated within-
subject correl. .224 . 212 .195 .216
Notes : * could not be calculated due to sparse data
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Table 6.11 Regression coefficients from the GEE model 
with and without adjustment for seasonality
Notes: * In this model, the constant term refers only to the first month 
of observation, and is therefore not directly comparable to the model 
without the seasonal factor
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Table 6.12 Summary of recommended analytic strategies for correlated response data
Type of 
covariate
Examples: Importance of 
confounding by age
Type of modelling 
strategy preferred
Width of time bands
Occasion-
specific
Sleeping patterns (in 
N . Ghana),
Air pollution/ 
temperature/humidity
May or may not be 
important; analysis 
focuses on changes in 
outcome variable 
within each individ. 
as exposure alters
Conditional models As short as possible; 
determined by 
frequency of data 
collection
Changes rapidly 
with time or age
Breastfeeding,
Weight/Age, W/Height 
Source of drinking 
water (in N. Ghana), 
Hygiene practices
Major confounding by 
age
GEE 1-2 months l
Changes slowly 
with time or age
Vitamin A dosing 
status, 
Height/Age, 
Immune function
Less severe 
confounding by age
GEE 4-6 months
Fixed Socio-economic status 
Demographic 
characteristics, 
Parental beliefs
Not associated with 
age of the child
Poisson regression with 
standard errors inflated 
by scale factor derived 
from residual deviance 
(or other similar 
parametric models)
Total follow-up time
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Figure 6.1 Percentage of occasions on which 
children reportedly slept inside (in 
children with 12 or more observations of this variable)
Count Midpoint
45
104 
78 
70
125
70
78
105 
78 
32 
81 
42 
40 
26 
25 
23 
13
5
5
7
0 40 80 120 160
Histogram frequency
n=1052
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Chapter 7
The Analysis of Prevalence Data
7.1 Measures o f  prevalence in longitudinal studies
Prevalence is a measure of disease frequency which differs from incidence in that 
it focuses on disease status rather than on events. It has been defined as "the 
proportion of people who have a disease at a specific instant" (Rothman, 1986). 
As such, it is quintessential^ a cross-sectional measure, not normally associated 
with longitudinal studies. Indeed, as mentioned in Section 1.2, the pioneers of 
the longitudinal approach in studies of common childhood illnesses felt strongly 
the need to overcome the severe limitations of the cross-sectional prevalence 
study as a tool for the study of morbidity and its interactions with nutritional 
status (Scrimshaw, 1967). Moreover, prevalence is a particularly complex and at 
times ambiguous outcome measure for those endeavouring to carry out 
aetiological research, since it reflects determinants of disease duration as well as 
of disease incidence (Rothman, 1986). On the other hand, io r health service 
planners, prevalence may be the most relevant of all outcome measures, since it 
indicates the potential demand for health services at any given moment in time.
Longitudinal studies by definition involve measurements of disease status at many 
different points in time. It is therefore possible to examine the "proportion of 
people who have a disease at a specific instant" repeatedly on each occasion that 
the study population is contacted. Alternatively, one could combine all the 
available information for all time points and all subjects, and estimate the 
proportion of all occasions on which disease was recorded. A third possibility 
is to focus on the individual, calculating the proportion of all days (or other time 
units) observed on which each individual was recorded as suffering from a given 
disease. "Each of these three strategies will be examined in turn in this section.
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The first approach is illustrated in Figure 7.1, which shows the point prevalence 
(presence of the disease on the day of the interview) of a fever-like complaint 
known as ‘intolegere’ over each of a total of 65 weeks of data collection in the 
Ghana VAST Child Health Study, described in Chapter 2. It will be recalled 
that each child was visited just once a week in this study, so that no more than 
one observation from each child is included in any of the 65 estimates of the 
point prevalence of ‘ intolegere’. This type of data, in which a single variable is 
measured regularly over a prolonged period of time, is known as time series 
data. The weekly prevalences can be related to other variables which also change 
over time, such as meteorological measures, or group-level changes in malaria 
parasitaemia rates, anthropometric status of diet. However, such analyses are 
complicated by the fact that there are strong correlations between the prevalence 
rate at time t and the same rate at time t-1 (referred to as lag 1 autocorrelation). 
This violates the assumptions of ordinary linear regression, and means that 
special models must be used (Gujarati, 1988). These characteristics of time series 
data are confirmed by the example of Figure 7.1, which - it can be shown - has 
the properties of a first-order Markov process (see Section 5.3.1), with a lag 1 
autocorrelation coefficient of over 90%.
Moving away from a focus on time to a focus on individuals, an alternative way 
of analysing data on disease status in longitudinal studies is to calculate what 
Kleinbaum et al. (1982) have termed ‘episodic prevalence’. This is, for each 
individual, the number of time units (days, in the current example) with illness 
divided by the total number of time units under observation. This measure may 
be interpreted as the probability that a given individual is sick at time t (which 
can be any time over the course of the period of observation), provided that it 
can be assumed that the individual’s probability of illness remains constant over 
the length of the observation period. Each day of observation appears only once 
in the denominator of this measure, but of course, individual days of sickness/ 
health are not independent when they are measured on the same individual (see
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below, Section 7.4.1). It should not therefore be assumed that this measure has 
the customary binomial variance for proportions. Furthermore, there m ay be 
some between-individual correlation, where - for example - a number of children 
live in the same residential unit.
Cobb (1962) has pointed out that the frequency distribution of these episodic 
prevalences (or, in his terminology, ‘protepV, proportion of time in episode) of 
all the individuals in a study population provides a full description of disease 
prevalence in that population over the observation period. Such a distribution 
is shown in Figure 7.2, which depicts the episodic prevalence of cough in  1103 
children with at least 300 days of observation in the Ghana study. Sim ilar 
distributions are seen for other signs/symptoms in this data set. When analysing 
these data, it will be important to incorporate information about the proportions 
of children with very low or very high prevalences, as well as about the ‘average’ 
prevalence in different groups.
A third approach to the analysis of prevalence data in longitudinal studies is to 
calculate what I shall call ‘block prevalence’, by dividing all the days of illness 
over the observation period by the total number of days of observation, for all 
subjects together. This measure is in fact a weighted average of the time series 
prevalences, with weights equal to the proportion of the total observation time 
that each individual unit of time contributes; or, equivalently, a weighted average 
of the episodic prevalences, with weights equal to the proportion of the total 
observation time that each study subject contributes. It is not equal to  an 
unweighted average of either measure, unless - by chance or design - a ll the 
weights are equal (i.e. all the children contribute data from the same period of 
observation, and there are no missing data). Moreover, the variance o f this 
measure is not equal to the customary binomial variance of a proportion because 
the use of repeated measures on the same individual introduces problems of 
correlated data more serious even than those discussed in the previous sections
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on measures of disease incidence (Section 5.2.3). The use of this measure is thus 
best avoided when analysing prevalence data from longitudinal studies.
In this chapter, no further consideration is given to the time series approach to 
the analysis of prevalence data, since this does not permit the examination of 
individual-level differences in disease status. Instead, I first consider the 
significance of episodic prevalence as a potential measure of ‘frailty’, and then 
consider a variety of statistical techniques which might be used to compare 
episodic prevalence in different sub-groups of a population. Finally, I consider 
in more detail the relationship between multiple days of illness/health measured 
on the same individual, and discuss the implications that these relationships may 
have for the appropriate analysis of illness prevalence.
7 .2  Episodic prevalence a n d  the concept o f 'frailty *
The tabulation of the distribution of episodic prevalences in the whole 
population, as illustrated in Figure 7.2, suggests that days of illness are not 
distributed ‘fairly’ between different individuals: some of the children in the 
Ghana VAST Child Health Study experience very little or no cough during the 
course of the study year, whilst others experience almost continuous coughing 
throughout the year. In fact, if days of illness were distributed completely at 
random, w ith a constant probability of illness for all individuals and all days, the 
distribution would be binomial with a mean of 7r=.14, as shown in Figure 7.3. 
The marked difference between this distribution and that observed in Figure 7.2 
confirms the existence of important heterogeneity of risk, a concept previously 
evoked in Section 5.2.3. It is convenient to refer to those children with a higher 
underlying risk of morbidity as frail, even though this term has hitherto 
generally been used to describe individuals at increased risk of mortality rather 
than morbidity (see, for example, Vaupel et al., 1979). An important
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consideration in extending this term to include individuals at increased risk of 
specific morbidities - over and above the axiomatic observation that mortality is 
caused by illness - is the fact that the various environmental and genetic factors 
that make some children more prone to common infectious illness than others 
are most unlikely to be specific to individual signs or symptoms. This 
phenomenon has been discussed in some detail by Mosley and Becker (1991), and 
is apparent in the Ghana VAST data set, where individuals who experience high 
episodic prevalences of one sign/symptom are likely to experience high 
prevalences of other symptoms also.
In addition to its importance as a possible indicator of frailty already established, 
episodic prevalence may have another role as an indicator of frailty in-the- 
making. The idea relates to the work of Alter and Riley (1989), who developed 
the concept of insult accumulation, meaning that "each ‘insult’ from illness or 
injury leaves the individual more susceptible to disease in the future". The 
precise mechanisms by which such insults could be brought about are discussed 
by Solimano and Vine (1980). A number of studies have examined the link 
between episodic prevalence of illness and anthropometric status, attempting to 
quantify the impact of illness on ‘acquired frailty’: for example, Lutter and 
colleagues (1992) have shown, using three different data sets, that each day of 
diarrhoeal illness between the ages of 0 and 36 months is associated w ith a .03 
cm decrease in attained length at 36 months in Colombia; with a .74 cm  decrease 
in attained length at 36 months in Guatemala, and with a significant impact on 
weight gain between 6 and 12 months in Peru. Rowland et al. (1988) have 
shown that in the Gambia, both diarrhoea and lower respiratory tract infections 
were associated with weight faltering in the first, but not the second year of life. 
All these studies are based on the premise that anthropometric status may be 
taken as a proxy measure of frailty. The strength of the associations 
demonstrated suggests that episodic prevalence may be an outcome measure of 
major clinical relevance in studies of common diseases of childhood.
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7.3 C om paring distributions o f  episodic prevalences between different 
groups o f individuals
In order to make a comparison of episodic prevalences between two different 
groups o f individuals, Cousens and Kirkwood (1990) have suggested dividing the 
distribution of prevalences into a number of discrete intervals (e.g. no 
illness; 1-20%, 21-40% and 41-100%) and comparing the groups by means of a chi- 
squared test for trend. This approach facilitates the visual comparison of the 
proportions of children with low or high episodic prevalences, and is illustrated 
in Table 7.1, which shows the distribution of cough prevalences in the Ghana 
data set in  children living in compounds with (n=116) and without (n = 981) an 
adult w ith  a chronic cough. The analysis is restricted to individuals with 300 or 
more days of observation. In this example, children living in compounds with 
an adult with chronic cough were much more likely to have high prevalences of 
cough than children living in compounds without an adult with chronic cough 
(x2= 12.16 on 1 df; P — 0.0005). Mathematically, the chi-squared test for trend is 
equivalent to a t-test using consecutive integers to represent each grouped interval 
instead of the true values. It is thus somewhat wasteful of information, since the 
actual data values are discarded.
On the other hand, using a simple r-test to compare actual episodic prevalences 
in the tw o groups is problematic, since the distribution of episodic prevalences 
is likely to be far from Normal, and the test assumption of equal variances in 
each group may be violated. In the example of the previous paragraph, the 
variance of the prevalences of children living in compounds with an adult with 
a chronic cough was 1.92 times the variance of children living in compounds 
without such an individual. With large numbers of observations in each group, 
it is possible to calculate a z-statistic robust to unequal variances (Kirkwood, 
1988). In this example, the resulting value of z was 2.75 (P -0.007).
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Alternatively, various transformations of the raw data values are possible to 
achieve more similar variances in the two groups: the logarithmic transformation, 
new_value = natural logarithm{episodic prevalence[%]+1}, proved in this 
example to be surprisingly adequate in this respect, giving a variance ratio of 1.19 
(not significantly different from 1). Using the log-transformed data, the separate 
variance estimate of z was 2.28 (P = 0.024), and the pooled variance estimate of 
t was 2.45 (P = 0.015). The means of the log-transformed data (minus 1, since this 
quantity was added when the logs were taken) may be interpreted as geometric 
mean episodic prevalences. Using ranks instead of the raw data values also 
proved to be variance-stabilising, with a variance ratio of 1.15, a separate variance 
estimate of z of 2.09 ( P - 0.038) and a pooled variance estimate of t of 2.22 
(P = 0.027). The r-test using ranks is essentially equivalent to the non-parametric 
Mann-Whitney test (Mann & Whitney, 1947), and can be interpreted as a test of 
the difference between two medians.
All the above tests seek to identify differences in the central point (however 
defined) of the distributions of episodic prevalences between different sub-groups 
of children. The approach favoured by Cousens and Kirkwood has the 
advantage that it also enables easy visual comparison of the proportions of 
children with high or low prevalences. A graphical comparison of the two 
distributions, as shown in Figure 7.4, is a useful complement to this approach. 
The logarithmic transformation, on the other hand, has the advantage that (a) the 
antilog of the difference between the two log-transformed means can be 
interpreted as an estimate of the episodic prevalence rate ratio, w ith  confidence 
intervals easily defined by standard methods, and (b) the approach can be 
extended to cover situations in which children have uneven lengths of follow-up 
and/or several episodic prevalences have been calculated for each child. These 
situations are discussed in the following section.
172
7 .3 .1  Uneven lengths o f  follow -up, and m ultiple measures o f
episodic prevalence
A practical problem associated with analysing data on episodic prevalences arises 
when children have differing lengths of follow-up, since episodic prevalences 
calculated using data on children with a relatively short period of follow-up will 
be less precisely estimated than those estimated using data on children with a 
long length of follow-up. This implies that some system of weighting should be 
used so that the contributions of children with incomplete follow-up are down­
weighted in the analysis. Ideally, the inverse of the variance of the individual 
episodic prevalence estimates should be used, but it is far from clear how the 
variance of these episodic prevalence estimates should be determined; although 
the episodic prevalences are nothing more than simple proportions, the 
conventional binomial variance of a proportion is not appropriate in this case 
since individual days of sickness/health measured on the same individual are not 
independent, and, furthermore, the binomial variance is by definition equal to 
zero when the episodic prevalence is zero or one.
One might argue that the whole concept of within-child variability is not 
relevant in the consideration of episodic prevalence, since this measure is 
effectively a score rating the child on a continuum from ‘very healthy’ to ‘very 
sick’, without any reference to individual days. In this case, the number of days 
observed for each child divided by the maximum possible number of days of 
observation is probably an acceptable weighting system (equivalent to weighting 
cluster-level estimates by cluster size in a cluster-randomised trial). An 
unweighted analysis, using data from all 1847 children in the Ghana VAST Child 
Health Study with known values for the presence or otherwise of an adult with 
chronic cough in their compound, and comparing (log-transformed) episodic 
prevalences of cough in children living with an adult with chronic cough
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(n = 215) and in those not doing (n=1632) gives a z-statistic of 3.65 (P = .000). 
Weighting the observations according to the scheme outlined above gives a z- 
statistic of 2.87 (P = .004), with an effective total n of 1365. Part of this reduction 
in the magnitude of the z-statistic is accounted for by an increase - when 
weighting is applied - in the geometric mean episodic prevalence of cough in the 
group with the lower prevalences and larger number of observations; this is 
explained by the fact that half of the 239 children with no recorded cough at all 
were observed for less than 30% of the total observation period, and are thus 
down-weighted in the weighted analysis.
Another issue which may arise in the analysis of episodic prevalence data is the 
question of incorporating information on time-dependent covariates. By 
definition, episodic prevalence refers to an individual’s experience over an 
extended period of time, and changes in covariate values over the course of that 
period cannot be modelled. It is possible, however, to calculate a number of 
different episodic prevalences for the same individual over consecutive periods of 
time, and to relate each prevalence measure to covariates measured at the 
beginning, middle or end of the period. In the case of the Ghana data, for 
example, episodic prevalences could be calculated separately for each dosing 
round (a period of 4 months). Since the episodic prevalences for any given 
individual w ill be highly correlated between different time periods, any 
subsequent analysis must take this into account. One fairly simple approach 
would be to use the Generalised Estimating Equations described in Chapter 6, 
taking the outcome measure as the log-transformed episodic prevalence, and using 
an identity link and a Normal error distribution. This type of analysis is 
illustrated in Table 7.2, using cough prevalence over each of the three dosing 
rounds of the Child Health Study, and relating these measures to the child’s age 
and anthropometric status at the beginning of the round. As it turns out, there 
is extremely little difference in this example between an analysis conducted using 
the Generalised Estimating Equations - part (a) - and the same analysis conducted
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using standard multiple linear regression, treating each round as an independent 
observation - part (b). This is despite the fact that relatively high within-child 
correlations were observed (r = 0.367). The effect of malnutrition (weight-for- 
height z-score less than -2) may have been slightly over-estimated when standard 
multiple linear regression methods were used.
7 .4  W ithin-child variability in disease status, an d acquired fra ilty
The use of episodic prevalence as the primary outcome measure in the analysis 
of disease prevalence necessarily implies discarding potentially valuable 
information about the timing and sequence of days of illness. Any approach 
which explicitly modelled these features of disease status would need to take each 
individual day of illness (or health) as the primary unit of analysis, and account 
for the full set of correlations between one day of illness and another, measured 
on the same individual. These correlations may be expected to change as the 
interval between the two days increases. Figure 7.5 shows the observed within- 
subject correlations between the presence of cough on the first day of the trial 
period and the presence of cough on subsequent days up to the 50th day of the 
trial period in the Ghana VAST Child Health Study. It can be seen that the first 
two days of illness/health were very highly correlated within each child, with an 
r  of over 0.8. These correlations then fell progressively with longer intervals 
separating the pairs of observations being compared. Rather stable correlations 
of the order of 0.2 were observed with intervals of two weeks or longer.
In theory, this correlation structure could be modelled using either the 
Generalised Estimating Equations described in Chapter 6 or the Multi-Level 
Modelling package ML3 (Section 5.3.2). However, because of the limitations of 
the current implementations of the Generalised Estimating Equations, it would 
not be possible to model anything other than exchangeable correlation if there
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were variable numbers of days of observation per individual. Furthermore, with 
a full year of follow-up, the equations could only be solved by inverting a 364 
x 364 matrix, an undertaking which is completely impracticable using micro­
computers. Although methods exist for modelling an exponential decline in 
intra-subject correlations using the Multi-Level Modelling package ML3, this 
package has rather restrictive data space specifications, and would be quite 
incapable of analysing data sets of the size of the Ghana VAST study, with 
nearly 2000 children and 364 days of observation.
One approach which could more feasibly be applied to the analysis of daily 
prevalence data in longitudinal studies - if  it were considered necessary to 
incorporate information about the timing and sequence of days of illness - would 
be to use conditional models (described in Section 5.3.1). These models seek to 
quantify the probability that an individual w ill experience illness on day t given 
that s/he did (or did not) experience illness on day t-1. A set of models 
appropriate for dependent binary outcomes of this kind has been developed by 
Bonney (1987). In the following section, Bonney’s approach is applied to data 
from the Ghana Vitamin A Supplementation Trials Child Health Study.
7.4 .1 Logistic regression fo r  dependent binary outcomes
In his paper, Bonney attempts to identify the different features of dependence in 
the outcome variable (presence of illness on day f; coded y, -  1 for illness present, 
and y ,-0  for illness absent) which need to be considered when modelling daily 
prevalence data. He introduces a general regression model in which 0„ the logit 
of the outcome on day t, is related to the illness status on the previous day (day 
t-1), the number of preceding ‘successes’ (in this case, days with illness), the 
number of preceding ‘failures’ (days without illness), and other covariates:
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0, - a + ypZ,_, +  y*S*,_, + y (-S',.,) + 0X,
where a  is a constant term, Z,_; is a function of the immediately preceding 
outcome (coded 1 for disease present and -1  for disease absent, so that if y,_, = 
1, the odds of y, increases by ey(p), and if yt_, -  0, the odds of y, decreases by the 
same amount). S*t_, is the number of preceding days of illness, S~,_, is the 
number of preceding days without illness, and X, is a vector of occasion-specific 
covariates.
This very general model includes (nested within it) a number of more specific 
models, such as the simple Markov model which specifies that the current 
outcome is determined only by the immediately preceding outcome (and other 
relevant covariates), with no terms relating to the number of previous days with 
or without illness. Comparison of a variety of models, with different 
assumptions about the structure of the dependence between successive days of 
illness or health, should help indicate to what degree the concept of a day of 
illness has any relevance removed from its context as part of an episode, and also 
to what degree ‘acquired frailty’ can be demonstrated using prevalence data. 
With this aim, a variety of models were fitted using data on daily prevalence of 
cough in 100 children with complete follow-up in the Ghana study, and the 
results are shown in Table 7.3.
Model 8 is the complete model described in the first paragraph of this section: 
in this model, the effect of the number of preceding days of illness is allowed to 
be of a different magnitude to the effect associated with the number of preceding 
days without illness (i.e. they are not equally predictive), and the immediately 
preceding outcome is included as a potential determinant of current illness status. 
This is the best fitting model, with a deviance of 6197 on 36,296 degrees of 
freedom. Other models were compared to this model by subtracting the 
deviance of the best model from the deviance of each of the other models, and
177
relating this to the difference in degrees of freedom (equal to the difference in the 
number of parameters). This is interpreted as a chi-squared statistic (Clayton & 
Hills, 1993). This analysis shows that four other models with a reduced number 
of predictor variables (numbers 3 and 5-7) are fairly adequate in describing this 
data set, though all are significantly less good than the ‘best’ model. All of these 
models include the variable referring to the child’s illness status on the previous 
day. The models which do not include this variable (numbers 1, 2 and 4) give 
a substantially poorer fit to the data.
The final ‘best’ model is given by the equation:
6 , -----1.09 + 2.94 x Z,_, + .012 x S*,_, + .004 x ( - S - ,./)
Because of the logit link, the regression coefficients must be anti-logged before 
they can be interpreted as odds ratios. Furthermore, since the preceding day’s 
illness status Z is coded (1,-1) the effect of having cough yesterday relative to not 
having cough yesterday is obtained b y  multiplying the coefficient by two before 
taking the anti-log. The results thus indicate that a child with cough yesterday 
is 360 times more likely to have cough today than a child without cough 
yesterday. A child who has already recorded 3 months of cough is 3 times more 
likely to have cough today than a child without any previous history of cough, 
and a child who has already recorded 3 months of no cough is 30% less likely to 
have cough today than a child without any previous history of days without 
cough.
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7.5 Discussion and conclusions
The results of the previous section demonstrate the profound dependence that 
exists between consecutive days of illness/health recorded on the same individual. 
Such a finding will hardly come as a surprise to those accustomed to thinking of 
illness in terms of episodes, but it has major implications for the analysis of 
prevalence data in longitudinal studies. Conventionally, such data are analysed 
using techniques - such as the simple chi-squared test for the difference between 
two proportions - which treat every day of observation as independent. Such 
techniques are inappropriate since they exaggerate both the precision of stand­
alone estimates, such as the proportion of days with illness, and the levels of 
statistical significance in comparisons between different population sub-groups.
These correlations that exist between different days of observation measured on 
the same individual cannot easily be accommodated using sophisticated modelling 
procedures such as Multi-Level Modelling or Generalised Estimating Equations. 
Indeed, any procedure which treats each child-day as a separate record will soon 
run into software problems due to the enormous size of the resulting files - these 
problems may be the result of limited work space or quite simply arithmetic 
‘overload’. Conditional models of the type proposed by Bonney (1987) are less 
problematic to fit, and can incorporate quite sophisticated models of dependence 
between multiple days of observation on the same individual, but they suffer 
from all the limitations noted in Section 5.3.1, most notably the impossibility of 
including any fixed (i.e. child-level) covariates in the analysis. Their practical 
usefulness is probably limited to the rare occasions when the major covariate of 
interest changes extremely rapidly with time.
An alternative, and more promising, approach to the analysis of illness 
prevalence involves moving away from a focus on individual days of
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illness/health, and basing analysis instead on ‘episodic prevalence’, a measure of 
the proportion of time each individual spends ill. Whilst this measure was first 
proposed by Cobb as early  as 1962, there was virtually no discussion of how 
such data should be analysed until the appearance of the guidelines developed by 
Cousens and Kirkwood in  1990. Cousens and Kirkwood suggested a number of 
different approaches, including a technique based on the chi-squared test for 
trend, and standard parametric analyses based on the log-transforms of the 
original episodic prevalences. I suggest two extensions to the latter parametric 
approach: firstly, weighting episodic prevalences differentially so as to 
incorporate information on the duration of follow-up of each individual, and 
secondly, using the Generalised Estimating Equations to deal with within-subject 
correlations between episodic prevalences calculated over multiple time periods.
I have suggested that episodic prevalence may play an important role in the 
epidemiology of childhood disease as an indicator of frailty. Heterogeneity of 
risk cannot be identified in cross-sectional studies because there is no way of 
telling whether a particular individual is sick at the time of the survey because 
they are generally sick more of the time than others, or because they are no 
different from other individuals, but just happen to be sick at that time. The use 
of episodic prevalence, calculated from longitudinal studies, offers one way of 
resolving this dilemma. The possibility that episodic prevalences, calculated over 
a reasonably long period of time, may be a reliable indicator of true underlying 
propensities to disease is reinforced by the quite different analysis of Section 
7.4.1, which shows that children with 90 days’ previous history of coughing were 
three times more likely to  cough on day r than children with no previous history 
of cough. Whilst it is not possible to say whether this finding points merely to 
the existence of an identifiable set of chronic coughers, or whether it really is a 
a demonstration of ‘acquired frailty’ , the evidence from various studies of the 
impact of multiple days o f illness on growth does seem to indicate that children 
are indeed rendered more vulnerable by the accumulation of morbidity insults.
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Table 7.1 Distribution of cough prevalences in children 
living in compounds with and without an adult with a chronic cough (Ghana VAST CHS)
Presence of adult 
with chronic cough 
in same compound:
Prevalence of cough over observation period 
None 1-20% 21-40% 241% TOTAL
1 Present No.
row % 
col %
S
(4.3%)
(7.2%)
77
(66.4%)
(9-6%)
15
(12.9%) 
( 9.7%)
19
(16.4%)
(25.7%)
116
(100%)
(10.6%)
Absent No. 
i row %
64
(6.5%)
722
(73.6%)
14 0
(14.3%)
55
(5.6%)
981
TOTAL N o .
row %
69
(6.3%)
799
(72.S%)
155
(14.1%)
74
(6.7%)
1097
Test for trend: x2 = 12.16 on 1 df; P = 0.0005
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Table 7.2 Regression analysis of cough prevalence over 3 dosing rounds in the Ghana VAST CHS
a) Using the Generalized Estimating Equations
Regression
coefficient
(0)
Exponentiated 
coefficient 
exp(d)
Standard error I 
SE<0)
Constant 3.167 22.7 0.072
Age: 0-5 months _ 1.00
6-11 months -0.179 0.84 O . 08212-17 months -0.474 0.62 O . 09218-23 months -0.717 0.49 O . 093
24-35 months -0.914 0.40 O . 08836+ months -1.076 0.34 O . 085
Round: 1 . 1.00
2 -0.666 0.51 O . 042
3 -1.089 0.34 O . 043
Anthropometry:
w/H z-score *-2 - 1.00
W/H z-score <-2 0.039 1.04 O . 093
Within-child
correlation 0.367
b) Using standard multiple linear regr ession
Regression
coefficient
Exponentiated
coefficient
Standard error
03) exp(0) SE (0)
Constant 3.199 23.5 0.080
Age: 0-5 months . 1.00
6-11 months -0.214 0.81 O . 094
12-17 months -0.548 0.58 O . 096
18-23 months -0.732 0.48 O . 096
24-35 months -0.942 0.39 O . 084
36+ months -1.137 0.32 0.081
Round: 1 - 1.00
2 -0.672 0.51 0.057
3 -1.094 0.33 O . 055
Anthropometry:
W/H z-score *-2 - 1.00
W/H z-score <-2 0.158 1.17 O . 102
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Table 7.3 Comparison of models to predict current illness status (presence of cough) in 100 
young children in Northern Ghana observed over 364 consecutive days
Model description Parameter
restrictions
-2 log 
Likelihood
No. of 
parameters
Difference (in 
-2LL) from model 8
(1) Complete independence Yp -  y‘ - r  -  0 17567.663 0 11370.6 on 3 df
(2) Equally predictive 7 *  " Y> T p  »  0 16577.100 1 10380.0 on 2 df
(3) Markov dependence (MD) Y  - r  - o 6302.242 1 105.2 on 2 df
(4) Not equally predictive 7 p  ■ 0 15954.780 2 9757.7 on 1 df
(5) Risk determined by number of 
previous days of illness + MD r  - o 6282.692 2 85.6 on 1 df
(6) Risk determined by number of
previous days without illness ♦ MD T *  - 0 6240.237 2 43.2 on 1 df
(7) Equally predictive given MD Y  - Y 6218.353 2 21.3 on 1 df
(8) Not equally predictive given MD - 6197.064 3
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Figure 7.1 Point prevalence of 'intolegere' over 65 consecutive weeks of data collection, 
northern Ghana
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Figure 7.2 Distribution of episodic prevalences of coughin 1103 children in northern Ghana
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Figure 7.3 Binomial distribution, tt . 14, n 364
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Figure 7.4 Distribution of episodic prevalences of cough in children living in compounds
with and without an adult with chronic cough, northern Ghana
1« c h r o n i c  cougher 
I -  c h r o n ic  cougher
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Figure 7.5 Within-subject correlations between cough on Day 1 and on subsequent days up 
to Day 50, Ghana VAST Child Health Study
C o r r e l a t i o n  C o e f f i c i e n t
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Chapter 8
The Analysis of Data on Episode Duration
8 .1  Introduction
If little has been written about the analysis of prevalence data in longitudinal 
studies of common diseases of childhood, next to nothing has been written about 
the analysis of data on the duration of illness episodes. Indeed, illness duration 
has rarely been a major focus of community-based studies of common diseases 
of childhood, having featured only in a small number of studies which examined 
the association between anthropometric status and diarrhoea duration in 
developing countries (Black et al., 1984; Schorling et al., 1990; Thongkrajai et al., 
1990; Guerrant et al., 1992). Just two groups have conducted exploratory 
analyses of risk factors for increased duration of diarrhoea (Househam et al., 
1990; Mahalanabis et al., 1991), and no articles could be located describing 
community-based studies of differentials in the duration of childhood respiratory 
diseases, or malaria.
On the other hand, a large number of clinical trials have been conducted looking 
at interventions to reduce the duration of acute watery diarrhoea in children. 
Many of these have focused on oral rehydration therapies of various descriptions 
(Ocampo et al., 1993; Bhan et al., 1991; Rahman et al., 1991; Gore et al., 1992). 
Others have looked at specific feeding practices (Brown et al., 1993; Alarcon et 
al., 1992; Lembcke & Brown, 1992), micronutrient interventions (Henning et al. 
1992; Sachdev et al., 1990; Haffejee, 1988) or drug therapies (Jacobs et al., 1994; 
Prado et al., 1993; Motala et al., 1990). Clinical trials have also been conducted 
to investigate the effects of specific interventions on the duration of malaria 
(Kremsner et al., 1993; Harinsuta et al., 1993) and pneumonia, particularly 
measles-associated pneumonia (Coutsoudis et al., 1991; Hussey & Klein, 1990).
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It is important to note that duration data generated by clinical trials may differ 
in some important respects from that generated in field trials or observational 
follow-up studies: firstly, since clinical trials are most often conducted in 
hospitals, there will be relatively little loss to follow-up, with the censoring of 
duration data that that entails. Secondly, since each child under observation in 
the field may potentially experience several episodes of diarrhoea, the possibility 
of within-child correlations in duration outcomes must be borne in mind.
The vast majority of the articles described above have used analytic methods 
based on Normal distribution theory. Often, untransformed duration data are 
analysed using t-tests, multiple linear regression or analysis of variance (see, for 
example, Black et al., 1984, or Mahalanabis et al., 1991). Not only is the 
underlying conceptual model which would lead to this choice of analytic 
approach unclear, but the highly asymmetric distribution of episode durations 
visibly leads to violations of the model assumptions: Black and co-workers, for 
example, use analysis of variance methods to compare mean durations of E. coli 
diarrhoea in three groups of children defined by their nutritional status, even 
though the standard error of the mean duration of E. coli diarrhoea is five times 
greater in the malnourished children (weight-for-age <60% of the NCHS 
reference population median) than in their eutrophic peers (weight-for-age >75% 
of the reference standard). Logarithmic transformations are sometimes used to 
reduce these imbalances in the within-group variances (Schorling et al., 1990; 
Bhan et al., 1991), but - as w ill be seen later in this chapter - it is far from clear 
that this remedial measure is sufficient to eliminate the problem. These methods 
make no allowance for possible within-subject correlations in the outcome 
measure, which we have shown in previous chapters to be extremely important 
in the analysis of disease incidence and prevalence.
The analysis of illness duration is considerably more developed in the area of 
cancer epidemiology, where ‘duration of response’ (time from documentation of
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favourable tumour response to documentation of disease progression for the 
subset of patients who respond to therapy) is often one of the most important 
variables to be studied (Morgan, 1988). Due to the chronic nature of cancer 
illness, the response times recorded often run into many months, if not years, 
and it is not uncommon for a substantial proportion of study subjects to be lost 
to follow-up before any progression of the illness is seen. This has led to the 
fairly widespread adoption of survival analysis techniques, which can 
accommodate these censored observations (some of these methods are described 
in Breslow and Day, 1987, Chapter 5). In field studies, censoring can be 
generated by a number of different mechanisms: observation can be curtailed 
during the middle of an episode, the beginning or end of the observation period 
can cut through the middle of an illness episode, individuals can move in or out 
of the study area in the middle of an illness episode, or another outcome (such 
as hospitalisation) can replace collection of data on the duration of the episode 
(Bressers et al., 1991). All of these situations occur frequently in longitudinal 
studies of common diseases of childhood. Depending on the mechanism by 
which the censoring is generated, the amount of censoring and distribution 
between different exposure groups, and the precise analytic techniques adopted, 
Bressers and co-workers have shown that ignoring the problem of censoring by 
treating censored results as uncensored, or omitting them from the analysis 
altogether, may lead to seriously erroneous conclusions.
There appears to be little realisation, however, that survival analysis techniques 
are equally appropriate for the analysis of durations of episodes of the far more 
common diseases of childhood, even though these illnesses are typically of much 
shorter duration. Censored illness episodes are quite likely to be in reality more 
protracted than uncensored ones (both because the most protracted illness is 
likely to cause the greatest upset to the family’s normal routine, and thus disrupt 
the surveillance procedures, and because events of long duration offer by 
definition greater potential for censoring). It is therefore highly desirable that
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the censoring should be allowed for in the analysis whenever more than a small 
proportion of all durations are censored. In this chapter, alternative methods for 
analysing episode duration data are compared. The implications of ignoring the 
censoring of episode durations, and the possibility of important within-subject 
correlations are investigated. The relationship between duration and other 
outcome measures is described, and the biological implications of the findings 
discussed.
8 .2  D uration data fro m  the Lim a  R otavirus Vaccine T rial
The discussion of the following pages is illustrated with data drawn from the 
Lima Rotavirus Vaccine Trial (see Section 2.3 for a description of this study). 
In this trial, children were visited in their homes and a full retrospective 
morbidity history taken twice each week, in contrast to the once-weekly visits 
conducted in the Ghana VAST Child Health Study. Since caretakers may find 
it difficult to place in time events which occurred several days prior to the 
interview, accurate information on episode duration is extremely difficult to 
obtain in community-based studies. The more frequently the interview's are 
conducted, the more accurately respondents are able to recall the exact starting 
and ending dates of different symptoms, since recall is limited to a maximum of 
a few days prior to the interview. For this reason, the Lima study has 
exceptionally reliable data on episode durations, and was chosen in preference to 
the Ghana data for the comparative analyses of episode duration. In accordance 
with the conclusions of Chapter 3, two days without symptoms were deemed 
necessary to mark the end of a diarrhoea episode. Diarrhoea was defined as three 
or more liquid or semi-liquid stool motions in the course of a single twenty-four 
hour period.
When the data were analysed in this way, 15 931 episodes of diarrhoea were
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recorded during the course of this trial. Only twelve children (out of 800) 
experienced no episode of diarrhoea during the two-year follow-up period. 804 
episodes (5.0%) were of unknown duration due to censoring, either of the start 
or of the end of the episode. The distribution of durations of those episodes 
which were not censored is shown in Figure 8.1. 43.7% of these were of just 
one day’s duration, and over 90% were of 5 days’ duration or less; just 19 
episodes were of more than 21 days’ duration.
The form of the distribution resembles that of a negative exponential 
distribution, previously described in Section 3.3. This is confirmed in  Figure 
8.2, where the actual durations are plotted against ‘Savage scores’, which are 
based on the theoretical exponential distribution (see Conover, 1990); a close 
linear relationship is observed between the two (r=0.9875). The exponential 
distribution is widely used in engineering applications to describe the lifetime of 
industrial components, and other similar variables. One can perhaps imagine a 
parallel between the persistence of a component confronted with a battery of 
‘insults’, and the persistence of a pathogenic process in the face of a multi-facetted 
immune response. The distribution is fully defined by the rate at which 
components fail (or in this case, symptoms of illness remit), referred to 
technically as the hazard rate. The close correspondence of the observed 
distribution to the theoretical model suggests that in this ‘population’ of illness 
episodes, recovery occurs at an approximately constant rate over tim e (i.e. the 
likelihood of recovery on the fourth day, given that the illness has lasted three 
days, is the same as the likelihood of recovery on the third day, given that the 
illness has lasted two days). The accuracy and biological plausibility of this 
assumption are examined in subsequent sections.
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8 .3  M odelling duration data
Various regression techniques have been developed for modelling exponentially 
distributed data (see Lee, 1992). All of them are able to incorporate information 
on censored observations. The results cited below are calculated using what has 
been termed the linear exponential (Lee, 1992), or log linear hazard (Aitkin et al., 
1989) model. In this model, mean survival times are related to the vector of 
covariates by a log link. One of the properties of the exponential distribution 
is that the mean survival time is equal to the reciprocal of the hazard rate (which, 
it has already been mentioned, is constant). The following results were obtained 
from modelling the Lima diarrhoea data:
Exponential regression
Log Likelihood »-20473.363
Number of obs 
Model chi2(0) 
Prob > chi2 
Pseudo R2
15931
0 . 0 0 0
0.0000
durât 1 Coef . Std. Err. z P>|z| [95% Conf. Interval]
_cons 1 1.010873 .0081306 124.329 0.000 .9949377 1.026809
The mean survival time is given by the exponentiated coefficient of the constant 
term, and is equal to 2.75 days. This can be compared with the estimate of the 
mean survival time which would be derived if censored data were simply 
excluded from the calculation (2.56 days; an underestimate of 7%), and the 
estimate which would be derived if the censored data were included, but the 
censoring ignored (2.61 days; an underestimate of 5%). It is thus moderately 
important to account for the censored nature of the data, even when censoring 
affects o n ly  a very small percentage of a ll observations, as in this example.
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As the next step in the analysis of these data, two potentially important 
covariates were introduced into the model: the A G E  of the child at the beginning 
of the episode, and the child’s S EX . A G E  was modelled as a categorical variable 
with 5 levels. The results are shown in Table 8.1. Negative regression 
coefficients [/3’s] indicate shorter durations, and positive coefficients indicate 
longer durations. When exponentiated, these coefficients can be interpreted as 
ratios of the mean durations in each group, with the constant term referring to 
the mean duration of illness in the baseline group. The reciprocal of these 
exponentiated coefficients can be interpreted as a hazard rate ratio, or baseline 
hazard rate in the case of the constant term. As previously indicated, the hazard 
rate in this analysis is equivalent to the (instantaneous) rate of recovery from 
illness. The results show that the recovery rate progressively increases, and 
therefore the duration of diarrhoeal symptoms progressively decreases, with age 
in this population, and also that girls have marginally shorter episodes of illness 
than boys. Although, due to the very large sample size, all the coefficients are 
highly significant in this analysis, the pseudo R2 (which is simply the log- 
likelihood value on a scale where 0 corresponds to the constant-only model and 
1 corresponds to perfect prediction) is less than 1%, indicating that age and sex 
are not important determinants of duration of diarrhoeal illness.
It is worth noting that whilst exponential regression is not generally available in 
the most widely used statistical software, almost identical results can be obtained 
by using Poisson regression, which is widely available, setting the outcome 
variable to 1 when the duration of the episode is known and 0 when it is 
censored, and treating logfduration) as an offset term (Aitkin et al., 1989). This 
procedure gives identical coefficients to those obtained in exponential regression 
(though with opposite signs), and very similar (in the case of the current analysis, 
indistinguishable) standard errors.
It may perhaps be considered surprising that the Lima duration data correspond
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so well to an exponential distribution, since this implies that the instantaneous 
rate of recovery from illness (the hazard rate) is the same regardless of how long 
the illness has already lasted (i.e. the process is memory-less). Another 
distribution, which allows the hazard rate to vary with the duration of the 
illness, is the Weibull distribution (see Lee, 1992). Table 8.2 compares the results 
of the same analysis using Weibull regression with that using exponential 
regression. The sigma parameter is a shape parameter which describes the change 
in the hazard rate: if sigma is smaller than 1, the hazard rate is increasing over 
time; if it is greater than 1, the hazard rate is falling, and if it is equal to 1, the 
hazard rate is constant (the case of the exponential distribution). In this example, 
sigma is somewhat smaller than 1, implying that the instantaneous rate of 
recovery from illness increases with the duration of the illness. The regression 
coefficients are not appreciably altered by the use of Weibull as opposed to 
exponential regression, but the standard errors are smaller. The goodness-of-fit 
statistic (model x2) is considerably greater for the Weibull than for the 
exponential model, indicating a much better fit.
Also shown in Table 8.2 are the results of conducting the same analysis using the 
non-parametric Cox Proportional Hazards regression (Cox, 1972). This model 
has as its dependent variable the natural logarithm of the ratio of the hazard rate 
for an individual with covariates x, to the hazard rate of an individual with all 
covariates equal to zero (the baseline hazard rate). This is related to a linear 
combination of covariates and coefficients, as with any linear model. By holding 
the x’s constant, the model is able to estimate hazard rate ratios for each of the 
relevant exposures. It should be noted that since this model estimates hazard 
ratios rather than group means, the signs of the coefficients are reversed relative 
to the two previous models.
In the example shown in Table 8.2, Cox Proportional Hazards regression gives 
similar, though not identical, estimates of covariate effects to those obtained
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using the parametric models, with standard errors identical to those of the 
exponential regression model. Since the underlying assumptions of the Cox 
Proportional Hazards model are more general than those of the parametric 
models (only proportionality of hazard rates is required), and the models are 
easily fit using widely available statistical software, this approach may be 
recommended as an alternative to exponential or Weibull regression.
Table 8.3 shows the results obtained when the durations are transformed to the 
log scale, and ordinary linear regression is performed. Using this technique, 
censoring is ignored, and comparisons are of between-group ratios of geometric 
means. The results are thus quite different from those obtained using any of the 
approaches which compare hazard rates or maximum likelihood estimates of the 
means of exponential or Weibull distributions. For a sample well approximated 
by an exponential distribution, the mean response estimated by exponential 
regression will be very close to the arithmetic mean of the individual 
observations in the sample. Likewise, when the sample is well approximated by 
a Weibull distribution, the sample mean estimated by Weibull regression will be 
close to the arithmetic mean of the individual observations in the sample. In 
neither case w ill these values fall anywhere close to  the geometric mean, due the 
extreme skewness of the distributions.
It should be noted that the logarithmic transformation of the duration data was 
in this case inadequate to completely stabilize the variances in the different age 
groups, with a between-group maximum-.minimum variance ratio of 1.683 
(compared to an even more extreme ratio of 3.325 when the untransformed 
duration data were used). Between-group differences in linear regression are 
tested using the equivalent of a pooled estimate of the assumed ‘common’ 
variance; however, in this case, testing the effect of age group 36+ months versus 
age group 0-2 months using the more robust separate variance estimates resulted 
in an increase in the estimated standard error of the difference from 0.0272 to 
0.0322 (+18%) compared to the result obtained using the pooled variance
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estimate. This implies that using linear regression with the log-transformed data 
would exaggerate the precision of this age effect. The other effect estimates 
would be less seriously affected.
8 .4  Accounting fo r  witkin-child correlation
None of the above methods take into account possible correlations between 
durations of different episodes experienced by the same child. If child-level 
characteristics (measured or otherwise) are important in determining the duration 
of diarrhoea episodes, then this within-child correlation could lead to biases in 
effect estimates, or mis-estimation of the precision of regression coefficients, in 
the same way as we have seen with other outcomes.
In order to test this, the Lima data set was analysed using the multi-level 
modelling package ML3 (see Section 5.3.2). Since this package allows Poisson 
regression (using algorithms described in Goldstein, 1991), a re-arrangement of 
the data using log(duration) as an offset term as described above enables a form 
of exponential regression to be carried out. The results are shown in Table 8.4. 
The effect estimates and standard errors are virtually identical to those obtained 
using ordinary exponential regression (although with the signs reversed, as 
expected when the Poisson approximation is used). The most interesting feature 
of these results is the disaggregation of the variance into two distinct 
components: within- and between-child variability. The within-child component 
is constrained to take the value 1, indicating Poisson variance. Beside this, 
however, the between-child variance component is negligible (0.037), indicating 
an almost complete absence of within-child correlation. Given this extremely 
low level of correlation, the methods described in the previous section, which do 
not attempt to partition the variance into different levels, should be adequate. 
This is fortunate, since use of the Poisson macro in ML3 is cumbersome.
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8 .5  Discussion a n d  conclusions
The duration of illness is determined by a constellation of factors, which may be 
assumed to include characteristics of the original infection (dose, pathogenicity 
etc.), characteristics of the host, and characteristics of the child’s environment 
during convalescence (many of which may be deliberately manipulated by the 
child’s carers). Although it is known that persistent diarrhoea (of longer than 
14 days’ duration) constitutes a major threat to the young child (WHO, 1988), 
little attention has been devoted to the search for correlates of episode duration. 
Even less is known about the durations of other common illnesses of childhood.
A ‘natural choice’ model for the analysis of duration data would appear to be 
some kind of failure-time model. These models allow statements about relative 
recovery rates in different population sub-groups (or, equivalently, mean 
durations). They also enable information about episodes whose duration is 
censored to be included in the analysis, which may be important if a substantial 
number of episodes have been censored. In the Lima example, the best fit is 
given by the Weibull model: the shape parameter of this model (sigma < 1) 
indicates that the longer the disease has already been established, the greater the 
probability of recovery in the next tim e period. This may reflect a build-up of 
the immune response in the host, or perhaps increasingly strenuous attempts to 
combat the illness with external interventions. Exponential models, which 
assume - unrealistically - a constant rate of recovery with no memory of how 
long the disease has already been established, also appear, however, to give a 
reasonably good fit to the data, and to yield very similar estimates of covariate 
effects. They can be fitted easily w ith standard statistical software, but the 
efficiency of the estimates is somewhat reduced by the use of this approximation: 
in the Lima example, standard errors were increased by between 23-28% 
compared to the more adequate W eibull model. If censoring is not a problem,
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a less ‘technical’ analysis would consist of transforming the duration data to a 
logarithmic scale, and conducting the analysis using linear regression. The output 
from this analysis is not directly comparable to that of the other models, for 
reasons described above in Section 8.3, and is liable to give exaggerated estimates 
of the precision of covariate effects when complete stabilisation of variances is 
not achieved.
Perhaps unexpectedly, there does not appear to be any within-subject correlation 
in the duration data examined in this section. For the statistician, this implies 
that standard regression techniques are likely to give satisfactory results, and 
sophisticated corrections do not need to be applied. For the epidemiologist, 
these findings are of the utmost importance: they imply that the determinants 
of disease duration must be sought in the particular circumstances of each 
episode, rather than in fixed characteristics of the child. It might have been 
expected that ‘frail’ children who are highly susceptible to new infections would 
also exhibit the least adequate response to those infections. However, this does 
not appear to be the case: there is no correlation in the Lima data set between 
the total number of diarrhoea episodes experienced over the two-year period, and 
the average duration of those episodes (r«.08). Since the determinants of 
duration must be sought at the level of the individual episode rather than at the 
level of the child, it would be inappropriate and highly wasteful of information 
to undertake analyses based on a summary measure of the average duration of 
episodes for each child. As yet, little is known about the episode-specific 
determinants of episode duration, but since it is known that occurrence of 
diarrhoea episodes of unusually long duration is particularly dangerous for young 
children, further work on this topic is indicated.
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Table 8.1 The effect of age and sex on diarrhoeaduration (exponential regression)
P SE(0) Ratio of means
Hazard
Ratios
Constant 1.50 0.040 VO 0.22*
Age (months)
0-2 -
3-5 -0.36 0.049 0.70 1.43
6-11 -0.35 0.046 0.70 1.43
12-35 -0.48 0.041 0.62 1.62
36 + -0.56 0.042 0.57 1.75
Sex
Male -
Female 1 o o 00 0.016 0.93 1.08
t Mean duration in the baseline group 
§ Baseline hazard rate
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Table 8.2 The effect of age and sex onduration (exponential, Weibullregression)
diarrhoea 
and Cox
Exponential Weibull Cox Proportional 
Hazard
ß SE(/3) ß SE(/3) ß SE(0)
Constant 1.50 0.040 1.58 0.032 -
Age (months)
0-2 -
3-5 -0.36 0.049 -0.34 0.039 0.31 0.049 !
6-11 -0.35 0.046 -0.36 0.036 0.29 0.046
12-35 -0.48 0.041 -0.49 0.032 0.39 0.041
36 + -0.56 0.042 -0.57 0.033 0.46 0.042
Sex
Male -
Female GOOO1 0.016 1 o o 00 0.013 0.06 0.016
Sigma - 0.791 -
Model x2 264.2 4 52.5 169.8
t Not directly comparable with model x2 from parametric models
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Table 8.3 The effect of age and sex on diarrhoea
duration (linear regression using log-
transformed duration data)
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Table 8.4 The effect of age and sex on diarrhoea 
duration (exponential regression with and 
without a correction for within-child correlation)
Exponential regression Exponential regression j using ML3 |
0 SE(0) 0 SE(/3) j
Constant 1.50 0.040 1 H * * 0.041
Age (months)0-2 - -3-5 -0.36 0.049 0.38 0.0496-11 -0.35 0.046 0.36 0.046 112-35 -0.48 0.041 0.49 0.041 i36 + -0.56 0.042 0.58 0.042
SexMale - - -Female GOOO• 0.016 0.07 0.023
Within-child variance component....... 1.000
Between-child variance component...... 0.037
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Figure 8.1 Lima Rotavirus Vaccine Trial - 
Frequency distribution of duration of diarrhoea episodes
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Figure 8.2 Actual and expected values (Savage 
s c o r e s , based on exponential 
distribution) of duration data in the Lima data set
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1SB92 cases plotted. Regression statistics of SAVDUR on DURAT:
Correlation .98754 R Squared .97523 Intercept(S .E.) -1.04639( .00176) S.E. of Est Slope(S.E.) .14846 Siq. .0000.40451( .00051)
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C h a p t e r  9  Summary, conclusions 
and recommendations
In this chapter, the findings of this thesis are brought together and summarised. 
Each specific objective described in Section 1.4 is considered in turn.
9 .1  O utcom e measures in longitudinal studies o f common diseases o f  
childhood
Many different outcome measures may be calculated using the data collected in 
longitudinal studies of common diseases of childhood. These different outcome 
measures provide descriptions of disease onset, or incidence; of disease status, or 
prevalence, and of disease duration. In some studies, all three aspects of disease 
frequency in the population will be of interest; in others, the scientific 
hypotheses driving the study will naturally suggest a more specific focus on one 
or other. The choice of primary outcome should generally be made before the 
data collection phase of any study begins, and is usually based on biological or 
clinical considerations.
In this thesis, considerable emphasis has been given to  questions relating to the 
analysis of disease I N C I D E N C E .  This is because this information is uniquely 
obtained from intensive, home-based, prospective studies, whereas cross-sectional 
studies are able to provide information on disease prevalence and duration. Two 
distinct measures of disease incidence are recognised: the first of these is the risk 
of any given individual experiencing one or more episodes of disease over a 
defined period of time, and the second is the instantaneous rate of illness, or 
force of morbidity. Risk is usually estimated by the calculation of a measure 
termed cumulative incidence, the proportion of individuals entering a study who 
experience disease within a specific time period. Strictly, this approximation is
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only valid for a fixed cohort design with no attrition. It may be biased as a 
measure of individual risk when levels of attrition from the initial cohort are 
high, or when a dynamic cohort design is employed. Furthermore, it is wasteful 
of information, since all information on non-initial episodes is discarded. The 
related epidemiological measure of association, the cumulative incidence ratio, has 
the undesirable property of rapidly approaching unity as the time referent 
increases. For all these reasons, the alternative approach to illness incidence, 
focusing on the instantaneous rate of illness, is to be preferred.
The incidence density rate is composed of two elements: in the numerator, the 
number of disease episodes experienced by a child, or group of children; and in 
the denominator, the number of time periods of observation. In Chapter 3, the 
issue of how to define an ‘episode’ of a common illness such as diarrhoea was 
considered, in the light of the observation that where diarrhoea is common, it 
is theoretically possible for a child to experience two aetiologically distinct bouts 
of illness separated by just one or two days without illness, so that it could 
appear that only one protracted bout was experienced. On the other hand, some 
longer episodes of diarrhoea might genuinely be interrupted by a day or two 
with milder or even inapparent symptoms. A simulation model was used to 
develop a pragmatic algorithm for determining how many days without 
symptoms of illness should be required to elapse in order to define the start of 
a ‘new’ episode.
The model demonstrated that, with a high incidence of ‘trigger events’ (events 
provoking clinical symptoms of illness in the immediately ensuing period) and 
clustering of diarrhoeal illness in a subset of high-risk children, many periods of 
diarrhoea resulting from genuinely distinct trigger events are separated from each 
other by intervals of just a few days. On the other hand, where there is no 
clustering and a relatively low incidence of trigger events, only around 5% of all 
periods of diarrhoea would be preceded by three or less symptom-free days.
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Thus, a definition in which two or three symptom-free days are considered 
sufficient to mark the beginning of a ‘new’ episode of diarrhoea is recommended, 
with a preference for the two-day definition in areas where the incidence rate is 
high and/or there is considerable clustering of illness in a small sub-group of 
children.
With respect to the person-time denominator of incidence rates, two alternative 
strategies were considered in Section 4.1: either the total number of new cases 
may be divided by the total person-time under observation, giving an estimate 
of the incidence of observed episodes, or else the total number of new cases 
may be divided by the total person-time under observation, minus the summed 
duration of illness, and minus the summed duration of the symptom-free 
intervals required to define a new episode. This procedure leads to an estimate 
of the true incidence of trigger events. The first of these two options is to be 
preferred: firstly, because the latter approach w ill underestimate the true 
incidence of trigger events if ever the durations of symptoms associated with 
consecutive trigger events overlap; secondly, because this approach is inconsistent 
with the options available for the analysis of episode duration, which must focus 
on observed durations rather than on the duration of symptoms associated with 
each trigger event; and thirdly, because the trigger event approach is one step 
removed from the experience of the child, in that the incidence rate no longer 
tells us the number of bouts of illness actually experienced, with all the 
physiological consequences that these m ay entail.
With respect to illness P R E V A L E N C E , three alternative outcome measures were 
considered in Chapter 7. Firstly, the proportion of individuals suffering from 
a particular complaint can be calculated separately for each time point at which 
observations were made (the classic measure of prevalence, but estimated 
repeatedly). The resulting figures can be treated as a time series, and may be of 
great interest in describing changes in the community burden of morbidity over
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time. Secondly, it is possible to calculate the proportion of time that each 
individual spends ill with a particular symptom over a defined period of time. 
This measure is not prevalence as classically defined, but is conceptually similar; 
it has been termed ‘episodic prevalence’ (Kleinbaum et al., 1982). This measure 
may be a good indicator of ‘frailty’, both because those individuals who 
experience high episodic prevalences of common diseases must have been in some 
way particularly ‘susceptible’ at the onset of the observation period, and because 
the experience of high episodic prevalences of disease is likely to lead to 
aggravated nutritional status and impaired immune function in the future.
A third possible measure of prevalence is what I have termed ‘block prevalence’: 
this is simply the sum of all the days on which a particular symptom was 
reported divided by the sum of all the days of observation. ‘Block prevalence’ 
is neither a simple average of the time series point prevalences, nor of the 
episodic prevalences, and is a rather unsatisfactory measure unless it can be 
assumed that the point prevalence of the symptom has not changed significantly 
over the observation period. Furthermore, because individual days of 
illness/health are strongly correlated within any particular individual, the 
variance of this measure is grossly underestimated if calculated using standard 
binomial theory.
DURATION is probably the simplest outcome measure to define, once the 
definition of an episode has been arrived at. Its calculation in longitudinal studies 
of common diseases of childhood presents no special difficulties, except for the 
fact that a significant proportion of episodes may be ‘censored’, because 
observation was interrupted before the illness finally resolved (it is also possible 
for episodes to be censored because observation began with the episode already 
in course).
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In Section 5.2, it was demonstrated that longitudinal studies on common diseases 
of childhood differ from cross-sectional studies because the outcome measure 
varies across two dimensions: not only from one study subject to another, but 
also within subjects from one time period to the next. It was shown that within 
individuals, the time-to-time variability in disease incidence is well approximated 
by the familiar Poisson model, which implies random occurrence of trigger 
events in time. However, the underlying rates of illness differ greatly from one 
individual to another. This excess of variation in disease incidence from one 
individual to another, which is referred to as over-dispersion, is partly a 
consequence of fixed, individual-level characteristics, such as genetic constitution 
and socio-economic status. However, a large part of the total between-individual 
heterogeneity cannot be explained, either because the relevant individual-level 
characteristics are known but intrinsically unmeasurable, or because they are 
simply not known.
The principal effect of this heterogeneity in individuals’ underlying propensity 
to illness is that disease rates measured at different points in time on the same 
individual w ill tend to be more similar than disease rates measured at the same 
time on different individuals. That is to say, there is within-subject correlation 
between disease incidence rates in different periods of time. This correlation has 
the effect of leading to the underestimation of the standard errors of covariate 
effects, such that the statistical significance of these effects is likely to be 
exaggerated. Furthermore, in the case of categorical outcome measures, the effect 
estimates themselves are liable to be biased when within-subject correlations are 
ignored.
9.2  Statistical features o f  longitudinal data on com m on diseases o f
childhood
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In Section 6.2, it was shown that this within-subject correlation can easily be 
detected when examining diarrhoea incidence rates in thirteen consecutive one- 
month periods in young children in northern Ghana. Adjusted correlations of 
between .11 and .31 are observed for pairs of observations measured on the same 
individual. In Section 7.4, it was shown that even higher correlations are 
obtained when disease status is compared over consecutive periods, with a child 
with cough yesterday 360 times more likely to have cough today than a child 
without cough yesterday (Ghana VAST Child Health Study). In Section 8.4, 
however, it was shown that in young children in Lima, there is no within-subject 
correlation in the duration of diarrhoea episodes.
9 .3  R ecent advances in statistical theory relevant to the analysis o f  
correlated, categorical outcomes
Several new techniques for the analysis of correlated, categorical outcomes have 
been developed in recent years. These were reviewed in Section 5.3. These 
techniques are, for the most part, fairly general, and can be applied to the 
analysis of any of disease onset, status or duration.
The first approach to be reviewed was the family of conditional models, widely 
favoured in econometrics. These models permit the estimation of the probability 
of a particular health outcome at time t, conditional on the value observed for 
the same outcome on the same individual at time t-1. This translates into 
research questions such as "Does the frequency of reported wheezing in children 
free of wheezing a year earlier vary according to the age of the child?", a rather 
different kind of question from the more usual type of enquiry about population- 
averaged associations between disease status and risk factors. Nonetheless, a 
considerable amount of experience with this type of model has already amassed 
in the field of environmental risk factors for respiratory infections. These studies
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have, however, all used continuous response variables, so that the models can be 
seen basically as extensions of classical multiple linear regression. There is far 
less experience of modelling categorical outcomes in this manner. A promising 
approach has been developed by Bonney (1987), discussed in Section 7.4.1. These 
models require no special computer software, but can be difficult to fit, and 
require uncomfortable assumptions about the stationarity of transition 
probabilities over time.
The second class of models to be examined were ‘multi-level models’, developed 
primarily in the field of education, and only recently beginning to diffuse into 
other areas of research. These models offer perhaps the most radical departure 
from traditional approaches, since they estimate ‘components of variability’ in 
addition to the familiar fixed covariate effects. The models are extraordinarily 
flexible, in that both intercept terms and effect parameters can be allowed to vary 
at the level of the individual, any structure of covariances can be allowed for, and 
important risk factors can be modelled at either, or both of the occasion-specific 
or the individual levels. Unfortunately, as a result of the flexibility of these 
models, it is often difficult to decide how any particular model should be set up, 
and the model output is difficult to interpret. The available software is far from 
user-friendly, and is known to contain a number of bugs (currently being 
rectified) in the routines for analysing categorical outcomes. The models also 
involve crucial assumptions which are difficult to assess other than by analysis 
of residuals, which can apparently take up to 24 hours to calculate on a standard 
micro-computer (John Rasbash, personal communication)!
The third set of models to be examined in this section was the extensive family 
of marginal models. The fully parametric formulations, such as negative 
binomial regression modelling, have the great disadvantage that only child-level 
(as opposed to occasion-specific) covariates can be modelled. A much more 
promising development has been the derivation of so-called ‘Generalised
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Estimating Equations’ based on quasi-likelihood theory, which yield ‘ robust’ 
estimates of covariate effects and their variances in the presence of correlation. 
These models are implemented in a special macro written for the widely-used, 
but not very user-friendly, analysis package SAS; alternatively, they can be 
implemented in the newer, and considerably more straightforward modelling 
package SPIDA. Although the user is required to state as one of the model 
inputs exactly what the correlation structure of the response variable is expected 
to be, the model is robust to mis-specification of this parameter. The output 
looks much like what would be obtained from any standard linear model; an 
estimate of the working correlation matrix is also obtained. Unfortunately, there 
is no facility for robust hypothesis testing, although a best-fit model selection 
option is available in SPIDA.
In Section 5.5, these three approaches to modelling correlated, categorical data 
were compared and contrasted using a set of five standard criteria proposed in 
Section 1.5.1. These criteria are based on the applicability of the modelling 
method to practical epidemiological problems, and the viability of obtaining the 
required inputs, as well as on the technical properties of the resulting estimators, 
and the potential for popularisation of the model. This last criterion is judged 
on the basis of its general ‘user-friendliness’, and the amount of learning tim e and 
computer resources that would be necessary to start working with it . The 
Generalised Estimating Equations approach was most favourably evaluated on the 
basis of these criteria.
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In Section 5.4, a review of current practice in the analysis of longitudinal studies 
of common diseases of childhood was carried out, taking as a case-study 19 
studies of the efficacy of potential new vaccines against rotavirus diarrhoea. It 
was apparent from this review that most epidemiologists working on longitudinal 
studies of common diseases in the field are unfamiliar with the statistical 
peculiarities of the data they are working with. In their analyses of the effects 
of the new vaccines on rotavirus-specific illness, 13 of the 19 studies avoided the 
issue of multiple episodes altogether, by analysing only cumulative incidence. Of 
the remaining six studies, one presented no data at all on the frequency of 
rotavirus-related illness, and two used an unspecified chi-squared type test to 
compare illness rates in the two treatment groups. Chi-squared tests take no 
account of correlation in the outcome, and are thus liable to overstate the 
precision of treatment group comparisons. In the three other studies where an 
attempt was made to incorporate information on clustering of disease, the 
methods adopted were unsuitable - either because they were premised on 
assumptions which were visibly violated, or because they were essentially 
techniques for significance testing, not permitting the estimation of 
epidemiological measures of effect. Over half of the 19 studies did not even 
attempt to assess the impact of rotavirus vaccine on all-cause diarrhoea, or else 
did not specify the analytic technique used.
Very few studies of common diseases of childhood could be located in which 
disease prevalence was analysed in detail. This presumably reflects the fact that 
longitudinal studies are generally set up with the aim of estimating incidence 
rates. On the other hand, several studies were identified in which the episodic 
prevalence of diarrhoea, or respiratory illness, was examined as a possible
9.4 C u rren t practice in  the analysis o f longitudinal studies o f  com m on
diseases o f childhood
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determinant of growth or attained anthropometric status (Section 7.2). Detailed 
analyses of illness duration were also found to be uncommon in longitudinal 
studies of common diseases of childhood; in Section 8.1, however, it was shown 
that in clinical trials, which more frequently have disease duration as a primary 
outcome, analytic methods such as analysis of variance or multiple linear 
regression, are almost invariably used. These methods take no account of the 
censoring, inequality of variances, and possible within-subject correlation which 
may characterise data of this type.
9 .5  To what degree does the application o f  traditional methods lead to 
inappropriate conclusions being draw n from  the d a ta ?
In Section 6.2, it was shown that ignoring within-subject correlation in the 
analysis of the incidence of common diseases of childhood is likely to lead to 
serious underestimation of the magnitude of the standard errors of covariate 
effects. In the example of diarrhoea incidence in young children in northern 
Ghana, these standard errors were between 1% and 73% larger (median 34% 
larger) when estimated by a technique accounting for within,-subject correlation 
than when this correlation was ignored. Several of the covariate effect would 
have been deemed ‘significant’ on the basis of the ‘naive’ standard errors, but 
non-significant when correlation was taken into account. In the same section, 
it was shown that the effect estimates themselves were only minimally affected 
by assumptions about the presence and structure of within-subject correlation in 
the outcome.
In Section 7.4, it was shown that consecutive days of illness/health measured on 
the same individual are even more highly correlated than disease incidence in 
consecutive time-bands. It was suggested in this chapter that the level of within- 
subject correlation in daily disease prevalence is so high, that any attempt to
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model within-subject variability in daily disease status is probably inappropriate. 
An approach based on a single measure for each individual was therefore 
recommended.
In Section 8.3, it was shown that ignoring censoring of duration data will 
generally lead to bias in the estimation of summary statistics. In the data used, 
however, only 5% of all episodes were censored, and the magnitude of the bias 
in the estimate of mean duration was correspondingly small (5-7%). It was also 
shown in the same section, that even when duration data were transformed to 
a log scale, sub-group differences in the variance of the outcome measure were 
sufficiently large to lead to difficulties with traditional techniques such as linear 
regression; specifically, the standard errors of covariate effects were 
underestimated by up to approximately 15%. It was found that Cox’ 
proportional hazards regression, a popular method for analysing time-to-event 
data, gave a significantly poorer fit to the data than fully parametric techniques 
such as exponential or Weibull regression.
9 .6  A ppropriate data-handling strategies
Any analysis of longitudinal data on common diseases of childhood is contingent 
on the data first being arranged in a manner which permits the appropriate 
manipulation. This was discussed in Section 2.2.6. Essentially, an arrangement 
in which each child-day of illness/health is represented by a separate record in 
the data file favours the calculation of prevalence-type measures, and considerably 
reduces the amount of programming that must be done prior to statistical 
analysis. This arrangement is recommended for small to moderately large data 
sets (say, up to 100,000 child-days of observation), especially when the focus of 
the analysis is on prevalence-type outcomes. The alternative arrangement, in 
which all the days of illness/health for a particular individual are concatenated
221
in a single string variable, facilitates visual inspection of the data and is more 
appropriate for the calculation of episodes, but requires considerable amounts of 
programming in a programming language such as Basic. It is recommended for 
very large data sets.
Various measures are recommended to ensure high data quality. In the computer 
centre, duplicate data entry, as well as the regular checking of variable ranges and 
internal consistency is essential to eliminate typographic or recording errors. 
W ith longitudinal data, serial consistency must also be checked on variables 
which change slowly over time, such as height. Ongoing tabulation by 
individual fieldworker of results such as the distribution of measured breathing 
rates or body temperature is a powerful quality control approach.
9 .7  Appropriate analytic strategy
9 .7 .1  The analysis o f  disease incidence
The choice of appropriate analytic strategy for the analysis of disease incidence 
depends on two factors: the frequency with which individuals experience the 
outcome of interest, and the type of covariate which this outcome is being 
related to. The following steps are recommended:
i. List the covariates which are to be related to the outcome of interest. 
Classify the covariates according to the following scheme: (A) covariates 
which do not change with time or age, such as socio-economic status, (B) 
covariates which evolve slowly with time o r age, such as stunting, (C) 
covariates which evolve rapidly with time or age, such as breastfeeding 
status, and (D) covariates which change extremely rapidly from one time 
point to the next, such as air pollution levels.
222
ii. If the covariates are all of type (A), then each child’s entire morbidity 
experience can be treated as a single observation. Standard Poisson 
regression may be used, with one record for each child, and the response 
variable set equal to the number of incident episodes over the observation 
period. To allow for unequal periods of observation, an offset term is 
introduced, equal to the logarithm of the time under observation. 
Consideration should be given to the possibility that children with very 
short observation periods (say, less than half the total observation time) 
may be in some respect unrepresentative of the study population. This 
can be checked by running a separate model with only these children, and 
comparing the estimated covariate effects with those estimated on the basis 
of children with more complete follow-up. If there are strong a priori 
reasons for believing that these children are different from the others, they 
may be excluded from the analysis. If, on the other hand, they differ only 
because of seasonal factors and/or age structure, the total observation 
period should be divided into shorter bands, and the analysis proceed as 
in (iii) below.
Model selection may proceed as normal, either by a structured 
(hierarchical) sequential entry of covariates, or by a procedure based on 
statistical criteria, such as stepwise inclusion/deletion of covariates. When 
a final model has been arrived at, a correction must be made to the 
estimated standard errors, to allow for over-dispersion. A simple 
correction factor is given by multiplying each standard error by the square 
root of (the residual deviance divided by its degrees of freedom). If a 
scaling procedure is available in the software being used, a further stage of 
model refinement is then possible, removing all non-significant variables. 
Very similar results w ill be obtained by using negative binomial regression 
instead of Poisson regression; in this case, no correction factor is required.
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iii. If some of the covariates are of type (B) or (C), a more complex approach 
is required because of the necessity of resetting the A G E  variable at various 
points during the course of the observation period. The morbidity 
experience of each child must be divided into a number of smaller bands, 
preferably of a fixed length. The exact length needs to be determined 
with reference to the type of covariate being modelled and the data 
collection system used - the objective is to keep the bands reasonably long 
without leading to any serious misclassification of exposure. This 
probably means bands of length 4-6 months for covariates of type (B), and 
bands of length 1-2 months for covariates of type (C). These lengths were 
estimated on the basis of the diarrhoea data from the Ghana VAST data 
set. Longer bands might be appropriate for rarer disease outcomes.
If the bands are short (type C), individuals with even a short period of 
missing data may be excluded from the calculations relating to the bands 
with incomplete information. Thus, all the bands are of equal length, and 
no offset term is required. If the bands are longer (type B), it is preferable 
to include individuals absent for up to half the duration of the band, and 
include an offset term.
Initial model selection is best done using Poisson regression in a user- 
friendly application. Since significance levels are exaggerated using this 
technique, only variables which are definitely non-significant w ill be 
eliminated from the model using this approach. A G E  and S E A S O N A L I T Y  
must usually be retained in the model to guard against potential 
confounding. Final model fitting should be done using the Generalised 
Estimating Equation approach, w ith  a log link and variance proportional 
to the mean. Exchangeable correlation may be assumed, and the ‘robust’ 
standard errors are used for the calculation of P-values.
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iv. If the analysis is of covariates of type (D), consider whether it is the 
child’s exposure status at time t which determines his/her health status 
over the following interval, or whether it is the proportion of time that 
s/he spends in any given state which is important. If the latter is the case, 
then the relevant new covariates should be calculated, and the analysis 
proceeds as in (A), (B) or (C). If the former is the case, then conditional 
models should be used.
9.7.2 The analysis o f disease prevalence
The choice of analysis strategy for the analysis of disease prevalence again
depends on the type of covariate which is being related to the disease outcome.
The following strategies are recommended:
i. Where the major covariate of interest changes extremely rapidly with 
time, and the focus of interest is on changes in the disease status, 
conditional models are recommended. These models relate the 
probability of having disease on day t to a series of covariates, conditional 
on the same individual’s known disease status on day t-1. The models can 
be implemented using standard logistic regression techniques, coding 
disease status on day t (the outcome) as 1 - present, 0 - absent, and disease 
status on day t-1 as 1 —present, -1 —absent. Other measures of between- 
child heterogeneity, such as the number of days experienced with illness 
since the first day of follow-up, and/or the number of days experienced 
without illness since the first day of follow-up can also be included in the 
model, but are not essential. With many children and/or many days of 
follow-up, these data sets required for these models become extremely 
large and unwieldy.
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ii. In other circumstances, it is recommended that analysis is based on the 
measure of ‘episodic prevalence’. The distribution of episodic prevalences 
is conveniently shown using a histogram. Differences between two or 
more groups can be simply demonstrated by graphical methods 
(histogram), or by dividing the distribution into a number of intervals and 
applying a chi-squared test for trend.
Regression modelling is also possible by taking a logarithmic 
transformation of the episodic prevalences and using standard multiple 
linear regression. When follow-up times are very unequal, a weighting 
system should be employed - the optimum weighting system is not 
known, but the number of days observed divided by the maximum 
possible number of days of observation is suggested. The period of 
observation may be divided into several shorter blocks if the inclusion of 
time-dependent covariates is desired. In this case, the use of Generalised 
Estimating Equations instead of standard multiple linear regression will 
ensure that any within-subject correlation was adequately accounted for; 
in the data examined, however, the use of standard multiple linear 
regression techniques appeared to give very similar estimates.
9 .7 .3  The analysis o f disease duration
Both parametric Weibull regression, and non-parametric Cox Proportional
Hazards regression may be recommended for the analysis of duration data.
Weibull Regression:
In this approach, the outcome measure is duration (however measured), 
and an indicator variable marks the duration as known or censored. The 
output consists of estimated regression coefficients for differences in mean 
recovery time - since these are calculated on a logarithmic scale, they may
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in fact be interpreted as ratio measures. The model can be implemented 
in statistical packages such as STATA or MINITAB.
Cox Proportional Hazards Regression:
The ratio of hazard rates in exposed and non-exposed groups is modelled
Two ‘second-best’ approaches may be used when neither of the above is feasible:
Exponential regression, which can be implemented as a special form of 
Poisson regression by setting the response variable to 1 when the duration 
is known and 0 when it is censored, and treating logfduration) as an offset 
term, gives essentially the same coefficient estimates as Weibull regression, 
but with greater standard errors, due to the poorer fit of the model.
Multiple linear regression, using the log-transformed duration data as the 
outcome variable, is liable to exaggerate the precision of the regression 
coefficients when the logarithmic transformation is not adequate to 
stabilise the variances between groups. This was the case in the data 
examined in this thesis.
9 .8  Further research needs fo r  the second h a lf o f  the 1990s
Much of the material presented in this thesis has necessarily been exploratory 
work based on just one - or at the most, two - data sets. There is no doubt that 
confirmation of the repeatability of the findings presented in these pages would 
be of great benefit. This is particularly true, for example, of the discussion of the 
analysis of data on disease duration, where a strong recommendation was made 
in favour of the use of a particular parametric model (the Weibull model), based 
on a single illustrative analysis. This lack of comparative data has not
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constrained the development of unambiguous guidelines in this respect, for the 
simple reason that it is clear that a move towards the use of the Weibull model 
could only be an improvement on the range of analytic strategies currently 
favoured in the epidemiological literature! It is expected, however, that the 
availability of other comparative material in the future will enrich and strengthen 
these guidelines further.
Experimentation w ith a greater range of outcome measures, and discussion of 
their relative merits, would also be of considerable benefit. Only very few 
investigators (Pickering and co-workers, 1987, being a notable example) have 
examined the impact of different choices of outcome measures on conclusions 
about which are the external factors which pre-dispose to disease in young 
children. The continued wide use of a measure of prevalence - ‘block prevalence’
- which is fraught with statistical difficulties, demonstrates vividly the urgent 
need for a wider discussion of these issues.
On the theoretical statistical side also, a number of important gaps have been 
identified: the absence of a procedure for robust hypothesis testing in the 
Generalised Estimating Equations approach is one of these, and the lack of 
adequate documentation of the underlying assumptions (and implications of 
violating these assumptions) of the multi-level modelling strategy is another. 
User-friendly fronts for both these techniques are required. A clear, non­
technical discussion of appropriate weighting strategies when subjects are 
followed up for differing lengths of time is urgently required, as is further work 
on the implications of missing data (an area not covered in this thesis).
It is clear that longitudinal studies of common diseases of childhood will be more 
popular than ever in  the second half of the 1990s. It is only to be hoped that the 
methods for their analysis enjoy a similar burst of interest, so that the benefits 
that they promise can be enjoyed by all.
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